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ABSTRACT 
 
Cornea is the clear outermost protective layer of the eye which enables transmission of light 
onto the retina. The corneal epithelium is regenerated by limbal stem cells (LSCs), whose 
loss/dysfunction results in limbal stem cell deficiency (LSCD). Transplantations of ex vivo 
expanded autologous LSCs from patient’s healthy eye onto the affected eye have provided a 
successful treatment for unilateral LSCD. This however is not applicable to patient with total 
bilateral LSCD, whose both eyes are affected. This thesis investigated the potential of human 
induced-pluripotent stem cell (hiPSCs) to differentiate into corneal epithelial-like cells as a 
source of autologous stem cell treatment for patients with total bilateral LSCD, and tested the 
engraftment of the differentiated cells in LSCD mouse model. Combined addition of bone 
morphogenetic protein 4 (BMP4), all trans-retinoic acid (RA) and epidermal growth factor 
(EGF) for the first nine days of differentiation followed by cell-replating on collagen-IV coated 
surfaces with a corneal-specific-epithelial cell media for an additional 11 days, resulted in step 
wise differentiation of human embryonic stem cells (hESCs) to corneal epithelial progenitors 
and mature corneal epithelial-like cells. Differences in the ability of hiPSCs lines to undergo 
differentiation to corneal epithelial-like cells were observed. These were dependent on the level 
of endogenous BMP signalling and could be restored via activation of this signalling pathway 
by a specific TGFβ inhibitor (SB431542). The hESC and hiPSCs-derived corneal epithelial 
cells were transplanted into a LSCD mouse model where they survived up to 14 days, but failed 
to provide long term engraftment and corneal surface regeneration. The findings showed a 
differential ability of hESCs and hiPSCs lines to generate corneal epithelial cells which is 
underlined by the endogenous BMP signalling pathway activity. However, the engraftment and 
functionality of the differentiated cells in the LSCD animal model has yet to be improved. 
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CHAPTER 1. INTRODUCTION 
 
1.1 Limbal Stem Cell Deficiency (LSCD) 
LSCD is a disease or condition caused by the loss or dysfunction of LSCs and the failure of 
limbus barrier function (Ahmad et al. 2010), leading to the loss of corneal epithelial integrity 
and function, resulting in neovascularisation, persistent pain and severe visual impairment that 
could progress to blindness (Holmes 2017) (Figure 1.1). Corneal blindness is the fourth leading 
cause (5.1%) of blindness and a major cause of visual impairment worldwide (Resnikoff et al. 
2004, https://www.seeintl.org/corneal-blindness/). In the United Kingdom alone, it is estimated 
that 2.7 million people will be affected by sight loss by 2030, and LSCD is one of the 
contributing conditions that caused the poor vision (http://www.rnib.org.uk/nb-online/eye-
health-statistics, The State of the Nation: Eye Health 2016). 
 
In a case such as a severe trauma, the damage to LSCs niche will tip-off the balance in the 
growth/differentiation/survival factors as well as the changes in environment will trigger the 
undamaged LSCs to differentiate into early TACs. This or any events that will reduce the LSCs 
in the site of trauma or disrupt the maintenance of growth and survival factors may result in 
LSCs deficiency (LSCD) (Stepp and Zieske 2005). LSCD can be classified into diffuse or 
partial and unilateral or bilateral, depending on the extent of limbal involvement (Lal et al. 
2016).  
 
 
Figure 1.1 : Bilateral limbal stem cells deficiency, before treatment (A), and after 
treatment (B). Photos reproduced from online source at http://www.osref.org/medical-
education-materials/limbal-stem-cell-deficiency-amt.aspx. 
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Partial LSCD affects only a section of limbus in an eye and the other region is spared, unlike 
diffuse LSCD that affect entire limbal are of the eye. Unilateral LSCD is affecting only one eye 
and the other eye is healthy, whilst both eyes are affected in bilateral LSCD (Dua et al. 2000). 
The healthy eye in partial or unilateral condition will be the main and best source for the 
treatment of LSCD affected eye. Bilateral total LSCD such as in Stevens-Johnson syndrome 
(SJS) patients could cause ocular surface diseases that lead to bilateral blindness (Gomes et al. 
2003). Unlike in partial or unilateral LSCD, patients with bilateral total LSCD have both their 
eyes devoid of LSCs needed for ex vivo expansion that could subsequently used for 
transplantation (Osei-Bempong et al. 2013).  
 
1.1.1 Causes of LSCD 
The visual impairments resulted from LSCD alone has many common contributing factors. 
Those contributing factors could be classified into primary; related to hereditary and congenital 
abnormalities such as aniridia  and epidermal dysplasia, secondary; that includes acquired 
factors from external environment that destroy and unable to nurture the LSCs such as 
chemical/thermal burns, multiple surgeries, Stevens-Johnson syndrome (SJS), ocular cicatricial 
pemphigoid, and idiopathic; where the exact cause of LSCD is unknown such as contact lens 
use and malignancy (Pfister 1994, Dua et al. 2000, Sevim and Acar 2013, Lal et al. 2016). The 
above factors will result in the LSCs niche destruction that in turn causes limbal dysfunction. 
 
1.1.2 Symptoms and diagnosis of LSCD 
Patients with LSCD might experience chronic eye inflammation and redness, tearing, decreased 
vision, photophobia and recurrent pain, present with varied corneal epithelium thickness and 
transparency. Those patients might also develop ingrowth of thickened fibro-vascular pannus, 
chronic keratitis, scarring and calcification as well as perforation of the cornea (Huang and 
Tseng 1991, Chen and Tseng 1991, Dua et al. 2000). The diagnosis of LSCD is mainly based 
on the patients’ symptoms and clinical signs (such as stated above) whilst the management 
plans are crucially depending on its diagnosis. Impression cytology, immune-histochemical 
assessment and in vivo confocal microscopy of the corneal surface could then be performed to 
confirm the diagnosis of LSCD. Those techniques will allow detection of mucin containing 
conjunctival goblet cells on the corneal surface rather than the normal CK3 expressing corneal 
epithelium as well as the presence of inflammatory cells (Egbert et al. 1977, Kenyon et al. 1990, 
Araújo et al. 2013).   
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1.1.3 Management of LSCD 
Inflammation of the ocular surface is a common condition accompanying LSCD at its acute 
stage. It is important to control the inflammatory reactions on the eye using local or systemic 
immune-modulation to restore the limbal microenvironment before advancing to more 
specialised treatment such as corneal transplant (Lal et al. 2016).  Managements of LSD in 
general range from conservative to invasive treatment depending on the LSCD severity. 
Various studies have also significantly contributed   to the development of new conservative as 
well as surgical treatments of LSCD (Haagdorens et al. 2016). 
 
Conservative management can be applied to partial LSCD where the visual axis is not affected. 
The conservative treatment could range from the use of amniotic membrane patch, bandage 
contact lenses, topical lubricant and anti-inflammatory agents to promote corneal and limbal 
re-epithelialisation (Kheirkhah et al. 2008, Romero-Rangel et al. 2000). However, in the case 
of compromised visual axis where the corneal surface is invaded by conjunctival tissue, surgery 
is the treatment of choice. The conjunctival tissue needs to be removed to allow the regrowth 
of corneal epithelium (Dua et al. 1994) and amniotic membrane transplant (AMT) is commonly 
carried out to help the healing process.  
 
Unilateral LSCD that is diffuse needs to be treated surgically by transplantation of LSCs 
following the removal of any fibrovascular tissue or pannus formed. This could be carried out 
by direct keratolimbal autograft or by expanding the autologous LSCs from the healthy other 
eye before transplanting them back into the LSCs deficient eye (e.g: Holoclar) (Shortt et al. 
2007, Kolli et al. 2010, Behaegel at al. 2017). This treatment however is not applicable to a 
significant number of patients with bilateral total LSCD. In contrast, patients with bilateral total 
LSCD have both their eyes affected, thus could only be treated with limbal transplant from 
living related or cadaveric donated corneas i.e. allogeneic transplant. Unfortunately, this type 
of management is becoming harder as there is global shortage of donated cornea for the 
transplant (Gain et al. 2016) and offers poor long-term outcome due to rejection (Bhalekar et 
al. 2013) and failure, as demonstrated in a report of 13 cases with 100% failure after 3 years 
(Shortt et al. 2014). The management strategies for LSCD are summarised in Table 1.1. 
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Acute stage Chronic stage 
Topical 
steroids  
Unilateral partial Unilateral 
diffuse/total 
Bilateral 
partial 
Bilateral 
diffuse/total 
Topical 
lubricants 
AMT 
PK 
Conservative 
management 
Scleral contact lens 
SSCE 
AMT 
CLAU 
CLET 
SLET 
KLAL (one eyed) 
Allo-CLET 
CLET 
Allo-CLET 
KLAL 
CLAL-lr/lnr 
KLAL 
Allo-CLET 
Keratoprosthesis  
PK=penetrating keratoplasty, SSCE=sequential sector conjunctival epitheliectomy, 
AMT=amniotic membrane transplant, CLAU=conjunctival limbal autograft, SLET=simple 
limbal epithelial transplant, CLET=cultivated limbal epithelial tansplant, Allo-
CLET=allogeneic CLET, KLAL=keratolimbal allograft, CLAL-lr/lnr=conjunctival limbal 
allograft-live related/nonrelated 
Table 1.1 : Strategies of LSCD management. Adapted from Lal et al. 2016. 
While other autologous epithelial cell sources were explored for corneal trans-differentiation 
for bilateral total LSCD treatment, oral mucosa epithelium (OME) was found to be one of the 
best sources, as it shares various characteristics with the corneal epithelium (Kolli et al. 2014). 
The surgical procedure that uses OME to treat LSCD is called the cultured oral mucosal 
epithelial transplantation (COMET) (Ma et al. 2009, Eslani et al. 2012). Nishida et al. used 
autologous OME grown on feeder cells for the treatment of bilateral LSCD in 2004. However, 
mild opacity and persistence of blood vessels was still observed in all transplanted corneas at 
13 – 15 months follow up, thus necessitating new scientific and clinical approaches (Nishida et 
al. 2004).  
 
A decade later, Kolli et al. reported successful transplantation of ex vivo expanded autologous 
multi-layered OME using a fully compliant good manufacturing practice, feeder- and animal 
product-free method on two patients with bilateral LSCD (Kolli et al. 2014). Although the 
above mentioned studies reported some degree of patients’ visual improvement during the early 
follow-ups, both teams still observed neovascularisation at later follow-ups. More recent studies 
with longer follow-up durations reported high success rate of LSCD treatment via COMET, 
despite some graft rejection and additional surgery needed post-transplant (Baradaran-Rafii et 
al. 2017, Prabhasawat et al. 2016).  A summary of previous clinical studies that used COMET 
for LSCD treatment is shown in Table 1.2.  
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Reference  Eye diseases / 
conditions treated 
Follow-up 
duration 
Outcome  
Baradaran
-Rafii et al. 
2017 
Bilateral total LSCD 
due to chemical burn 
14 - 40 
months 
Following COMET, the overall and 
rejection-free graft survival rates are 
92.9 and 69.2%, respectively. 13 from 
14 eyes had stable ocular surface 
covered by transparent epithelium 
without significant neovascularization 
Prabhasaw
at et al. 
2016 
Bilateral LSCD 
of any cause 
8 – 50 
months 
14 from 20 eyes (70 %) exhibited 
improvement in visual acuity after 
COMET, and some eyes required 
subsequent cataract surgery, 
penetrating keratoplasty, or 
keratoprosthesis implantation. 
Dobrowol
ski et al. 
2015 
Aniridia patients who 
underwent  
autologous cultivated 
epithelium 
transplantation  
12 – 18 
months 
At the end, 76.4% of the eyes had 
regular transparent epithelium and 
23.5% had developed epithelial defects 
or central corneal haze; in 88.2% of 
cases visual acuity had increased. (13 
patients; 17 eyes) 
Gaddipati 
et al. 2014 
Alkali burn-induced 
bilateral total LSCD 
11 to 13 
months 
Transplanted OME cells survived and 
reconstructed the ocular surface, 
transformed into stratified epithelium 
with vasculatures and acquire some of 
the corneal epithelial-like features. 
Kolli et al. 
2014 
Bilateral total LSCD 24 months  Successful reversal of LSCD within the 
follow up period 
Kocaba et 
al. 2014 
Bilateral LSCD 18 to 48 
months 
Cultured Autologous Oral Mucosal 
Epithelial Cell-Sheet (CAOMECS) 
technology  demonstrated the presence 
of a functional epithelium over the long 
term for 62.5% of the patients. 
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Burillon et 
al. 2012 
Bilateral total LSCD 15, 30, 60, 
90, 180 
and 360 
days 
Following a CAOMECS graft, 5 of 23 
patients showed reconstructed corneal 
epithelium without ulcers or neovessels 
Dobrowol
ski et al. 
2011 
Aniridia or chemical 
burn related LSCD 
6 to 12 
months 
76.4 % of eyes showed stable 
epithelium and 23.5 % of eyes corneas 
remained cloudy due to recurrent 
conjunctival neovascularization or 
stromal haze 
Ma et al. 
2009 
Alkaline or thermal 
burn LSCD 
26 to 34 
months 
Cornea surface was completely 
reepithelialized in 3–10 days in all but 
one patients. 
Chen et al. 
2009 
Alkaline or thermal 
burn LSCD 
10 to 22 
months 
Cultivated OMECs exist for long term 
on the cornea after COMET 
Inatomi et 
al. 2006 
SJS and chemical eye 
injury 
22.5 months The surviving OME consisted of  
irregular, nonkeratinized, stratified 
epithelium without goblet cells 
expressing K3 but  not  K12. 
Nishida et 
al. 2004 
Bilateral LSCD 13 to 15 
months 
Mild opacity and persistence of blood 
vessels observed in all transplanted 
corneas 
Table 1.2 : Several clinical studies on LSCD treatment with COMET. 
1.1.4 The need of alternative cellular source for LSCD treatment  
Various limitations in bilateral total LSCD treatment using COMET or allogeneic cells have 
made researchers to turn to human embryonic stem cells (hESCs) and human induced-
pluripotent stem cells (hiPSCs) as potential alternative treatment sources. To date there are a 
handful of papers on corneal epithelium differentiation using both hESCs and hiPSCs. Those 
two PSCs were cultured in different conditions and supplements given at different time points 
during the specially defined differentiation condition and period to produce high percentage of 
corneal epithelial lineages cells or 3D corneal organoids (Zhang et al. 2017, Foster et al. 2017). 
There is however no good manufacturing practice (GMP) compatible protocols for robust 
hESCs and hiPSCs derived corneal epithelium differentiation that reflects in functional corneal 
epithelium or LSCs to be used clinically to date. The following Table 1.3 summarises the in 
vitro PSC differentiation studies that were referred to while designing our project. 
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Differentiati
on method  
Medium & 
supplements 
Cell 
line(s) 
Outcomes & 
Authors 
Remarks / Points 
taken 
Monolayer on 
collagen IV 
coated dish 
Limbal fibroblasts 
conditioned 
epithelial medium 
supplemented 
with fetal calf 
serum (FCS) 
hESCs 
lines (hES-
NCL1, 
H1) 
CK3/12 were 
expressed in the first 
and second week 
after differentiation 
induction, and 
declined thereafter. 
Ahmad et al. 2007 
Monolayer 
differentiation 
method and 
collagen IV 
coated surfaces 
and time points 
used 
Monolayer on 
feeder 
Cells were grown 
in DMEM/F-12, 
15% KOSR, 
NEAA, 
mercaptoethanol. 
BMP4 was added 
for 3 days and 
cells were 
cultured in 90% 
DMEM/F-12, 
FBS, NEAA, and 
mercaptoethanol 
or in 60% 
DMEM, 30% 
Ham’s F-12 
medium, and FBS 
supplemented 
with insulin, 
hydrocortisone, 
ascorbate, and 
EGF. 
mESCs Ectodermal cell 
(K8/K18+) are 
produced in large 
numbers, some of 
them become 
keratinocytes 
(K5/K14+) after 
addition of serums. 
Aberdam et al. 2007 
BMP4 
supplementation 
drives cells 
differentiation 
away from neural  
hiPSCs were 
grown on 
collagen-IV 
coated plates 
Corneal 
fibroblasts or 
limbal fibroblasts 
conditioned 
hiPSCs 
from hair 
follicle 
keratinocy
Expression of 
ΔNP63 and K14 
peaked at day 8, 
while markers of 
Monolayer 
differentiation 
method and 
collagen IV 
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medium added 
with epithelial 
media contained 
DMEM/F12, 
FCS, insulin, 
hydrocortisone, 
EGF, adenine, and 
cholera toxin. 
tes and 
dermal 
fibroblasts  
terminally 
differentiated corneal 
epithelium (K3, K12) 
peaked at day 14. 
20%–25% of the cell 
population was K14+ 
progenitor cells, 
while most (>90%) 
cells expressed K3 at 
day 14. Shalom-
Feuerstein et al. 2012 
coated surfaces, 
markers (ΔNP63, 
K3, K12) and time 
points used  
Monolayer on 
Matrigel 
coated plates 
Cells were 
cultured for 
preplacodal 
ectoderm, neural 
and epidermal 
differentiation 
using various 
conditions. 
hESCs 
(H9) 
Seeding density 
(1.7–2.0 
× 104 cells/cm2) with 
a 3-day pre-
differentiation to 
reliably produce 
about 70% of pre-
placodal (SIX1+) 
cells in the cultures. 
Leung et al. 2013 
Cell density for 
seeding, Matrigel 
coated plates, cell 
disassociation 
using Accutase, 
differentiation 
start point and 
ROCKi used in 
for replating 
Three 
dimensional 
cell 
aggregates 
and replating 
on collgen IV 
coated plates 
Induction: CnT-
30, serum-free 
and xeno-free 
RegES-, RegES− 
medium 
supplemented 
with SB-505124, 
IWP-2, human 
bFGF 
hiPSCs 
and hESCs  
lines 
Up to 95% of cells 
were p63+ after 5 
weeks of 
differentiation. 
Corneal epithelial-
like cells were 
obtained upon further 
maturation. 
Mikhailova et al. 
2014 
hiPSCs used, 
SB505124 and 
IWP-2 
supplementation 
Cell spheres 
formation  
and single-
Ectodermal 
induction: low 
glucose DMEM, 
SSEA4+ 
and 
SSEA4- 
During ectodermal 
induction, mRNA 
levels of p63 and 
BMP4, RA and 
EGF 
supplementation 
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cell 
suspensions 
on matrigel 
coated plates 
RA, BMP4, EGF. 
Corneal epithelial 
differentiation 
medium: low 
glucose 
DMEM/F12 (3:1), 
FCS, PS, 
hydrocortisone, 
insulin, tri-
iodothyronine, 
adenine, EGF 
limbal 
fibroblasts 
or bone 
marrow 
mesenchy
mal stem 
cells 
CK8 were highest 
levels between days 
3 and 5. By day 9 of 
corneal epithelial 
differentiation, the 
majority of SSEA4+ 
cells exhibited 
epithelial 
morphology and 
CK3 and CK12 were 
expressed only in the 
SSEA4+ subgroups. 
Katikireddy et al. 
2014  
with low glucose 
DMEM/F12 
medium and 
markers (K8) used 
Monolayer on 
LN511E8-
coated dishes 
with serial 
pipetting 
during each 
differentiatio
n stages 
Differentiation 
medium (DM); 
GMEM 
supplemented 
with KOSR, 
sodium pyruvate, 
NEAA, l-
glutamine, PS and 
2-ME or 
monothioglycerol 
and Noggin or 
LDN-193189. 
Corneal 
differentiation 
medium (CDM); 
DM and Cnt-20 or 
Cnt-PR (w/o; 
EGF and FGF2) 
(1:1), KGF, Y-
27632 and PS. 
hiPSCs 
lines 
201B7, 
253G1, 
454E2, 
1231A3 
and 
1383D2 
Ocular cells were 
generated from a  
self-formed 
ectodermal 
autonomous multi-
zone (SEAM). At 
day 40 of 
differentiation, cells 
in zone 3 were 
unique with its 
PAX6/p63-double-
positive phenotype, 
representative of 
ocular surface 
ectoderm as well as  
K18, and E-cadherin. 
Approximately 99% 
of the cells expanded 
from zone 3 were 
stratified K14+ 
Monolayer 
differentiation 
method and CnT-
PR medium for 
corneal 
differentiation 
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Corneal 
epithelium 
maintenance 
medium (CEM); 
DMEM/F12 (2:1), 
B27, PS, KGF and 
Y-27632. 
epithelial cells, 95% 
were of corneal 
epithelial lineage 
(SSEA-4+), and 70% 
were differentiated 
corneal epithelial 
cells (K12+). 
Hayashi et al. 2016. 
Table 1.3 : Summary of various studies on corneal and limbal epithelial differentiation 
using human stem cells. 
 
1.2 Human stem cells 
Stem cells are undifferentiated cells with potential to differentiate into specialized cells and 
with extended self-renewal capacity (Walia et al. 2012). There are three broad types of stem 
cells: i) embryonic stem cells (ESCs), which are isolated from the inner cell mass (ICM) of a 
blastocyst; ii) adult stem cells (ASCs), that are found in various tissues such as bone marrow, 
blood and adipose tissue; and iii) induced-pluripotent stem cells (iPSCs), that are reprogrammed 
from adult differentiated somatic cells such as fibroblasts (Yu et. al. 2007).  
 
ESCs can differentiate under defined in vitro and in vivo conditions, into the cells of all the 
three germ layers; namely the ectoderm, endoderm and mesoderm hence they fall under the 
category of pluripotent stem cells. In an adult, the ASCs act as a repair system for the body, 
replenishing the adult specialized tissues and also maintaining the normal turnover of 
regenerative organs, such as blood, skin, or intestinal tissues (Wobus and Boheler 2005). 
However, the differentiation potential of ASCs is more limited when compared to ESCs, and 
for this reason they are named multipotent, or unipotent depending on the number of cell types 
they can differentiate to make up our organs. iPSCs, on the other hand, are reprogrammed to 
become pluripotent. This pluripotency allows these reprogrammed cells to differentiate into 
various cells based on the conditions and factors that are supplemented to the iPSCs (Sugawara 
et al. 2012).  
 
Potency of stem cells specifies the cells’ differentiation potential. It ranges from totipotent down 
to unipotent, which can be seen in progenitor cells (Figure 1.2). Totipotent stem cells can 
differentiate into both embryonic and extraembryonic cell types. Such cells can form a complete, 
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viable organism. These cells are produced from the fusion of an egg and sperm cell: e.g. 
fertilised zygote. Pluripotent stem cells are the descendants of totipotent cells and can 
differentiate into nearly all cells that derived from any of the three germ layers, such as human 
embryonic stem cells (Baker and Pera 2018). Multipotent stem cells can differentiate into a 
number of cell types, but only those of a closely related family of the cells, for example the 
haemopoietic stem cells. Unipotent cells however, can produce only one cell type, their own, 
but have the property of self-renewal, which distinguishes them from non-stem cells. Some 
examples of these cells are progenitor cells, corneal epithelial stem cells and muscle stem cells 
(Wobus and Boheler 2005). 
 
Figure 1.2 : Hierarchical potential of stem cells. Adapted from Sugawara et al. 2012. 
  
The ESCs lines have been used in a wide range of medical research. However, there are always 
some ethical issues that come with the human ESCs (hESCs) studies especially in its 
conventional acquisition methods that involved the destruction of developing human embryos 
(Thompson et al. 1998). Despite that, they are still considered as one of the promising 
candidates for future therapies especially in regenerative medicine based on several previous 
and on-going clinical trials such as the Geron study on spinal cord injury and the Advanced 
Cell Technology trials on Stargardt’s Macular Dystrophy, wet and dry age-related macular 
degeneration, diabetes type 1 and heart failure (Wobus and Boheler 2005, Schwartz et al. 2012, 
Schulz 2015, Ilic et al. 2015). 
 
Advancement in medical research have enabled the culture of ASCs and their differentiation 
into cells with specialized characteristics, which is consistent with cells of various tissues such 
iPSCs       ESCs 
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as muscles, skin or nerves. The resulting autologous stem cell therapy has a great potential 
without the issues of rejection (Walia et al. 2012). ASCs are now extensively used in research 
and medical therapies, for example in bone marrow and cornea transplantation as well as wound 
healing (Koizumi et al. 2001, Sasaki et al. 2008). Since ASCs are only multipotent or unipotent, 
its differentiation potential and applications are more limited compared to the hESCs.  
 
Since the publication of Yamanaka team’s work in 2007, an increasing number of publications 
have focused on reprogramming the adult differentiated somatic cells from human to produce 
human iPSCs (hiPSCs). Other than its easily available source, the hiPSCs method avoids the 
debatable ethical issues for its acquisition despite its remarkable similarities to hESCs (refer to 
Table 1.4) (Yamanaka 2012).  
 
Features  hESCs  hiPSCs 
Cells of origin Inner cell mass (ICM) cells of an 
embryo 
Differentiated somatic cells 
Characteristic 
morphology 
High nuclear to cytoplasm ratio, 
prominent nucleoli  
High nuclear to cytoplasm ratio, 
prominent nucleoli 
Cell culture 
growth 
Compact flat colonies with 
distinct edges 
Compact flat colonies with distinct 
edges 
Gene expression  NANOG, OCT4, SOX2, LIN28, c-
MYC, hTERT, KLF4, GDF3, 
REX1, FGF4, TDGF1, NODAL, 
DPPA4, EBAF, GRB7, LEFTB, 
ESG1 
NANOG, OCT4, SOX2, LIN28, c-
MYC, hTERT, KLF4, GDF3, REX1, 
FGF4, TDGF1, NODAL, DPPA4, 
EBAF, GRB7, LEFTB, ESG1 
Acquisition 
method  
Derived from the ICM of fresh or 
frozen embryos at the blastocyst 
stage, somatic cell nuclear 
transfer (SCNT) 
Derived by reprogramming of 
somatic cells to a pluripotent state 
through overexpression of a key set of 
transcription factors, cell lines can be 
easily derived from cells with variety 
of genetic backgrounds 
Surface markers SSEA-1, SSEA-3, SSEA-4, 
TRA-1-60, TRA-1-81 
SSEA-3, SSEA-4, TRA-1-60, TRA-
1-81, TRA-2-49/6E 
Epigenetic 
memory 
Not applicable, as it is derived 
from embryo  
May retain the epigenetic marks from 
the cells of origin after differentiation 
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Self-renewal 
capacity 
Highly efficient, show high 
telomerase activity 
Highly efficient, show high 
telomerase activity 
Developmental 
potential 
Able to form embryoid bodies 
(EBs) and differentiate into all the 
three germ layers tissues, form 
teratomas if injected into immune 
compromised mice, also could 
form interspecies (with mouse) 
chimaera in vivo 
Able to form EBs and differentiate 
into all the three germ layers tissues, 
form teratomas if injected into 
immune compromised mice, also 
could form interspecies (with mouse) 
chimaera in vivo 
Function / 
Aplication 
Development and differentiation 
of human tissue, new drug 
discoveries, but difficult to 
generate patient-specific cells for 
transplantation and patient 
specific therapies 
Research on human tissue/organ 
development and differentiation, 
patient specific cell lines generated 
easily, personalised cell transplants 
with no immune rejection problems, 
new and personalised drug 
development, disease modelling 
Table 1.4 : The characteristic features of hESCs and hiPSCs (Adapted from Mascetti 
and Pedersen 2016, Narsinh et al. 2011, Takahashi et al. 2007 and Yu et al. 2007). 
 
The most exciting quality of hiPSCs is that it could escape the immune matching or rejection 
problems when it comes to therapeutic application (Wang et al. 2011).  Although the hESCs 
and hiPSCs hold promises for various medical innovations, there is a phenomenon that could 
affect their basic cellular manipulation, called dissociation-induced apoptosis (Ohgushi and 
Sasai 2011).  This condition was found to be related to Rho kinases (ROCK) activity that 
regulates apoptosis via myosin hyperactivation in dissociated PSCs while maintaining their 
metastable states of pluripotency (Ohgushi et al. 2010). This problem was solved by Watanabe 
in 2007, via the inhibition of ROCK and allowing the dissociated PSCs to be maintained in 
adherent and suspension cultures (Watanabe et al. 2007). 
 
1.2.1 Human embryonic stem cells (hESCs) 
Human embryonic stem cells (hESCs) are pluripotent stem cells derived from the ICM of an 
early-stage embryo (Baker and Pera 2018). Human embryos reach the blastocyst stage 4–5 days 
post fertilisation, at which time they consist of 50–150 cells. hESCs can give rise to all the 
derivatives of the three primary germinal layers; they have the potential to differentiate into 
more than 200 cell types of the adult body when given sufficient and necessary stimulation for 
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a specific cell type. They are also capable of unlimited proliferation in vitro (Thomson et al. 
1998). However, these cells are conventionally derived from embryos produced by in vitro 
fertilisation and allowed to proceed to blastocyst stage, thus the acquisition process involved 
the disruption of otherwise living embryo (Thompson et al. 1998). Due to this acquisition 
method, the ethical debates on the hESCs related research are still going on to date (King and 
Perrin 2014). In line with this issue, recent research advancements have made it possible to 
acquire hESCs via somatic cell nuclear transfer (SCNT) method (Figure 1.2). A mature somatic 
cell is fused to an enucleated oocyte to generate a one-cell embryo which then is allowed to 
develop into blastula stage (Condic and Rao 2008, Wang and Gurdon 2013). Recently, this 
SCNT method had successfully applied to clone monkeys that could be used for future animal 
and disease modelling in primates (Liu et al. 2018). 
 
 
Figure 1.3 : Methods for the derivation of hESCs. Adapted from Condic and Rao 2008. 
Mouse embryonic stem cells (mESCs) were derived more long before the naïve pluripotent 
state of ESCs was discovered (Martin 1981, Nichols and Smith 2009). mESCs could either 
derived from the ICM of pre-implantation or post-implantation mouse embryo and these 
methods of acquiring ESCs will produce a naïve pluripotent (i.e: mESCs) or  a primed state of 
stem cells respectively (Figure 1.4). The mESCs in the primed pluripotent state which is more 
differentiated compared to the naïve are called the mouse epiblast stem cells (i.e: mEpiSCs) 
(Brons et al. 2007, Tesar et al. 2007).  The naïve state of mESCs is maintained in vitro via the 
use of two or three types of differentiation inhibiting molecules (2i/3i) to inhibit fibroblast 
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growth factor receptor (FGFR), mitogen-activated protein kinase/extracellular signal-regulated 
kinases (MAPK/ERK) and glycogen synthase kinase-3 (GSK3) (3i) or MAPK and GSK3 (2i) 
in combination with or without leukocyte inhibition factor (LIF) (Olariu 2013). 
 
Nearly two decades later, hESCs were successfully derived using the preimplantation method 
(Thomson et al. 1998). Although the hESCs were derived during pre-implantation stage, their 
pluripotent state was found to be more similar to those of mEpiSCs, which is primed 
pluripotency (Nichols and Smith 2009). hESCs share more similarity to mEpiSCs rather than 
mESCs in term of their colony morphology, growth-factor responses, gene expression pattern 
and inactivation status of the X chromosome (Ohgushi and Sasai 2011).  
 
 
Figure 1.4 : Schematic picture of the origins and properties of the mouse pluripotent 
stem cell lines, mESCs and mEpiSCs. Adapted from Ohgushi and Sasai 2011. 
 
However, the primed pluripotency status of hESCs can be reverted back to the naïve state by 
ectopic induction with the combination of OCT4, KLF4, KLF2, LIF, GSK3β inhibitor and 
mitogen-activated protein kinase pathway inhibitor (Hanna et al. 2010) or provision of 5i/L 
supplemented with fibroblast growth factor (FGF) and Activin A (5i/L/FA) (Theunissen et al. 
2014). Unfortunately, this interconversion of primed and naïve states has a time limitation of 
about 24 - 48 hours for safeguarding the DNA methylation integrity of the cells (Martello and 
Smith 2014, Weinberger et al. 2016). Recently, the two pluripotent states of hESCs were 
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defined via specific molecular markers that could determine the human PSC state (Collier et al. 
2017).  
 
During terminal differentiation process, the lineage-specific markers for naïve hESCs were 
upregulated, but their ability to undergo terminal differentiation towards functional cell types 
is limited compared to primed hESCs (Warrier et al. 2016). The naïve hESCs could also 
differentiate into primed hESCs by supplementation of medium containing serum and FGF 
(Theunissen et al. 2014). The hESCs in the primed state was also reported to be efficiently 
changed into another alternative pluripotent state called region-selective pluripotent stem cells 
(rsPSCs) via changes in the culture conditions. These alternative rsPSCs unlike hESCs, are 
capable of forming post-implantation interspecies chimaeric embryos (Wu et al. 2015). The 
different characteristics of the naïve and primed pluripotency, based on murine cells are 
summarised in Table 1.5 below. 
 
Naïve pluripotent stem cells Primed pluripotent stem cells 
Efficiently repopulate the host’s ICM and 
contribute to chimaeric embryos 
Form differentiated teratomas, inefficient 
in repopulating the ICM when injected into 
host blastocysts 
Maintain both x-chromosomes in active state 
(XaXa) in female cells 
Predominantly undergone x-chromosome 
inactivation (XiXa) 
Refractory potential to differentiate into 
primordial germ cells in vitro 
Readily differentiate into primordial germ 
cells in vitro 
Can be cloned with high efficiency Intolerance to single cells passaging 
Grow as packed domed colonies Grow as flattened colonies 
Stabilised by LIF/Stat3 and destabilised  by 
bFGF and TGFβ/Activin signalling 
Depend on bFGF and TGFβ/Activin 
signaling 
Showed better differentiation into endoderm 
and mesoderm 
Better ability to differentiate into 
neuroectoderm 
Table 1.5 : The characteristics of naïve and primed pluripotent stem cells (Nichols and 
Smith 2009, Hanna et al. 2010). 
 
The hESCs, being pluripotent, require both paracrine and autocrine signals to proliferate and 
maintain their pluripotency (Pyle et al. 2006, Schatten et al. 2005, Amit et al. 2000). Specific 
signals and conditions are also pertinent for efficient differentiation of hESCs into specific 
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differentiated cells lineages. Their differentiation outcome is influenced by various endogenous 
factors such as its growth, methods of handling, epigenetic modifications (Hoffman et al. 2005), 
transcriptional profiles (Abeyta et al. 2004, Bhattacharya et al. 2004), and sensitivity to various 
conditions of hESCs population itself, as well as exogenous factors, for example the culture 
media composition and the method of differentiation induction (Kitsberg 2007, Bauwens et al. 
2008). Some exogenous factors (noggin and bFGF) were reported to maintain the hESCs 
pluripotency, while others (miR-145, BMP) repress pluripotency and induce differentiation 
process (Xu et al. 2005, Xu et al. 2009). Some of the hESCs differentiation experiments are 
listed in Table 1.6 below. 
  
Culture conditions Differentiated  
cells / tissue 
References 
hESC colonies were transferred into petri dishes 
precoated with collagen IV (coll-IV) in medium 
containing Dulbecco’s modified Eagle’s medium 
(DMEM)/Ham’s F12 (F12), fetal bovine serum (FBS), 
non-essential amino acid (NEAA), penicillin, 
streptomycin (PS), SCF, vascular endothelial growth 
factor (VEGF), and basic fibroblast growth factor 
(bFGF). Differentiation was performed with similar 
efficiency in knockout serum replacement (KOSR) with 
the addition of heparin, bone morphogenetic protein 4 
(BMP4), stem cell factor (SCF), VEGF, activin A, 
bFGF followed at day 4 by TGFβ1. 
Endothelial cells 
expressing 
immunological 
markers (vWF, 
CD105), specific 
genes (VE-
cadherin, KDR, 
GATA-2, GATA-3, 
eNOS), and formed 
cord-like structures 
on collagen matrix 
Lagarkova 
et al. 2008 
Differentiation induction with combinations of activin 
A, BMP4, bFGF, VEGF and dickkopf homolog 1 
(DKK1) in serum-free media 
Cardiovascular 
progenitor cells that 
differentiate further 
to generate greater 
than 50% 
contracting 
cardiomyocytes 
Yang et al. 
2008 
hESCs derived endoderm cells were cultured on mouse 
embryonic fibroblasts (MEF), treated with Wnt3a + 
activin A in advanced RPMI supplemented with L-
Pancreatic lineage 
cells 
Chen et al. 
2009 
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glutamine and PS for 1 d, then activin A in advanced 
RPMI supplemented with L-glutamine, PS and FBS. 
Medium was changed 2 d later to FGF10 + KAAD-
cyclopamine in advanced RPMI supplemented with L-
glutamine, PS and FBS, and maintained for 2 d. Cells 
were transferred to FGF10 + KAAD-cyclopamine + 
retinoic acid in DMEM supplemented with L-
glutamine, PS and B27 and cultured for 4 d. 
Differentiation to endocrine or exocrine cells: the ILV-
treated populations were cultured in DMEM/F12 
supplemented with N2, albumin fraction V and bFGF 
for the first 4 d. Nicotinamide was added and 
maintained for 8 d, changing the medium every 3 d. 
Nanoscale ridge/groove pattern arrays constructed 
using UV-assisted capillary force lithography. The 
dimension and alignment were finely controlled over a 
large area. hESCs seeded onto the 350-nm ridge/groove 
pattern arrays in the absence differentiation-inducing 
agents and maintained for 5 days.  
Neuronal lineage 
cells 
Lee et al. 
2010 
Undifferentiated hESCs were cultured in mesoderm-
inducing medium for 1 week. Adherent cells were 
expanded in monolayer for 3–4 week and seeded on 
decellularized bone scaffolds in osteogenic medium for 
3 days to allow cell attachment. Cell-seeded constructs 
were then cultured in osteogenic medium for 5 week in 
either perfusion bioreactors or static dishes. Tissue 
development was evaluated after 3 and 5 week.  
Bone tissue Marolt et al. 
2012 
hESCs were plated on a Matrigel-coated 96-well plate. 
After overnight culture, cells were exposed to BMP4 
and activin A or CHIR99021 in a previously established 
serum-free media APEL for 2–3 days, then FGF9 and 
heparin in APEL media for 4 days to induce IM cells. 
Subsequently cells were exposed to FGF9, BMP7, 
retinoic acid (RA) and heparin for 4–11 days in case of 
Renal lineage cells 
that form self-
organizing 
structure, including 
nephron formation 
Takasato et 
al. 2014 
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BMP4/activin A induction. In case of CHIR99021 
induction, cells were exposed to FGF9 and heparin for 
6 days then cultured in APEL basal media for another 6 
days. 
hESCs were preplated on gelatin for 45 min to remove 
feeder cells and then plated on Matrigel in feeder 
conditioned media. Feeder-free cultured hESCs were 
plated directly on Matrigel in TeSRTM1. When cells 
reached >80% confluence, differentiation was initiated 
by switching to DMEM-F12/Neurobasal media (2:1) 
supplemented with N2 and retinol-free B27 (N2B27). 
For the first 10 days, cultures were supplemented with 
SB431542, LDN-193189 and dorsomorphin. Some 
initial experiments were performed with noggin instead 
of LDN. Where indicated, Shh or cyclopamine was 
added to the cultures. Cells remained in basal N2B27 or 
were supplemented with activin A  from day 9. BDNF 
and GDNF were added from day 28 to aid neuronal 
maturation and survival. 
GABAergic striatal 
medium-sized 
spiny neurons 
(MSNs) 
Arber et al.  
2015 
Confluent hESC cultures were scraped and cultured in 
low-attachment plates with NutriStem to form EBs with 
Rock inhibitor during the first 24 hr. At week 5, 
pigmented structures were cut out with a scalpel and 
dissociated into single cells. Cells were plated on 
different substrates and cultured until homogeneous 
pigmentation is reached (week 9). 
Retinal pigment 
epithelial cells 
Reyes et al. 
2016 
hESCs were plated into 24-well plates in mTesR1 with 
Y-27632. Definitive endoderm (DE) differentiation 
started by adding Activin A, NEAA, FBS in RPMI 1640 
medium for 3 days. BMP4 was added on the first day. 
DE was differentiated to posterior foregut endoderm by 
exposure to FGF4, and noggin for 3 days in RPMI 1640 
supplemented with NEAA and FBS. RA was added on 
day 6. The resulting posterior foregut spheroids were 
3D foregut 
spheroids-gastric 
organoids 
McCracken 
et al. 2017 
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collected and transferred to a 3D culture system until 
day 34. 
Table 1.6 : Differentiation of hESCs into various cell lineages/tissues. 
Additionally, extensive work has been carried out to differentiate hESCs into eye lineages.  In 
view of treating visually disabled patients, researchers have tried to obtain fully compatible in 
vitro differentiated cells to treat those patients.  Differentiation protocols developed for several 
eye lineages were summarised in Table 1.7. 
 
Supplements / Conditions Differentiated 
cells / tissue 
obtained 
References  
 
RPE differentiation: embryonic bodies (EBs) were 
subjected to neuroectodermal induction with SB-
505124 and IWP-2. Then the EBs were transferred onto 
well plates coated with LN-521 and coll-IV in XF-Ko-
SR medium. Pigmented foci were manually separated, 
and disasssociated with TrypLE™ Select enzyme, and 
the resulting single-cell suspension replated to culture 
wells coated with LN-521 and col IV.  For the final 
passage, the RPE cells were plated to similarly coated 
polyethylene terephthalate (PET) hanging cell culture 
inserts. 
LESC differentiation: EBs were subjected to surface 
ectodermal induction with XF-Ko-SR medium 
supplemented with SB-505124 and bFGF, followed by 
XF-Ko-SR medium with BMP4. Then the EBs were 
transferred onto well plates coated with LN-521 and col 
IV in a defined and serum-free medium CnT-30 at a 
density of approximately 15 EBs per cm2. The cells 
were thereafter maintained in CnT-30.  
1) hPSC-RPE cells 
with mature tight 
junctions, 
expression of RPE 
genes and proteins, 
and 
phagocytosis and 
key growth factor 
secretion capacity.   
2) hPSC-LESCs 
expressing LESC 
markers such as 
p40/p63α 
Hongisto et 
al. 2017 
Differentiation: DMEM/F12 and defined keratinocyte 
serum-free medium (KSFM) (1:1). Airlifting: 
DMEM/F12 and DMEM (1:1) with PS, FBS, epidermal 
growth factor (EGF), insulin, hydrocortisone, cholera 
ABCG2+ cells 
from 7% CO2 group 
isolated as CEPCs 
formed 3 - 4 layers 
Zhang et al. 
2017 
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toxin, and 3,3',5-triiodo-L-thyronine. Different carbon 
dioxide (CO2) levels in culture. 
of epithelioid cells 
by airlifting and 
expressed ABCG2, 
p63, CK14 and 
CK3. 
Human limbal fibroblast conditioned medium Cells similar to 
epithelial 
progenitor cells, 
undergo trans-
differentiation and 
exhibit squamous 
metaplasia 
Brzeszczyns
ka et al. 
2014 
Vitro HES, 5% FBS and 10ul/ml Hygromycin for 16 
days and transplanted onto Bowman’s membrane  
Cells that expressed 
corneal-related 
markers: PAX6 and 
CK3 
Hanson et 
al. 2013 
Induction: 90% BHK21-medium/Glasgow modified 
Eagle’s medium (GMEM), glutamine, KOSR, 
pyruvate, NEAA, β-mercaptoethanol, PS, co-cultured 
with murine PA6 cell line  
Corneal keratocytes Chan et al. 
2013 
hESCs were differentiated with ventral neural induction 
media (VNIM) that was supplemented with 
recombinant mouse (rm) Noggin, recombinant human 
(rh) Dickkopf-1 (Dkk1), rhIGF-1, rhLefty A, Human 
Sonic Hedgehog (Shh) and 3,3′,5-triiodo-L-thyronine 
(T3) until day 37. KOSR-free media was then 
supplemented with rmNoggin, rhDkk1, rhIGF-1, 
rhbFGF, retinoic acid, T3, taurine, and Shh until day 60. 
During days 37-41, PR-induction medium was 
supplemented with human Activin-A, to encourage the 
photoreceptor progenitor cells maturation 
Retinal 
photoreceptor cells 
Mellough et 
al. 2012 
Cells were cultured on Matrigel-coated plate in 
DMEM/F-12 supplemented with bovine serum albumin 
(BSA), NEAA, PS, N2, B27, bFGF. 
Progenitor and 
mature lens cells 
Yang et al. 
2010 
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Cells were grown in 85% DMEM/F-12, 15% KOSR, 
NEAA, mercaptoethanol. At day 4, BMP4 added for 3 
days. At day 7, BMP4 was removed, and cells were 
cultured in 90% DMEM/F-12, FBS, NEAA, and 
mercaptoethanol or in 60% DMEM, 30% Ham’s F-12 
medium, and FBS supplemented with insulin, 
hydrocortisone, ascorbate, and EGF. 
Ectodermal cells Aberdam et 
al. 2008 
Cells were cultured on a layer of irradiated MEF in 
unconditioned medium (UM): DMEM/F-12 containing 
KSR, MEM, NEAA, L-glutamine, mercaptoethanol, 
and bFGF. Alternatively, hESCs were plated on 
Matrigel in medium conditioned by MEF. EBs were 
cultured in UM without bFGF or N2 medium: 
DMEM/F12 containing N2 supplement and MEM 
NEAA. After 1–2 days, EBs were transferred to a new 
vessel to remove adherent MEF. Differentiated EBs 
were plated onto gelatin-coated plates in defined 
keratinocyte serum-free medium (DKSFM). Direct 
differentiation: hESC colonies were grown on Matrigel 
in MEF-conditioned hESC medium before switching to 
differentiation medium, which contained UM or N2 and 
a combination of DMSO, RA, BMP4, or Noggin.  
Keratinocytes  Metallo et 
al. 2008 
Cells were maintained on MEF before manually 
passaged and transferred onto col IV coated plate and 
supplemented with   medium containing low-glucose 
DMEM/F12 (3:1), FBS, PS, hydrocortisone, insulin, tri-
iodothyronine, adenine, cholera toxin and EGF. 
Corneal epithelial-
like cells 
Ahmad et 
al. 2007 
Table 1.7 : Differentiation of hESCs into several eye lineages. 
1.2.2  Human-induced pluripotent stem cells (hiPSCs) 
Human induced-pluripotent stem cells (hiPSCs) are derived from somatic cells which have 
undergone reprogramming process to return to the pluripotent stem cell stage. Unlike hESCs, 
hiPSCs derivation does not require the destruction of human embryos, therefore avoids the 
ethical debate as that on the conventional way of hESCs derivation (Narsinh et al. 2011). The 
reprogramming process generally comprise three phases; initiation, maturation and stabilisation 
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(Mikkelsen et al. 2008, Buganim et al. 2014). Mesenchymal-to-epithelial transition (MET) was 
prominent in the initiation phase (Li et al. 2010) while the OCT4, SOX2, KLF4, c-MYC (OSKM) 
transgene repression was vital during the transition of maturation to the stabilisation phase 
(Golipour et al. 2012). This multi-step process also involved both transcriptome and proteome 
resetting (Sancho-Martinez and Izpisua Belmonte 2013). Apart form those transcriptional 
changes there are epigenetic alterations that allow the conversion of somatic cells into stem 
cells. The changes include histone modifications during early reprogramming process, 
chromatin reorganisation, DNA demethylation of promoter regions and X reactivation during 
late reprogramming process (Takahashi et al. 2007, Maherali et al. 2007, Wernig et al. 2007, 
Fussner et al. 2011).  
 
The first hiPSCs were produced by Yamanaka lab in 2007 by reprogramming adult human 
dermal fibroblasts using viral vectors (Takahashi et al. 2007). During the reprogramming 
process, the genome of somatic cell is reprogrammed to a pluripotent state in vitro by the 
introduction and forced expression of genes that are important for pluripotency maintenance 
equivalent to that of hESCs. Those genes include OCT4, SOX2, NANOG, KLF4, c-MYC and 
LIN28 (Takahashi and Yamanaka 2006, Takahashi et al. 2007, Yu et al. 2007). The resulting 
hiPSCs have similar characteristics to primed hESCs. These cells have similar characteristics 
to hESCs in their characteristic morphology, surface antigens gene expression profiles, 
epigenetic status, self-renewal capacity, differentiation potential and function as described 
previously (Chin et al. 2009, Narsinh et al. 2011). They are characterised in vitro by their ability 
to give rise to cells belonging to all three germ layers in vitro and in vivo (Walia et al. 2012). A 
recent report stated that it is possible to generate naïve hiPSCs via directly reprogramming the 
somatic cells (Kilens et al. 2018). Thus similar to hESCs, there will be naïve and primed states 
of hiPSCs. 
 
There are various reprogramming methods developed for hiPSCs derivation (Figure 1.5). 
Viruses such as retrovirus, adenovirus and sendai virus (Sendai) were initial vectors used to 
introduce the reprogramming factors into somatic cells (Fusaki et al. 2009, Sommer et al. 2009, 
Zhou and Freed 2009). These viral transduction processes need to be carefully controlled and 
tested before the technique can lead to useful treatment for humans. This is because, in animal 
studies, the virus used to introduce the stem cell factors may cause genomic insertion of viral 
transgenes leading to tumour formations (Okita et al. 2007). The integrative retroviral 
reprogramming methods stated above used genetic material in the process, hence they are 
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unreliable for clinical therapeutic purposes because of increased risk of tumorigenesis 
associated with uncontrolled gene integration into the cell’s genome (Medvedev et al. 2010). 
However, other DNA free methods for hiPSCs induction that directly delivering the 
reprogramming proteins attached to the cell penetrating peptides (CPPs) have been developed. 
Although this method is simpler, more economical and avoids the risk of genomic integration, 
it has much lower efficiency and kinetics, and a much longer time is needed to produce viable 
hiPSCs after its induction (Walia et al. 2012).  
 
 
Figure 1.5 : Methods for derivation of hiPSCs. Adapted from Narsinh et al. 2011. 
 
The use of adenovirus has successfully produced hiPSCs without the transgene integration but 
this method was more effective in only certain types of cells such as hepatocytes (Fusaki et al. 
2009, Zhou and Freed 2009). The use of Sendai based RNA virus has also avoids transgene 
integration as virus does not integrate into the human cells’ gene and will be removed by 
sequential dilution every time a cell divides. This Sendai method was successfully used to 
reprogram fibroblasts and blood cells (Jin et al. 2012, Chen et al. 2013, Hunihan et al. 2017). 
 
Investigations have also been done on non-viral vectors, such as repeated nucleofection of a 
non-viral polycistronic plasmid containing reprogramming gene sequences and the use of non-
integrating episomal vectors (Abujarour and Ding 2009). But these methods showed lower level 
of transgenes expression and lower efficiency compared to viral reprogramming. One of the 
most efficient (0.1 - 1% efficiency) non-viral gene delivery system uses excisable piggyback 
(PB) transposon carrying the coding of c-MYC, KLF4, OCT4 and SOX2 (MKOS cassette) 
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which is excised from its integration site without changing the original DNA sequence (Woltjen 
et al. 2009, Somers et al. 2010, Gonzalez et al. 2011, Robinton and Daley 2012). 
 
The most recent DNA free technique for hiPSCs reprogramming involves the use of 
synthetically modified messenger ribonucleic acid (mRNA) and CPPs to deliver the 
reprogramming proteins (Kim et al. 2009). The resulting iPSCs are called RNA induced 
pluripotent stem cells (RiPSCs) and protein-induced human iPSCs (p-hiPSCs) respectively. 
These are to date the most efficient (1 - 4.4%), non-mutagenic, with high cell survival and safe 
non-integrating cell reprogramming method (Kim et al. 2009, Warren et al. 2010, Robinton and 
Daley 2012).  
 
Another method of hiPSCs reprogramming is via the application of microRNAs (miRNAs). 
MicroRNAs are short RNA molecules that bind to complementary sequences on messenger 
RNA and block gene expression (Bao et al. 2013). This reprogramming method was shown to 
be highly efficient as reported by Anokye-Danso et al. stating that a single miRNA cluster 
(miR302/367) can reprogram fibroblasts four-fold more efficiently than the standard OCT4, 
SOX2, KLF4, c-MYC expression (OSKM) method (Anokye-Danso et al. 2011, Hu et al. 2013). 
These findings may also lead to non-viral, non-transcription factor mediated procedure for 
generating hiPSCs for use not only in basic stem cell biology studies, but also for high 
throughput hiPSCs generation for large patient populations. The various methods of cell 
reprogramming and their efficiencies are summarised as below. 
 
Vector types Delivery methods Efficiency for 
human cells (%) 
Multiple cell types 
reprogrammed 
Retroviral  Integrating 0.02 – 0.08 Yes 
Lentiviral  Integrating 0.02 - 1 Yes 
Lentiviral 
(miRNA) 
Non-integrating 10.4 – 11.6 No 
miRNA (direct 
transfection) 
Non-integrating, 
DNA-free  
0.002 Yes 
Adenoviral Non-integrating 0.0002 No 
Sendai Non-integrating 0.5 – 1.4 Yes 
mRNA Non-integrating, 
DNA-free 
0.6 – 4.4 No 
Protein Non-integrating, 
DNA-free 
0.001 No 
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Episomal Non-integrating 0.0006 – 0.02 Yes 
PiggyBac Integrating, excisable  0.02 – 0.05 No 
Plasmids Non-integrating 0.005 No 
Table 1.8 : Various published methods of reprogramming and their efficiencies. 
Adapted from Rao and Malik 2012 and Stadtfeld and Hochedlinger 2010. 
 
1.2.3 Human ESCs and iPSCs for regenerative medicine, drug discovery and disease 
modelling 
In regenerative medicine, it is most important to establish robust, cost effective systems for 
culturing and differentiating the pluripotent cells and eliminating the need to use of animal-
derived substances or feeder cells to meet the clinical grade standard (Skottman and Hovatta 
2006). It has also been shown that their self-renewal and differentiation capacity are the two 
inherent aspects influenced by its pluripotency status and initial culture conditions (Lee et al. 
2014, Lee et al. 2017). Differentiating hESCs into usable cells while avoiding transplant 
rejection are just a few of the hurdles still faced by researchers. Many nations currently have 
special law on either hESCs research or the production of new hESCs lines. This is because 
that conventional way of hESCs retrieval involved the destruction of otherwise alive human 
embryos. Thus this raised significant concerns on ethical and religious ground (Rao and Condic 
2008). However, because of their combined abilities of unlimited expansion and pluripotency, 
embryonic stem cells remain a theoretically potential source for regenerative medicine and 
tissue replacement after injury or disease.  
 
Immune rejection is a more serious challenge that could be faced by patients following stem 
cells transplantation should the immune issue arise. This is due to the dispersed integration of 
the stem cells after transplantation which will either require immune suppression drug treatment 
for lifetime or the removal of the transplanted cells (Condic and Rao 2008).The recently 
discovered capacity of human somatic cells, for example fibroblasts to be relatively easily 
reprogrammed into embryonic stem cell-like cells, named hiPSCs and their differentiation 
capability to almost any cell type in the adult organism (Takahashi et al. 2007) offers new 
approaches to avoid immune rejection issues. Amongst others, hiPSCs have started to be used 
for the generation of autologous cells for patient-specific transplantation that avoid post-
transplantation rejection by patient’s immune system (Tucker et al. 2014). Tissues derived from 
hiPSCs will be a nearly identical match to the donor’s cell and thus more likely to avoid 
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rejection by the immune system following an autologous transplant (Guha et al. 2013, Morizane 
et al. 2013).  
However, an increasing number of data demonstrated that hiPSCs derived cells could induce 
immune reactions following autologous treatment (Kruse et al. 2015). The risks of autologous 
immune reactions towards hiPSCs could arise from the abnormal epigenetic signature (Lister 
et al. 2011, Ruiz et al. 2012) and somatic coding mutations that will result in the formation of 
fusion proteins (Gore et al. 2011) as well as the genomic instability that could lead to cancer 
(Yoshihara et al. 2017).   Although additional research is still needed, hiPSCs have already been 
useful tools for drug development and modelling of diseases, and scientists hope to use them in 
transplantation medicine and drug discovery (Condic and Rao 2008).  
 
These new avenues for personalised cell transplantation using hiPSCs and hESCs, however still 
need further consideration and clarification especially on the effects of subtle differences 
between the two stem cell types on their therapeutic applications (Robinton and Daley 2012). 
The in vivo efficacy and safety following transplantation of these cells have yet to be established. 
One of the unfavourable effects of immune matching feature of patient specific stem cell 
transplant is the lack of immune reactions that naturally detect tumour formation. Thus, tumour 
formation might be enhanced after transplantation of impure or unstably differentiated hiPSCs 
and hESCs (Condic and Rao 2008).  
 
Despite the small window of uncertainty in the long term outcome of stem cell therapy, there 
are a few recently approved human stem cell therapy trials for spinal cord injury and macular 
degeneration and diabetes. Those trials use differentiated cells derived from hESCs or hiPSCs 
for treating the respective conditions (Lu et al. 2009, Sharp et al. 2010, Schulz 2015, Ilic et al. 
2015, Garber 2015). Another on-going trial for age-related macular degeneration (AMD) 
treatment in Japan uses in vitro differentiated retinal pigment epithelium (RPE) from allogeneic 
hiPSCs (Riken Press Releases 2013, Cyranoski 2014, Hildreth 2016, Mandai et al. 2017).  
 
Drugs development costs were also significantly increased due to delayed detection of side 
effects in clinical settings. This cost could well be saved with the use of hESCs or hiPSCs that 
can be induced to differentiate into various tissues for the evaluation of the drug clearance, 
absorption and side effects. These tissues could be generated from cells of different donors, 
thus each will carry different genotypes that may reflect the variation in the drug metabolisms 
in different individuals (Pouton and Haynes 2007, Wilmut 2007, Zuba-Surma et al. 2012, Ko 
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and Gelb 2014). Apart from cost saving, the application of stem cells in drug discovery will 
also minimise the need of human or patient involvement in the clinical trial, which to some 
degree pose an unknown risk to the patient (Rubin and Haston 2011).  
 
Human disease modelling research field is aiming to generate models of human diseases using 
disease specific pluripotent stem cells as summarised in Table 1.9. This may sound feasibly 
possible to achieve and will give a valuable insight into various life-threatening diseases for 
example common genetic diseases such as the cardiovascular diseases and also inherited 
diseases that will affect the vision (Liang and Du 2014, Nguyen et al. 2015). However, there 
are still various points that need to be considered in the choice of disease to be modelled, such 
as availability of animal model, sources of somatic cells for reprogramming, availability of both 
healthy and affected tissues from patients (Colman and Dreesen 2009, 2009a).  
 
Disease model 
& Authors 
Methods  Findings  
Severe aplastic 
anemia (SAA). 
Melguizo-
Sanchis et al. 
2018 
hiPSCs were derived 
from unaffected controls 
and SAA patient and 
differentiated into 
hematopoietic 
progenitors. 
The in vitro model mimics 2 key features of 
SAA: (1) the failure to maintain telomere 
length during reprogramming process and 
hematopoietic differentiation resulting in 
SAA-iPSC and iPSC-derived-hematopoietic 
progenitors with shorter telomeres than 
controls; (2) the impaired ability of SAA-
iPSC-derived hematopoietic progenitors to 
gave rise to erythroid and myeloid cells.  
Miller-Dieker 
síndrome 
(MDS).  
Bershteyn et al. 
2017 
MDS patients derived 
hiPSCs and hiPSCs lines 
and  were differentiated 
into cerebral organoids 
Cell migration defect in the patient-derived 
organoids was rescued when the MDS 
causative chromosomal deletion were 
corrected  
Zika virus 
(ZIKV) 
infection. Qian 
et al. 2016 
hiPSCs lines were 
differentiated into 
forebrain, midbrain and 
hypothalamic organoids 
The organoids recapitulate key features of 
human cortical development, including 
progenitor zone organization, neurogenesis, 
gene expression, and a distinct 
humanspecific outer radial glia cell layer. 
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The forebrain organoid model of ZIKV 
exposure revealed preferential, productive 
infection of neural progenitors with either 
African or Asian ZIKV strains. ZIKV 
infection leads to increased cell death and 
reduced proliferation, resulting in decreased 
neuronal cell-layer volume resembling 
microcephaly. 
Dilated 
cardiomyopathy 
(DCM). Hinson 
et al. 2015 
Normal and DCM patient 
T cells were 
reprogrammed into 
hiPSCs via lentiviral 
delivery method and  
differentiated into 
cardiomyocytes 
Titin mutations in hiPSCs from DCM 
patients define sarcomere insufficiency as a 
cause of dilated cardiomyopathy 
Age-related 
macular 
degeneration 
(AMD). Chang 
et al. 2014 
T cells from patients with 
dry AMD were 
reprogrammed into 
hiPSCs via integration-
free episomal vectors and 
differentiated into retinal 
pigmented epitelial 
(RPE) cells 
The RPE cells derived from AMD patients 
have decreased antioxidative defense and 
are more susceptible to oxidative damage 
leading to AMD formation. Curcumin was 
found to effectively restore the neuronal 
functions in AMD patient-derived RPE. 
Ectodermal 
dysplasia (ED). 
Shalom-
Feuerstein et al. 
2013 
Fibroblasts from healthy 
donors and ED patients 
carrying two different 
point mutations in the 
DNA binding domain of 
p63 were reprogrammed 
into hiPSC via lentiviral 
infections and 
differentiated into 
epidermal cells 
EEC-iPSC from patients showed early 
ectodermal commitment into K18+ cells but 
failed to further differentiate into K14+ cells 
(epidermis/limbus) or K3/K12+ cells 
(corneal epithelium). APR-246 (PRIMA-
1MET), a small compound  that restores 
functionality of mutant p53 in human tumor 
cells, could revert corneal epithelial lineage 
commitment and reinstate a normal p63-
related signaling pathway. 
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Retinitis 
pigmentosa 
(RP). Tucker et 
al. 2013 
Normal and patient’s 
skin fibroblasts and 
keratinocytes were 
reprogrammed into 
hiPSCs via infection with 
Sendai viruses. The 
hiPSCs were allowed to 
form EBs which then 
differentiated into  multi-
layer eye cup-like 
structures with features 
of human retinal 
precursor cells 
Patient’s  hiPSCs were differentiated into 
multi-layer eye cup-like structures with 
features of human retinal precursor cells. 
Analysis showed the disease is caused 
through protein misfolding and endoplasmic 
reticulum (ER) stress. Transplantation  of 
the cells into 4-day-old immunodeficient  
mice resulted in the formation of 
morphologically and 
immunohistochemically recognizable 
photoreceptor cells, suggesting that the 
mutations in this patient had caused post-
developmental photoreceptor degeneration. 
Best disease 
(BD). Singh et 
al. 2013 
Normal and patient’s 
skin fibroblasts were 
reprogrammed into 
hiPSCs via lentiviral 
infection. The hiPSCs 
were differentiated into 
RPE cells 
Impaired photoreceptors’ outer segments 
(POS) handling was ssen in the 
pathophysiology of the disease using the 
RPE from mutant hiPSCs and contribute to 
the clinical picture of BD and studies on 
maculopathies. 
Retinitis 
pigmentosa 
(RP). Jin et al. 
2012 
Patient’s dermal 
fibroblasts were 
reprogrammed into 
hiPSCs by using a 
Sendai-virus vector. 
hiPSCs were 
differentiated into RPE-
like cells 
RP patient-specific rod cells recapitulated 
the disease feature and revealed evidence of 
ER stress and rod degeneration. 
Dystrophic 
epidermolysis 
bullosa.  Itoh et 
al. 2011 
Normal and patient’s 
dermal fibroblasts were 
reprogrammed into 
hiPSCs by retroviral 
transduction. The hiPSCs 
3D skin equivalents was generated 
using hiPSCs-derived keratinocytes, 
suggesting that the keratinocytes were fully 
functional. Autologous hiPSCs have the 
potential to provide a source of cells for 
31 
 
were differentiated into 
keratinocytes 
regenerative therapies for specific skin 
diseases. 
Table 1.9 : Various disease modelling experiments using hiPSCs. 
Recent advances in genetic editing created ways for the generation of complex genetic disease 
models. The application of genomic editing methods such as zinc-finger nucleases (ZFNs), 
transcription activator-like effector nucleases (TALENs) or clustered regularly interspaced 
short palindromic repeat–CRISPR-associated 9 (CRISPR–Cas9) substantially increases the 
efficiency of gene editing to correct the gene mutations afflicted by the diseases (Sterneckert et 
al. 2014) as well as inserting mutation in vitro to model a pathology (Hinson et al. 2015, Avior 
et al. 2016). Additionally, a more recent approach allowed RNA to be transiently edited by 
using CRISPR-Cas13 method (Abudayyeh et al. 2017). These techniques will offer a new hope 
for the patients with genetic disease through a treatment called genetic therapy (Niu et al. 2016, 
Maeder and Gersbach 2016). 
 
1.3 Anatomy of the Cornea and Limbus 
In an adult human, cornea is the transparent tissue layer located at the anterior part of eyeball. 
It covers the outermost surface of the iris, serving as a protective layer, refracting as well as 
allowing light to pass through to reach the retina (Zieske 2004). Unlike its peripheral 
neighbouring conjunctiva, it is devoid of blood vessels (Figure 1.6). Cornea consists of six 
layers (Dua et al. 2013) with three different types of cells (Figure 1.7). The outermost epithelial 
layer of cornea consists of 5 to 6 layers of non-keratinized stratified corneal epithelial cells, 
which express both cytokeratin 3 (CK3) and cytokeratin 12 (CK12) (Moll et al. 1982). 
 
 
Figure 1.6 : The cornea and limbus or corneoscleral junction in horizontal section (A), 
and anterior view (B). Adapted from 
http://medicine.academic.ru/137051/limbus_corneae 
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The cuboidal basal epithelial cells express cytokeratin 14 (CK14) (Merjava et al. 2011) and are 
called the corneal epithelial stem cells (CESCs). Unlike the basal cells, the suprabasal cells are 
flatter and express the corneal cytokeratins (CK3 & CK12) (Merjava et al. 2011). The corneal 
epithelium is resting on a basement membrane that connects the epithelium to the Bowman’s 
layer. This basement membrane component includes collagen-IV and laminin, where at adult 
stage the collagen-IV was found to be absent from the central cornea (Cleutjens et al. 1990).  
The Bowman’s layer beneath the basement membrane separates the epithelium and the corneal 
stroma that makes up 90% of the total corneal thickness (Figure 1.7).  
 
The corneal stroma comprises mainly extracellular matrices such as collagen I and V bundles 
and different types of proteoglycans with fibroblast-like keratocytes, dendritic cells and 
macrophages/monocytes scattered within it (Hamrah et al. 2003, Katikireddy et al. 2014). The 
keratocytes are neural crest-derived mesenchymal cells that could respond to injury by 
resuming repair phenotypes (West-Mays and Dwivedi 2006). The most anterior part of the 
corneal stroma has a specific architecture which is important in preserving the corneal smooth 
curvature even during extreme hydration (Müller et al. 2001, Bron 2001). The sub-basal region 
of the stroma contains the corneal nerve plexuses (Patel and McGhee 2005). Corneal stroma is 
supported by a strong well-defined layer (Dua’s layer) and Descemet’s membrane, which 
separate the stroma from a single layered endothelium on the innermost corneal layer (Dua et 
al. 2013). 
 
The corneal endothelium originates from neural crest cells, forms a monolayer posterior to 
Descemet’s membrane and controls corneal hydration and nutrition (Waring et al. 1982). It was 
reported that the adult, corneal endothelium express cytokeratins 8 and 18 (Merjava et al. 2009). 
It also forms a barrier between the corneal stroma and anterior chamber that maintains corneal 
transparency by regulating corneal hydration (Joyce 2003). These cells were also reported to be 
arrested in G1-phase that causes its non-replicative state. The non-replicative state is age-
relatedly reversible and important for the cells’ functional importance as a barrier and ‘pump’ 
(Joyce 2003). The corneal endothelial cells function and integrity is maintained by its own 
secreted Descemet’s membrane (Lwigale 2015).  
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Figure 1.7 : Representative histological diagram of cornea, showing the six different 
layers, based on Dua et al. 2013 and Lwigale 2015. 
 
Limbus is a junctional annular zone between the cornea and conjunctiva or sclera (Figure 1.6). 
It is also called the corneoscleral junction separating the avascular cornea from the surrounding 
conjunctiva, and is lined basally by the limbal stem cells (Ahmad 2012). Limbus was suggested 
to serve as an area where the corneal epithelial precursors with stem cell properties can be found, 
by Davenger and Evensen early in 1971 (Davenger and Evensen 1971). These stem cells reside 
on the basal epithelial layer of the limbus (Menzel-Severing 2011) in the highly pigmented 
areas called the Palisades of Vogt, as shown in Figure 1.8 (Higa et al. 2005, Li et al. 2007). 
These cells are called the limbal stem cells (LSCs) and have an important role in maintaining 
the homeostasis of the corneal epithelium, especially in response to injury (Cotsarelis et al. 
1989, Stepp and Zieske 2005). These basally located LSCs express cytokeratin 14 (CK14), 
cytokeratin 15 (CK15), ABCG2 and ΔNp63 (Watanabe et al. 2004, Kawasaki et al. 2005, de 
Paiva et al. 2005, Di Iorio et al. 2005, Figueira et al. 2007, Lyngholm et al. 2008).  
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Figure 1.8 : The cornea (image from https://discovery.lifemapsc.com/in-vivo-
development/eye/corneal-epithelium). 
 
In adult eyes, corneal epithelial cells are normally lost in the tear film. Homeostasis is 
maintained by the migration of the transient amplifying cells (TACs) centripetally from the 
limbus to central cornea, and they differentiate while moving from the basal to superficial layer 
of the cornea, to give rise to differentiated corneal epithelial cells (Figure 1.9). This pattern of 
movement of corneal cells is described as: x + y = z hypothesis by Thoft and Friend in 1983. 
Where x is the proliferation of basal cells, y is the centripetal movement of cells and z is the 
cell loss from the corneal surface (Thoft and Friend 1983).  
 
The LSCs niche is maintained by several intrinsic and extrinsic factors comprises a combination 
of anatomical and biochemical events that occurred during development as well as factors 
released by neighbouring cell populations (Espana et al. 2003, Kawakita et al. 2005). This niche 
is vital to protect the LCSs from unnecessary differentiation and apoptosis that compromise the 
stem cells reserve (Li and Xie 2005, Moore and Lemischka 2006).  The LSCs are more abundant 
in superior and inferior limbus, compared to the nasal and temporal side (Wiley et al. 1991). 
Following a minor corneal injury, LSCs will undergo asymmetrical mitosis and replicate to 
produce daughter cells, some of which will remain as stem cells and the rest are called TACs. 
These TACs are the progenitors that will differentiate to ultimately generate the terminally 
Palisades of Vogt 
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differentiated corneal epithelium to replace the damaged cells (Schlötzer-Schrehardt and Kruse 
2005). 
 
 
Figure 1.9 : The different cells in limbus and cornea. Adapted from Li et al. 2007.  
1.4 The Human Embryonic Development  
1.4.1 The TGFβ signalling pathways 
Embryonic development in human is largely regulated by the transforming growth factor β 
(TGFβ) superfamily of cytokines (Gordon and Blobe 2008). This superfamily includes more 
than 30 growth factors such as TGFβs, activins, inhibins, bone morphogenetic proteins (BMPs), 
growth differentiation factors including myostatin, nodal, leftys and Mullerrian-inhibiting 
substance (Heldin et al. 1997, Miyazono et al. 2005, Caestecker 2004). The TGFβ superfamily 
signalling pathways consist of type I and type II receptors where the TGFβ superfamily 
ligandscould bind. Activated receptors will interact with intracellular mediators (SMADs), 
either BMP (SMAD 1/5/8) or TGFβ (SMAD 2/3) responsive SMADs that will later form a 
complex with a common SMAD4 (Wrana and Attisano 2000). The complex will then be 
translocated into the nucleus where it could interact with other transcription factors to regulate 
cellular responses such as proliferation, differentiation, migration and apoptosis (Gordon and 
Blobe 2008).  Nodal/Activin and BMP subfamilies have also been shown to be important during 
the formation of the three germ layers of vertebrates, where low BMP activity in vertebrate 
ectoderm indicates neural tissue (Wu and Hill 2009). Any alterations in the TGFβ superfamily 
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pathways or its members could result in human diseases and developmental disorders 
(Massague et al. 2000).  A schematic diagram showing the TGFβ signalling pathways is shown 
below.  
 
 
Figure 1.10 : The TGFβ and BMP signalling pathways. Adapted from Villapol et al. 
2013. 
 
1.4.2 The development of eye and cornea 
Human eye development in utero begins as early as 3 weeks post-gestation with the formation 
optic grooves followed by optic vesicles at either sides of the forebrain. The process starts with 
the formation of its major structures that originated from four main embryonic sources; 
neuroectoderm, optic neural crest, mesoderm and surface ectoderm (O’Rahilly 1975, 1983, Jean 
et al. 1998). The development of the eye in the anterior neural plate of prosencephalon region 
(Figure 1.11A and B) involved complex interactions and mechanisms (reviewed by Jean et al. 
1998, Sinn and Wittbrodt 2013).  
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The early stages of eye development are mainly regulated by PAX6 (Collinson et al. 2003, Graw 
2010), a key gene that has also been shown to induced ectopic eyes and ectopic expression of 
other early eye development genes such as OTX2, RX, and SIX3 when misexpressed (Chow et 
al. 1999, Chow and Lang 2001). Initially, PAX6 induces a single eye field formation in the 
anterior neural plate. Later, SHH overexpression causes PAX2 expression and represses PAX6 
during the separation of the eye field as shown in Figure 1.11 C (Litwack 2012). 
 
 
Figure 1.11 : Formation and separation of eye field in the anterior neural plate. External 
view of a neural plate at 3 weeks (A). Sectional views of the developing brain, 
prosencephalon region (B and C). Figures taken from Sadler 2014. 
 
At 3 weeks after gestation, the two eye fields are the first to appear, and soon the optic vesicles 
start to form as shown in Figure 1.12 B – D (Sadler and Langman 2010). Evagination of the 
eye primordia on either sides of the forebrain tube lead to the formation of optic vesicles that 
extend toward overlying surface ectoderm. During this process, inductive signals are exchanged 
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between the optic vesicles and its adjacent ectoderm resulting in the formation of lens placode 
and early optic cup (Chow and Lang 2001, Martinez-Morales and Wittbrodt 2009). During the 
fourth and fifth weeks, the lens placodes and optic vesicles become invaginated to form the lens 
pits/vesicles and optic cups respectively (O’Rahilly 1975). 
 
 
Figure 1.12 : Development of optic vesicles. External view of 5 – 6 weeks embryo (A). 
Sections from developing embryos at different time points (B, C, D). Adapted from Sadler 
and Langman 2010. 
 
During the optic vesicles formation process, TGFβ and FGFs are released by surrounding 
mesenchyme and surface ectoderm respectively (Figure 1.13A), enhancing optic vesicle cells’ 
migration and differentiation during the morphogenesis (Sanford et al. 1997). Retinoic acid 
(RA) was also reported to have an influence in the peri-ocular mesenchyme migration in mice 
eye morphogenesis (Matt et al. 2005). Then MITF and CHX10 expression were detected and 
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localised in the invaginating optic cup regions, where the pigmented and neural retina will later 
develop from respectively (Nguyen and Arnheiter 2000). As development proceeds, the 
expression of PAX2 is maintained in the optic stalk and PAX6 in the lens placode (Figure 1.13 
C) (Sadler 2014). At this stage PAX6 regulates the lens formation, while the optic vesicles 
express BMP4 (Chang et al. 2001). BMP4 improves and maintains the expression of SOX2 and 
LMAF, the genes that act together with PAX6 to initiate lens crystallin formation (Matsushima 
et al. 2011). The crystalline formation gene is in turn regulated by SIX3 (Goudreau et al. 2002) 
during lens morphogenesis.  
 
 
Figure 1.13 : Molecular regulation in early stages of eye development (3 – 4 weeks). 
Adapted from Sadler 2014. 
 
At around 5 – 6 weeks of gestation, cornea starts to develop as the surface ectoderm closes 
following the formation of lens vesicles. Corneal development is also regulated by a complex 
process involving interactions between the surface ectoderm and the adjacent developing 
tissues such as the lens (Cvekl and Tamm 2004). During this period, the space between the lens 
vesicles and surface ectoderm is filled with mesenchymal cells from the neural crest. These 
cells later differentiate into corneal stroma and endothelium (Figure 1.14). The surface 
ectoderm that covers the anterior side of the mesenchyme will develop into corneal epithelium 
(Graw 2010, Zavala et al. 2013). At the same time the eyelids develop covering the external 
surface of the cornea.  
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Figure 1.14 : Formation of the cornea. Adapted from Zavala et al. 2013. 
Although the cornea as a whole comprises three closely located main components; corneal 
epithelium, its stroma and the endothelium, those components actually developed from different 
embryological origins. The corneal epithelium developes from surface ectoderm (Hay 1980) 
and the stroma and the endothelium developed from the mesenchymal tissue and neural crest 
cells (Amano et al. 2006, Graw 2010, Swamynathan 2013). The corneal epithelium shares the 
same characteristics as other non-keratinised stratified squamous epithelia, with an exception 
of being transparent. New epithelial cells are continuously regenerated by the limbal stem cells 
(LSCs) which are thought to reside at the Palisades of Vogt in the limbus (Schlotzer-Schrehardt 
& Kruse 2005, Li et al. 2007).  
 
Those cells progressively migrate from peripheral to central region of the cornea, and ascend 
from basal to superficial layer to form a new stratified layer of non-keratinised squamous 
epithelium (Lu et al. 2001). These new epithelia compose of intermediate filaments that ensure 
them to anchor each other and stay firmly on the cornea, namely cytokeratins 3 and 12 (CK3 
and CK12). Thus making CK3 and CK12 as useful markers for differentiated human corneal 
epithelium (Auw-Haedrich et al. 2011). Markers for the various stages of human corneal 
epithelial differentiation from pluripotent stem cells (PSCs) are listed in the following table.  
 
Development stages Markers  Function / location  
PSCs OCT4, NANOG Pluripotency markers / embryonic stem cells 
Eye field  PAX6, SIX2, SIX3 Eye development master genes /  neural 
plate & adult corneal stroma progenitor cells 
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Ectoderm  BMP4 Non-neural ectoderm marker / pre-placodal 
ectoderm 
Epithelium  K8, K18 Simple epithelium / superficial corneal cells 
ECadherin Cell adhesion / cornea and limbus 
Corneal progenitors ΔNp63, ABCG2 Putative limbal stem cells marker / basal 
limbus 
CK14, CK15 Structural proteins / basal limbal and basal 
corneal cells 
Corneal epithelium CK3, CK12 Structural proteins / superficial cells of 
central cornea 
CK19 Structural protein / peripheral cornea, 
limbus and conjunctiva 
Conjunctiva  CK13 Structural protein / conjunctiva 
Table 1.10 : Markers of various corneal epithelial differentiation stages. Adapted from  
Funderburgh et al. 2005, Moll et al. 2008, Merjava et al. 2011 and Mort et al. 2012). 
 
Based on the eye and corneal development process together with the outcomes of various 
studies in the corneal epithelial differentiation and LSCD treatment fields, it is evident that there 
is still no robust and efficient protocol that could differentiate both hESCs and hiPSCs towards 
functional corneal epithelium lineages. Furthermore, successful engraftment of hESCs or 
hiPSCs-derived corneal epithelial cells in animal model of LSCD has also not been reported to 
date. Thus our project was planned and aimed to address those needs. 
 
1.5 Project Aims 
1. To define efficient protocols for hESCs differentiation to corneal epithelial lineages. 
2. To assess the efficiency of the hESCs derived protocols on hiPSCs. 
3. To investigate the engraftment of hESCs and hiPSCs derived corneal epithelial-like cells 
in a mouse model of LSCD.  
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CHAPTER 2. GENERAL MATERIALS AND METHODS 
 
2.1 General Laboratory Practice 
All experiments were carried out according to the Control of Substances Hazardous to Health 
(COSHH and BIOCOSHH) regulations. Cells and tissue culture experiments were performed 
in compliance with regulations for containment of Class II pathogens. All experimental 
procedures were in compliance with Newcastle University current safety policies. 
 
2.2   Cell Culture 
Human embryonic stem cell (hESC) line, H9 was purchased from WiCell (WiCell Research 
Institute, Inc. USA) and human induced-pluripotent stem cells (hiPSCs), SB-Ad2 and SB-Ad3 
were generated and fully characterised in our group (Baud et al. 2017). All cell culture 
experiments were performed in a Class II biosafety cabinet laminar air flow tissue culture hood. 
Cells between passages 18 to 50 were used. 
 
2.2.1  Preparation of mTeSR™1 medium (STEMCELL Technologies, Cambridge, MA) 
A bottle of 5 x Supplement for mTeSR™1was thawed overnight at 2 - 8°C. The thawed 100 
mL supplement was aseptically added to 400 mL mTeSR™1 Basal Medium to make a total 
volume of 500 mL. 5.0 mL of Penicillin/Streptomycin (Pen/Strep)(Gibco, UK) was added and 
the medium was well mixed. The complete mTeSR™1 medium is stable when stored at 2 - 8°C 
for up to 2 weeks. 
 
2.2.2  CORNING Matrigel matrix (Corning, USA) coated plates preparation 
A working solution of CORNING Matrigel (hESC-qualified) was the solution prepared for 
actual use by adding cold 240 µL Matrigel stock aliquot (thawed from -20°C on ice) to 15 mL 
of cold knock-out DMEM (Gibco, UK) to coat two and a half 6-well plates. 1.0 mL of the 
Matrigel working solution was pipetted onto each well of a cold 6-well plate. Formation of air 
bubbles was avoided by carefully pipetting the liquid into the wells. Matrigel solution was 
evenly spread by carefully swirling the solution across the surface. A chilled pipette tip was 
used to break any trapped air bubbles in the plate. Plates were incubated at room temperature 
(15-25°C) for at least 1 hour before use. Excess coating solution was aspirated carefully prior 
to adding 1.0 mL of mTeSR™1 medium into each coated well, before plating in cells. Coated 
plates were stored at 4°C for up to a week. The plates were sealed to prevent dehydration (e.g. 
using parafilm). 
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2.2.3 Thawing cryopreserved hESCs or hiPSCs 
The hESCs/hiPSCs vial was removed from the liquid nitrogen storage tank. The vial was rolled 
between gloved hands for about 10-15 seconds to remove the frost. The vial was immersed and 
gently swirled in a 37°C water bath using long forceps without submerging the cap. The vial 
was removed from the water bath once only ice crystal remained in it. The outer surface of the 
vial was sterilised by spraying the tightly capped vial with 70% ethanol. The cells were then 
transferred gently into a sterile 15 mL conical tube using a 5.0 mL pipette. 11 mL of mTeSR™1 
medium was added drop-wise to cells in the 15 mL conical tube. At the same time the tube was 
gently moved back and forth to mix the pluripotent stem cells and to reduce osmotic shock to 
the cells. The cells were then centrifuged at 1000 rpm for 5 minutes. The supernatant was 
aspirated and the cell pellet was resuspended 0.5 mL mTeSR™1 medium for every well that 
will receive cells. The cells were then gently pipetted up and down in the tube.  
 
A 6-well plate coated with Matrigel was labelled with the cell line name, the passage number 
from the vial, the date and initials. Excess Matrigel coating solution was removed from the 
wells and 1.5 mL mTeSR™1 medium containing 10 µM Rho kinase inhibitor (ROCKi) 
(Y27632) (Chemdea, NJ, USA) was added to each well. Then 0.5 mL of the cell suspension 
was added drop-wise into each well. The plate was gently shaken back and forth and side to 
side to evenly distribute the cells. Circular motion was avoided to prevent pooling of cells in 
the centre of the well. Cells in each well were examined under a microscope and the plate was 
gently placed in the incubator. Spent medium was replaced daily from the wells. 
 
2.2.4  Feeding pluripotent stem cells 
The hESCs/hiPSCs were observed using a microscope to monitor cell growth or for any 
differentiating cells. The spent medium was aspirated and 2.0 mL of fresh mTeSR™1 medium 
was added into each well. This procedure was repeated daily until the cells require passaging. 
 
2.2.5  Passaging hESCs or hiPSCs on Matrigel with EDTA 
Cells were passaged every 3 to 4 days using 0.02% ethylene diamine tetraacetic acid 
(EDTA)(Versene, Belgium) solution. Initially, spent medium was aspirated and each well of a 
6-well plate was washed with 2.0 mL of calcium and magnesium free Dulbecco phosphate 
buffered saline (DPBS) (Gibco, UK). The DPBS was aspirated and 1.0 mL of EDTA 0.02% 
solution was added to the well. The cells were incubated in a tissue culture incubator in a dark 
at 37°C and 5% CO2 for 3 – 5 minutes. After the incubation period, cells were observed under 
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a microscope to check if the cell colonies were detaching from the plastic surface. The EDTA 
was aspirated and 3.0 mL of mTeSR™1 medium (1:3 passaging ratio) was added. The cell 
colonies were detached mechanically by pipetting and the resulting cells suspension from one 
well was added drop-wise into three wells of pre-warmed 6-well plate coated with Matrigel and 
supplemented with 1.0 mL mTeSR™1 medium per well. The plate was gently shaken back and 
forth and side to side to evenly distribute the cells. Cells in each well were examined under the 
microscope and the plate was gently placed in the incubator.  
 
2.2.6  Cryopreservation of hESCs or hiPSCs grown on Matrigel 
Spent medium was aspirated and each well of a 6-well plate containing 90% confluent cells 
was washed with 2.0 mL of calcium and magnesium free DPBS (Gibco, UK). The DPBS was 
aspirated and 1mL of warm StemPro Accutase (Gibco, UK) solution was added to the well.  
The cells were incubated in a tissue culture incubator in dark at 37°C and 5% CO2 for 3 – 5 
minutes. After the incubation period, cells were observed under a microscope to check if the 
cell colonies could easily be detached from the plastic surface. 3.0 mL of cold mTeSR™1 
medium was added to each well. The cell colonies were detached mechanically by pipetting to 
produce a single cells suspension. The cell suspension was then being centrifuged at 1000 rpm 
for 3 minutes. Supernatant was discarded and the cell pellet was resuspended in 1.0 mL of filter-
sterilised freezing medium consisting of 90% fetal bovine serum (FBS, Gibco, UK), 10% 
dimethyl sulfoxide (DMSO, Sigma Aldrich, Germany) and 10 µM ROCK inhibitor. The cell 
suspension in freezing medium was then transferred to a cryovial labelled with cell name, 
passage number, date and initial. The cell vial was transferred to a pre-cooled isopropanol-
containing freezing container and stored in -80°C freezer for 1 or 2 days before being 
transferred into a liquid nitrogen storage container for long-term storage.  
 
2.2.7  Preparation of 3T3 fibroblasts medium 
3T3 fibroblast medium was prepared by mixing 89% high glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM) + GlutaMAX, 10% FBS and 1% Pen/Strep. The resulting medium 
was filter-sterilised and stored at 2 - 8°C for 2 to 4 weeks. 
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2.2.8  Thawing and culturing 3T3 fibroblast cells 
The fibroblast medium was warmed up to room temperature. A volume of 5.0 mL of the 
fibroblast medium was transferred to a 15 mL falcon tube. Cryovial containing 3T3 cells was 
quickly defrosted in a hot bath, until only small crystals of ice were left in the vial. A volume 
of 1 mL of fibroblast medium was added drop by drop to the cryovial containing the cells. The 
cells suspension was then transferred drop by drop to the falcon tube containing 5.0 mL of 
fibroblast medium. The falcon tube with cell suspension was then being centrifuged at 1000 
rpm for 3 minutes. While the centrifuge is running, 5.0 mL of fibroblast medium was added to 
a labelled T25 flask. After centrifugation, the supernatant was discarded and the cell pellet was 
resuspended in 1.0 mL fibroblast medium. The cell suspension was then transferred to the T25 
flask and the flask was gently rotated in order to uniformly spread the cells. The flask containing 
cells was incubated at 37°C in 5% CO2. 
 
2.2.9  Passaging of 3T3 fibroblasts 
Spent medium was aspirated from the 80% confluent T75 culture flask. The flask was briefly 
washed with PBS. A volume of 5.0 mL of 0.05% Trypsin-EDTA (Gibco, UK) was transferred 
into the T75 flask to cover the surface of the flask. The flask was incubated for 5 minutes at 
37°C. A double quantity (10 mL) of 3T3 fibroblast medium was added to the flask to inactivate 
the trypsin. The cell suspension was transferred into a 50 mL falcon tube. The falcon tube was 
centrifuged at 1000 rpm for 3 minutes. While the centrifugation was taking place, 15 mL of 
fibroblast medium was transferred into each of the new T75 flasks. The supernatant was 
aspirated and the cell pellet was resuspended in 1.0 mL of fibroblast medium. The cell 
suspension was split in the ratio desired (e.g:1:4), and transferred into new labelled flasks. The 
flasks were incubated at 37°C in 5% CO2. Medium was changed on the third day and every 
other day from then on. 
 
2.2.10  Cryopreservation of 3T3 fibroblasts 
Freezing medium was prepared as follows: 90% FBS and 10% DMSO. The medium was then 
filter sterilised and stored at 4°C. Cryovials were labelled with the cell line, passage number, 
and cryopreservation date and name initials. Spent medium was aspirated from the T75 culture 
flask with the 80% confluent 3T3 fibroblasts. The flask was then briefly washed with PBS. 5.0 
mL of 0.05% Trypsin-EDTA was added to the T75 flask to cover the surface of the flask. The 
flask was then incubated at 37°C for 5 minutes. A double quantity (10 mL) of 3T3 fibroblast 
medium was added to the flask to inactivate the trypsin. The cell suspension was transferred 
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into a 50 mL falcon tube. The falcon tube was centrifuged at 1000 rpm for 3 minutes. 
Supernatant was discarded and the cell pellet was resuspended in 2.0 mL of freezing medium. 
The resulting suspension was transferred into two cryovials. The cryovials were then stored in 
-80°C and then transferred to a liquid nitrogen storage 24 – 48 hours later. 
 
2.2.11   Inactivation of 3T3 fibroblasts using mitomycin C 
2.0 mg of mitomycin C (MMC) from Streptomyces caespitosus (Sigma-Aldrich, Germany) 
powder was dissolved in 2.0 mL of knock-out DMEM to make a stock concentration of 1 
mg/mL mitomycin C solution. The stock solution was kept at 4°C in the dark. Spent medium 
from a T75 flask containing 80% confluent 3T3 fibroblasts was aspirated. The flask was briefly 
washed with DPBS. Then, 7.5 mL of fresh fibroblast medium was added to the flask. 7.5 µL of 
1 mg/mL mitomycin C was added to the medium in the flask making up a final concentration 
of 1.0 µg/mL mitomycin C in the mixture. The mixture was mixed well and allowed to cover 
all the growing cells in the flask. The flask was incubated for 2 hours in the incubator at 37°C 
in 5% CO2.   
 
2.2.12   Preparation of gelatine coated plates 
2.04 g of porcine gelatine powder was dissolved in 100 mL distilled water in a glass bottle. The 
solution mixture was autoclaved. The autoclaved 2% gelatine solution was aliquoted in 15 mL 
falcon tubes and stored in -20°C as long term stocks. The 2% gelatine solution was diluted in 
PBS to make up 0.2% gelatine/PBS solution. The 0.2% gelatine in PBS was filter sterilised and 
kept at 37°C before being used to coat the plastic plates. A volume of 1.5 mL of 0.2% 
gelatine/PBS was added into each well of a 6-well plate. The plate was incubated at 37°C for 1 
hour or for 2 hours at room temperature in a laminar flow cabinet. The excess gelatine was 
aspirated from the wells. The wells were allowed to dry briefly before 2.0 mL 3T3 fibroblast 
medium is added. 
 
2.2.13   Preparation of 3T3 fibroblasts feeder plates 
After 2 hours of incubation, the fibroblast medium with added mitomycin C was removed from 
the 3T3 cells in T75 flask. The cells were then washed three times with PBS. Then 5.0 mL of 
0.05% Trypsin-EDTA was added to the flask and the cells were incubated with trypsin for 5 
minutes at 37°C. After 5 minutes, 10 mL of fibroblast medium was added to the flask. The cell 
suspension was then transferred to a 50 mL falcon tube and centrifuged at 1000 rpm for 3 
minutes. Supernatant was discarded and the cell pellet was resuspended in 5.0 mL of fibroblast 
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medium. Cell count was performed using dual-chamber haemocytometer and a light 
microscope. 24.03 x 103 cells were added into each well of the 6-well gelatine coated plates 
containing fibroblast medium. The plates were gently rocked forward and backward, and from 
side to side to spread the cells evenly on the plate. The plated cells were incubated at 37°C. The 
feeder plate will be ready to use on the following day. 
 
2.2.14  Preparation of limbal epithelium medium (Yu et al. 2016) 
The limbal epithelium medium was prepared by mixing together and filter-sterilising the 
following reagents: for a 500 mL epithelial medium: 75% low-glucose Dulbecco's modified 
Eagle's medium (DMEM) and 25% Ham's F12 medium (both Gibco, UK). This composition 
was supplemented with the following: 10% fetal bovine serum (FBS), 1% 
penicillin/streptomycin (both Gibco, UK), 500 µL hydrocortisone (0.4 mg/mL), 250 µL insulin 
(5 mg/mL), 35 µL triiodothyronine (1.4 ng/mL), 300 µL adenine (24 mg/mL), 84 µL cholera 
toxin (8.4 ng/mL) and 50 µL EGF (10 ng/mL) (all Sigma-Aldrich, UK). 
 
2.2.15   Seeding cells on 3T3 fibroblasts feeder plates for colony forming efficiency (CFE) 
assay 
Cell suspensions from different experimental groups on day 9 and day 20 were mixed well in 
their respective vial. Cell counts were performed for each group using a dual-chamber 
haemocytometer and a light microscope. Fibroblast medium was removed from the feeder 
plates and it was replaced by the limbal epithelial medium. 500 – 1000 cells were added to each 
well containing the feeder cells and the limbal epithelial medium. Three wells of CFE were set 
for each group in each biological replicate. The limbal epithelial medium was replaced after 
three days and every other day thereafter. The CFE plates were regularly observed and kept in 
culture for 14 days. 
 
2.2.16   Staining the cell colonies with rhodamine-B (Sigma-Aldrich, Germany) 
After 14 days, spent medium was aspirated from the CFE plates and the wells were washed 
with PBS once. Then 1.0 mL of 3.7% formaldehyde (VWR chemicals, UK) was added into 
each well. The cell colonies were fixed in formaldehyde for 10 minutes at room temperature. 
Then the formaldehyde was discarded. The wells were washed with PBS once before enough 
volume of 1% rhodamine-B in absolute methanol (VWR chemicals, UK) was added to each 
well. The colonies were stained for 10 minutes before the stain being washed three times with 
PBS. Stained cell colonies (shown by the arrows) in cell culture plates (Figure 2.1) were 
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observed and counted with the aid of a dissection microscope. Adult human limbal epithelial 
cells were used as positive control for all CFE. 
 
Figure 2.1 : A representative photo of cell colonies stained with rhodamine-B in a cell culture 
plate from differentiating hESC (H9) in a 6-well plate. Black arrows showing some of the stained 
cell colonies.  
 
2.3  RNA Isolation From Cells 
RNA was extracted from the cells collected from experimental hESCs and iPSCs and at days 
0, 3, 6, 9, 14, 20 of the monolayer experiment. This was achieved using the ReliaPrepTM RNA 
Cell Miniprep System (Promega, WI) following methods as described in the instruction manual.  
 
In brief, cell pellets were mixed with 500 µL BL buffer with added 1-Thioglycerol to lyse the 
cells.  Then sample tubes were briefly centrifuged. A collection tube and a mini column for 
each sample were prepared and the mini column was labelled accordingly. 170 µL of 100% 
isopropanol (VWR chemicals, UK) was added to the sample cell lysate and the solution was 
carefully mixed by pipetting. The sample mixture was then transferred into the mini column 
and being centrifuged for 30 seconds at 12,000 – 14,000g at 20 – 25°C. The mini column was 
removed and the liquid in the collection tube was discarded before the mini column was placed 
back into the collection tube. 
 
500 µL RNA wash solution (diluted with ethanol) was added to the mini column and then being 
centrifuged for 30 seconds at 12,000 – 14,000g at 20 – 25°C. The collection tube was emptied 
as before. DNase I incubation mixture was prepared by combining 24 µL of Yellow Core Buffer, 
3.0 µL of MnCl2 (0.09M) and 3.0 µL of DNase I enzyme to make up the total of 30 µL of 
solution mixture. This mixture was mixed gently by pipetting. 
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30 µL of freshly prepared DNase I incubation mix was directly applied to the membrane inside 
the mini column to thoroughly cover the membrane. The DNase 1 mixture on the mini column 
membrane was allowed to incubate for 15 minutes at room temperature. Then, 200 µL column 
wash solution (added with ethanol) was added to the mini column before being centrifuged for 
15 seconds at 12,000 – 14,000g at 20 – 25°C. 500 µL of RNA wash solution (ethanol added) 
was added and the mini column was centrifuged again for 30 seconds at 12,000 – 14,000g at 
20 – 25°C. The mini column was transferred into a new collection tube and 300 µL of RNA 
wash solution (ethanol added) was added. The mini column was centrifuged at high speed for 
2 minutes and then the mini column was transferred to a labelled elution tube. 15 µL of nuclease 
free water was added to the mini column membrane to completely cover the membrane surface 
with water. The mini column in elution tube was then being centrifuged for 1 minute at 12,000 
– 14,000g at 20 – 25°C. Then the mini column was discarded and the elution tube was capped. 
The purified RNA was stored at -80°C. 
 
2.3.1 RNA quantification 
The RNA concentration was measured using a Nanodrop Spectrophotometer 2000 (Thermo 
Fisher, MA) machine. Initially the spectrophotometer was calibrated with 1.0 μL nuclease free 
water as a blank solution and followed by 1.0 μL of the RNA sample. A260/280 is the 
absorbance ratio to determine the purity of RNA or DNA. A value of 1.5 – 2.5 is acceptable for 
DNA or RNA purity.  
 
2.4 Reverse Transcription 
GoScriptTM Reverse Transcription System (Promega, WI) was used to convert 1.0 µg of 
extracted RNA into cDNA following the method described in the instruction manual. 
Experimental RNA, Primer Oligo (dT)15 (0.5 µg/reaction) and Nuclease-Free water were 
briefly centrifuged and mixed to make up a total volume of 5.0 µL. The mixture was then heated 
in a 70°C heat block for 5 minutes. It was then immediately chilled in ice water for at least 5 
minutes before being centrifuged for 10 seconds and stored on ice. The reverse transcription 
mix was prepared on ice by mixing 4.0 µL of GoScript 5x Reaction buffer, 3.0 µL of MgCl2 
(final concentration (1.5 – 5.0 mM), 1.0 µL of Oligo (dT)15 primer, 1.0 µL of  GoScript Reverse 
Transcriptase and 6.0 µL of  nuclease-free water to a final total volume of 15 µL for each cDNA 
reaction. 15 µL of reverse transcription mix was combined with the 5.0 µL of RNA and primer 
mix prepared earlier. Then the reaction mixture was annealed in a heat block at 25°C for 5 
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minutes, extended in a heat block at 42°C for up to 1 hour using a thermal cycler machine 
(Eppendorf, UK), and then stored at -20°C. 
 
2.5 Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-
PCR) 
2.5.1  Primer design 
Gene sequences were obtained from National Centre for Biotechnology Information (NCBI) 
and Basic Local Alignment Search Tool (BLAST®) databases specified for human species. 
NCBI/Primer-BLAST was used to design forward and reverse primers for all the genes. 
Designed primers were generally 17-25 nucleotides in length within the 100-200 bp product 
size and both the forward and reverse primers are spanning an exon-exon junction so that 
genomic contamination can be avoided. The melting temperature (Tm) was determined for both 
the forward and reverse primers using the formula: 
Tm = 4(G+C) + 2(A+T). The initial annealing temperature (Ta) used for each PCR reaction 
was generally 5°C below the lowest Tm of the primer pair (forward and reverse primers). 
 
2.5.2 Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and 
analysis 
For quantification of genes expression in the control and experimental hESCs and hiPSCs, qRT-
PCR was used. For each of qRT-PCR reaction mixture, 1.0 µL of cDNA produced from 1.0 µg 
of RNA was amplified in a 384-well plate using the 2x GoTaq® qPCR Master Mix (consisting 
of Hot Start Polymerase, MgCl2, dNTPs and reaction buffer) with carboxy-X-rhodamine (CXR) 
reference dye (both by Promega, WI). In summary, Forward primer, Reverse primer and 
Nuclease-free water were mixed to make up 1.0 µM primers mixture solution for each target 
gene. The resulting solution was briefly centrifuged before being kept on ice. The cDNA 
samples were then diluted in micro-eppendorf tubes and kept on ice. Diluted cDNAs were then 
added to qPCR mastermix in 1.5 mL eppendorf tubes before nuclease-free water was added to 
the mixture. Then, CXR reference dye was added to the mixture and the tubes containing 
sample mixtures were centrifuged briefly then kept on ice. A qPCR plate was labelled before 
7.5 µL of each sample mixtures was loaded to each well. Unopened stickers were used as guide 
and to avoid cross contamination during sample loading.  
 
The qPCR plate was then centrifuged briefly and checked to ensure that all the wells were 
loaded with sample solution. 2.5 µL of primer mix was added to each sample containing wells. 
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The plate was centrifuged again for 1 minute and checked for any missing reaction solution. A 
sticker sheet was then applied on the plate and properly pressed down onto the plate. The sticker 
edges were trimmed. The plate was then centrifuged for 5 minutes. The qPCR machine was 
turned on and the qPCR program was started, a new experiment was set up and the programme 
was set to ‘RUN’ after the qPCR plate was placed on the machine tray. 
 
The reactions analyses were carried out using The Applied Biosystems 7900HT Fast Real-Time 
PCR System by Life Technologies in a similar sequence to that of standard PCR. Following 
completion of the PCR program, the data was analysed using SDS v2.4 software (Applied 
Biosystems) for ΔΔCt and 2- ΔΔCt calculations (Livak and Schmittgen 2001).      
 
2.6 Immunocytochemistry (ICC) 
Cells were dissociated and kept as suspension in 2% FBS/PBS on ice. Cell count was manually 
performed using dual-chamber haemocytometer and a light microscope prior to cytospin step. 
 
2.6.1 Cytospining cells suspensions for slides preparation 
Slides were initially labelled, and then the slides and filters were correctly placed into 
appropriate slots in the cytospin with the cardboard filters facing the center of the cytospin. 
Each filter and slide pair is clipped with each other and the hole in the filter is in proper position 
so that cells will be able to reach the slide. 100 µL of cell suspension with known number of 
cells per µL (1000 cells/µL) was quickly aliquoted into a cyto-funnel chamber corresponding 
to a correctly labelled slide. The lid of the cytospin was carefully placed over the samples and 
spun at 1000 rpm for 3 minutes. The filters were removed from their slides without contacting 
the smears on the slides. A border line encircling the cells’ area on the slide was then drawn 
using an ImmEdge Hydrophobic Barrier Pen (Vector Laboratory, Burlingame, CA). 
 
2.6.2  Antibody dilution optimisation 
Dilution optimisations for each of primary antibodies was carried out by diluting the primary 
antibody in antibody diluent comprising PBS, 0.1% bovine serum albumin (BSA) (Sigma 
Aldrich, Germany) and 0.3% Triton-X-100 (Sigma Aldrich, Germany), to make up 1:50 and 
1:100 dilutions. Similar optimisation step was carried out for secondary antibodies, where the 
dilution factors used were 1:600 and 1:800. Dilutions that gave bright signal and less 
background were selected. 
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2.6.3  Immunostaining the cytospun cells 
On the first day, cytospun cells on slides were first fixed in 4% paraformaldehyde (Sigma 
Aldrich, Germany) for 30 minutes at room temperature. The cells were washed with PBS for 3 
times (5 minutes each time). Cells were permeabilized with 0.1% Triton X-100 for 15 minutes. 
A blocking solution consisting of 5% BSA, 5% goat serum (SigmaAldrich, Germany) and 0.3% 
triton-X-100 was added for 1 hour. For surface markers, the same blocking solution was used 
but without the addition of Triton-X. Primary antibody was diluted in antibody diluent to give 
desired working concentration. Diluted primary antibody was added to the cells and left in the 
fridge/cold room in a wet chamber overnight at 4°C.  Control immune-labelling where only 
secondary antibody was added was prepared in all experiments.  
 
On the next day, the secondary antibody was diluted in antibody diluents as for the primary 
antibody. The cells were washed with antibody diluent for 3 times (3 minutes each wash). 
Secondary antibody was then added and left at room temperature for 2 hours.  The secondary 
antibody is photosensitive and must be kept in the dark to avoid bleaching of the fluorochromes. 
The wells were washed using antibody diluent for 3 times (3 minutes each time). 4',6-
diamidino-2-phenylindole (DAPI) (dilution 1:10) was added to the wells to stain the cell nuclei 
for 5 minutes. The wells were then washed 3 times (3 minutes each) using PBS. The slides were 
mounted using Vectashield (Vector Laboratories, Burlingame, CA) with Hoechst 33342 
Solution (2000:1) (Thermo Scientific, UK) and they were covered with cover slips in the case 
of plates. Plates were stored in the fridge in the dark for up to 4 weeks and imaging repeated.  
 
2.7 Microscopy and Quantification Software 
2.7.1 Inverted microscopy 
Cells in cultures, plates, and flasks were observed using a Bioscience Axiovert 200M 
microscope in combination with the associated CarlZeiss software-AxioVision, which allows 
the performance of transmitted light bright field, phase contrast and epifluorescence technique. 
Images were then processed using the AxioVision40 version 4.8.2.0 software (Zeiss AxioVert 
1, Germany).  
 
2.7.2 Fluorescence microscopy 
Dry slides were observed under a fluorescence microscope. Pictures were taken at different 
magnifications on the same day up to 2 days after fluorescence staining to keep the quality of 
the images all the same. The images captured at 20x magnification using the fluorescence 
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microscope were exported as JPEG files. Three images were captured for each slide from each 
of the experimental groups. ImageJ software was then used to count the stained and unstained 
cells from the pictures. Five fields, each containing more than 100 cells were counted for each 
group. 
 
2.8 Statistical Analysis 
Quantitative data were presented as mean ± standard error of mean. Statistical analysis and 
graphs generation were carried out using Microsoft Excel and GraphPad Prism 7 software. 
Significance differences between the data were analysed using one-way ANOVA, in which a p 
value less than 0.05 (p<0.05) was considered as statistically significant. In each figure the 
shown values represent the mean ± SEM (n = 3). * denotes p < 0.05; ** denotes p < 0.01, *** 
denotes p< 0.001 and **** denotes p< 0.0001. 
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CHAPTER 3. DIFFERENTIATION OF HESCS AND HIPSCS INTO 
CORNEAL EPITHELIAL LIKE CELLS 
 
3.1 Introduction 
Cornea is the transparent region at the front of the eye which enables transmission of light to 
the retina. It comprises the corneal epithelium, stroma and endothelium. The corneal epithelium 
is continuously regenerated by limbal stem cells (LSCs) (Schlotzer-Schrehardt and Kruse 2005, 
Li et al. 2007) which migrate from peripheral to central region of the cornea and ascend from 
basal to superficial layer in order to differentiate and form a new stratified layer of non-
keratinized squamous epithelium (Lu et al. 2001). The corneal epithelium develops from 
surface ectoderm (Hay 1980), whilst the stroma and endothelium developed from the 
mesenchymal tissue and neural crest cells (Amano et al. 2006).  
 
Limbal stem cell deficiency (LSCD) is a disease caused by the loss or dysfunction of LSCs, 
leading to loss of corneal epithelial integrity and function, resulting in persistent pain and severe 
visual impairment (Dua et al. 2000). Work done by our group and others have shown that the 
transplantation of ex vivo expanded autologous LSCs is able to reconstruct the corneal surface 
and to restore vision in patients with unilateral total LSCD (Kolli et al. 2010, Rama et al. 2001, 
Dua and Azuara-Blanco 2000). This treatment however is not applicable to a significant number 
of patients with total bilateral LSCD where patient’s both eyes are devoid of LSCs which are 
needed for the ex vivo expansion and subsequently used for transplantation. Hence alternative 
sources of cells that could be used to replace the missing LSCs in total bilateral LSCD are being 
sought after by many researchers.  
 
Of those, transplantation of ex vivo expanded oral mucosa epithelial (OME) cells has been the 
most used cell source in clinical studies of bilateral LSCD treatment with a reported ‘success’ 
rate of 48-75% within follow up times up to 34 months (Inatomi et al. 2006, Nishida et al. 2004, 
Burillon et al. 2012, Hirayama et al. 2012, Sotozono et al. 2013, Chen et al. 2009, Ma et al. 
2009, Sheth et al. 2015, Kolli et al. 2014). Our group also showed that cultured oral epithelial 
cells retained a gene expression profile that was attributed to epithelial stem cells in general, 
but they did not acquire a typical limbal expression pattern after 10-14 days in culture (Kolli et 
al. 2014), thus indicating that the transplanted cells did not fully transdifferentiate into corneal 
epithelium. 
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Recent advances in somatic cell induced reprogramming have shown that it is possible to 
reprogram somatic cells back to an “embryonic like cells” through overexpression of four key 
pluripotency factors. These are named induced pluripotent stem cells and like human embryonic 
stem cells (hESCs) they are characterised by unlimited self-renewal and potential to 
differentiate into any cell type of the adult organism (Takahashi et al. 2007, Lewitzky and 
Yamanaka 2007). The most important advantage of human induced pluripotent stem cells 
(hiPSCs) is the ability to avoid post-transplantation rejection by patient’s immune system 
(Tucker et al. 2014).   
 
Previous studies in the field have replicated early developmental mechanisms by blocking the 
transforming growth factor β (TGFβ) and Wnt-signaling pathways with small-molecule 
inhibitors and activating fibroblast growth factor (FGF) signaling (Mikhailova et al. 2014) to 
generate corneal epithelial-like progenitor cells capable of terminal differentiation toward 
mature corneal epithelial-like cells within 44 days. TGF-β pathway has been shown to play 
multiple roles in maintenance of pluripotency and early cell fate decisions. Work done by other 
groups (Vallier et al. 2004) and ours (Zhu et al. 2016) has shown that low activity of this 
pathway (either through application of inhibitors or low endogenous activity) results in 
neuroectodermal default pathway which skews pluripotent stem cells away from non-neural 
ectoderm and corneal epithelial differentiation.  
 
For this reason, we designed our differentiation protocol to include growth factors and 
morphogens (BMP4, RA, EGF) that have been shown to promote non-neural ectodermal 
commitment (Gambaro et al. 2006, Aberdam et al. 2007, Metallo et al. 2008, Li and Lu 2005) 
and proliferation of corneal epithelial progenitors. In the second window of differentiation, we 
attempted to replicate the LSC niche by coating the cell culture surfaces with collagen-IV 
shown to be the key component of limbal stroma and (Schlotzer-Schrehardt et al. 2007, 
Blazejewska et al. 2009) and feeding the cells with a defined media (CnT-Prime) which is used 
to maintain the ex vivo expansion of human corneal epithelial progenitors (Gonzalez et al. 
2017). 
 
Traditionally, differentiation of hESCs and hiPSCs to corneal epithelial cells has relied on usage 
of feeder cells, undefined conditioned media or amniotic membrane (Ahmad et al. 2007, 
Hanson et al. 2013, Hayashi et al. 2012, Hewitt et al. 2009, Shalom-Feuerstein et al. 2012). 
More recently, small molecule driven protocols have become available resulting in generation 
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of corneal epithelial–like cells within six weeks (Mikhailova et al. 2014). However, no 
protocols for robust hESCs and hiPSCs derived corneal epithelium differentiation that reflects 
in fully functional corneal epithelium or LSCs has been reported to date.  Thus this chapter 
describes the development of a defined feeder-free monolayer differentiation method which 
results in differentiation of hESCs and hiPSCs to corneal epithelial like cells within 20 days. 
 
3.2 Specific Objectives 
The specific objectives of this chapter are: 
a - to define efficient protocols for robust hESCs differentiation to corneal and limbal epithelial 
cells using monolayer culture methods. 
b - to apply and assess the efficiency of hESCs-derived protocols on hiPSCs. 
 
3.3 Materials and Methods 
3.3.1   Cell culture 
All cell culture was performed in a Class II biosafety cabinet laminar air flow tissue culture 
hood as detailed in Chapter 2. Cells were between passage 18 and 50, and maintained in 
mTeSR™1 medium. Every 3 to 4 days, cells were passaged using 0.02% ethylene diamine 
tetraacetic acid (EDTA) (Versene, Lonza, Belgium) solution. 
 
3.3.2  Plating the human pluripotent stem cells (hPSCs) for monolayer experiment 
a. Plating pluripotent cells on day0 
 
 
Used mTeSR™1 media was aspirated from the wells and the wells were gently washed with 
2.0 mL calcium and magnesium free Dulbecco phosphate-buffered saline (DPBS). The DPBS 
was aspirated and 1.0 mL of warm StemPro Accutase (Gibco, UK) was added to each well. The 
cells in accutase were incubated for 2 – 3 minutes at 37°C before 3.0 mL cold mTeSR™1 
medium per well was added to inactivate the accutase. Cells were collected from all wells and 
transferred into a 50 mL falcon tube. The cells were then centrifuged at 800 rpm for 4 minutes. 
mTeSR™1 Differentiation induction medium (8 media) CnT/CnT+FBS/CnT+Ca
2+
 
Day 0 Day 9 to 20 Day 3 
Cells plated on Matrigel coated plates in 
mTeSR™1  added with ROCK inhibitor 
Cells re-plated on collagen-IV coated 
plates 
Figure 3.4.1 : A schematic of the monolayer differentiation method. i re .1 : A schematic of the monolayer differentiation method. 
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Supernatant was removed and cell pellet was resuspended in 5.0 mL of warm mTeSR™1 
medium. The cells were counted using a dual chamber haemocytometer and a light microscope. 
 
Cells were plated at the density of 1.7 – 2.0 x 104 cells/cm2 in each well of a 6 well plate with 
mTeSR™1 media supplemented with ROCK inhibitor at concentration of 10 µM. The ROCK 
inhibitor was added only on the day of plating cells to aid the stem cells survival as single cells 
(Watanabe et al. 2007). Fresh mTeSR™1 medium without ROCK inhibitor was used to replace 
the used medium on days 1 and 2. The remaining cells were collected as day 0 cell pellet for 
qPCR. Three wells were assigned for every experimental group and two additional wells of 
cells were plated for qPCR cell sample at day 3. The mTeSR™1 medium was changed every 
day until day 3. At day 3, the mTeSR™1 medium was replaced with prepared and filter 
sterilised eight different serum free differentiation media according to the experimental groups. 
The basic supplements such as N2 (Lifetech, Thermo Fisher Scientific, UK), B27 (Lifetech, 
Thermo Fisher Scientific, UK), non-essential amino acids (NEAA), glutamine and 
penicillin/streptomycin solution were all added into the basal medium of low glucose 
DMEM/F12 (1:1) to provide the essential nutrients needed for the optimal cell growth as a 
substitute to serum. The resulting medium was called the “control medium” (CM). 
 
Photos of growing cells were taken at days 3 (before adding differentiation media), 6 and 9 
using Bioscience Axiovert 200M microscope in combination with the associated CarlZeiss 
software-AxioVision as detailed in Chapter 2. Medium change was performed daily from day 
3 to day 9 for all groups. One well of cells from each group was collected for qRT-PCR on day 
6 and day 9. RNA extraction and complementary DNA (cDNA) generation was done before 
real-time quantitative PCR (qRT-PCR) to assess the expression of ΔNp63, ECadherin, CK8, 
BRACHYURY, PAX6, BMP4  and OCT4 was performed at days 0  and 9. 
 
b. Replating differentiating cells under limbal epithelial culture conditions (day 9 - 20)  
Collagen IV coated 12-well plates were prepared based on method by Ahmad et al. 2007 and 
detailed in section 3.2.4 of this chapter. Cells from the remaining well of each experimental 
group in stage 1 were disassociated with TrypLe express (Gibco, UK). Cells were plated at the 
density of 1.7 – 2.0 x 104 cells/cm2  in three different media prepared using CnT-Prime 2D Diff. 
(CellnTec, Switzerland) media with or without the addition of 10% FBS and 0.07 mM calcium 
supplement (CaCl2) (Sigma-Aldrich, Germany). 
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Photos of cells were taken every 3-5 days using Bioscience Axiovert 200M microscope in 
combination with the associated CarlZeiss software-AxioVision as detailed in Chapter 2. Cell 
samples were collected at days 14 and 20 for RNA extraction, cDNA generation and qRT-PCR 
for all conditions. Real-time qRT-PCR was performed for the limbal and corneal epithelial cell, 
epithelial cell junction proteins and neuro-ectodermal markers: ΔNp63, ABCG2, CK3, CK12, 
ECadherin, and PAX6. 
 
3.3.3  Preparation of the differentiation media and supplements 
The supplements needed for the differentiation media was prepared first prepared as follows: 
 
a. Reconstitution of rhBMP4 (RnD Systems) 
50 µg rhBMP4 powder needed to be dissolved in sterile 4 mM HCl (Sigma-Aldrich, Germany) 
in at least 1% bovine serum albumin (BSA)(Sigma-Aldrich, Germany). Initially the 4 mM 
hydrochloric acid (HCl) was prepared by diluting 3.0 µL of 12 M HCl in 10 mL of sterile dH2O. 
0.1 mg of BSA was then dissolved in the diluted HCl. 2.0 mL of the resulting solution was then 
used to dissolve the rhBMP4 powder to make up a 25 µg/mL stock solution. The stock solution 
was then being aliquoted in micro centrifuge tubes and stored at -20°C. 
 
b. Preparation of all trans retinoic acid (Sigma-Aldrich, Germany) solution 
3 mg of all trans retinoic acid (RA) powder was dissolved well in 10 mL DMSO (Sigma Aldrich, 
Germany) to make up 10 mL of 1 mM RA stock solution. The solution was then aliquoted in 
micro centrifuge tubes and stored in -20°C. 
 
c. Reconstitution of IWP-2 (Merck Milipore) 
10 mg of IWP-2 powder was dissolved in 2.14 mL DMSO to make up a 10 mM stock solution. 
The resulting stock solution was aliquoted and stored in -20°C. 
 
d. Reconstitution of SB505124 (Sigma-Aldrich, Germany) 
5 mg of SB505124 powder was dissolved in 1.49 mL DMSO to make up a 10 mM stock solution. 
The resulting stock solution was aliquoted and stored in -20°C. 
 
e. Reconstitution of LDN 193189 (Stemgent) 
2 mg of LDN 193189 powder was dissolved in 4.52 mL of DMSO to make up a 1 mM stock 
solution. The resulting stock solution was aliquoted and stored in -20°C. 
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f. Reconstitution of human EGF (Sigma-Aldrich, Germany) 
500 µg EGF was dissolved in 1000 µL sterile dH2O to make up a 0.5 mg/mL stock solution. 
The resulting stock solution was aliquoted and stored in -20°C. 
 
g. Preparation of eight differentiation media  
The eight differentiation media were prepared by adding the appropriate csupplements and 
filter-sterilising the resulting medium. Each medium comprise the components listed in the 
following cluster of tables. 
Group 1 Materials / final concentration 
 DMEM-F12 (1:1) 
 N2 supplement (100x); 1 % (v/v) 
 B27 supplement (50x); 2 % (v/v) 
 Non-essential amino acids (100x); 1 % 
 L-glutamine (100x); 1 % 
 Pen/strep; 1 % 
 
Group 2 Materials / final concentration 
 Group 1 medium  
 rhBMP4; 25 ng/mL 
 
Group 3 Materials / final concentration 
 Group 1 medium 
 All trans retinoic acid; 1 µM 
 
Group 4 Materials / final concentration 
 Group 1 medium 
 EGF;  10 ng/mL 
 
Group 5 Materials / final concentration 
 Group 1 medium 
 rhBMP4; 25 ng/mL 
 All trans retinoic acid;  1 µM 
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 EGF; 10 ng/mL 
 
Group 6 Materials / final concentration 
 Group 1 medium 
 SB-505124; 10 µM 
 IWP-2; 10 µM 
 
Group 7 Materials / final concentration 
 Group 1 medium 
 rhBMP4; 25 ng/mL 
 SB-505124; 10 µM 
 IWP-2; 10 µM 
 
Group 8 Materials / final concentration 
 Group 1 medium 
 LDN193189; 100 nM 
Table 3.1 : List of components for each differentiation media. 
3.3.4  Collagen-IV coated plates preparation (Ahmad et al. 2007) 
A 0.25% acetic acid (VWR chemicals, UK) in sterile distilled water (dH2O) was prepared to 
reconstitute the lyophilized collagen IV from human placenta (Sigma-Aldrich, Germany) to a 
concentration of 0.5 mg/mL. The solution mixture was placed at 4°C for 3 hours with 
intermittent swirling once the acetic acid was added. The reconstituted collagen aliquots can be 
stored at -20°C for 1 - 3 years. A 2 cm2 tissue culture well was coated with collagen-IV by 
adding 200 µL of the collagen solution into each well and then the culture plates were then 
sealed and placed at 4°C overnight.  Excess collagen-IV solution was removed and the wells 
were briefly washed with DPBS before plating of cells on day 9. 
 
3.3.5 RNA isolation and cDNA synthesis 
RNA was extracted from the cells collected from experimental hESCs and hiPSCs and at days 
0, 9, and 20 of the monolayer experiment. This was achieved using the ReliaPrepTM RNA Cell 
Miniprep System (Promega, WI) following methods as described in the manufacturer’s 
instruction manual. RNA was quantified before cDNA synthesis was performed using Promega 
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GoScript™ Reverse Transcription System following the manufactures instructions and as 
previously detailed in Chapter 2. 
 
3.3.6 Quantitative PCR (qRT-PCR) 
Quantification of endogenous pluripotency and differentiation genes expression in the control 
and experimental hESCs and hiPSCs was assessed by qRT-PCR as previously detailed in 
Chapter 2. The sequences of the primers (Sigma-Aldrich, UK) used are listed in the following 
table. 
Gene name/Primer Sequence (5’ – 3’) 
PITX2 F: CCTTACGGAAGCCCGAGT 
R: CCGAAGCCATTCTTGCATA 
BMP4 F: TCCACAGCACTGGTCTTGAG 
R: GGGATGTTCTCCAGATGTTCTT 
CK12 R: GAAGAAGAACCACGAGGATG 
R: TCTGCTCAGCGATGGTTTCA 
ABCG2  F: CGAGTCTGTTGGTCAATCTC 
R: TCCTGTTGCATTGAGTCCTG  
CK8 F: GATCGCCACCTACAGGAAGCT 
R: ACTCATGTTCTGCATCCCAGACT 
OCT4  F: TCTCGCCCCCTCCAGGT 
R: GCCCCACTCCAACCTGG 
SOX2  F: GGCAGCTACAGCATGATGCAGGACC 
R: CTGGTCATGGAGTTGTACTGCAGG 
SIX1 F: TAAGAACCGGAGGCAAAGAG 
R: CCCCTTCCAGAGGAGAGAGT 
GATA3 F: CTCATTAAGCCCAAGCGAAG 
R: TCTGACAGTTCGCACAGGAC 
ECADHERIN F: CCCGGGACAACGTTTATTAC 
R: GCTGGCTCAAGTCAAAGTCC  
ΔNp63 F: CTGGAAAACAATGCCCAGAC 
R: GGGTGATGGAGAGAGAGCAT 
BRACHYURY F: CCCTATGCTCATCGGAACAA 
R: CAATTGTCATGGGATTGCAG 
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SIX3 F: CCCACACAAGTAGGCAACTG 
R: GTCCAATGGCCTGGTGCT 
EN1 F: GCACACGTTATTCGGATCG 
R: GCTTGTCCTCCTTCTCGTTC 
RAX F: GGCAAGGTCAACCTACCAGA 
R: GCTTCATGGAGGACACTTCC 
SOX10 F: GACCAGTACCCGCACCTG 
R: GCGCTTGTCACTTTCGTTC 
CK3 F: CGTACAGCTGCTGAGAATGA 
R: CTGAGCGATATCCTCATACT 
PAX6 F: TCTTTGCTTGGGAAATCCG 
R: CTGCCCGTTCAACATCCTTAG 
GAPDH  
 
F: TGCACCACCAACTGCTTAGC 
R: GGCATGGACTGTGGTCATGAG 
Table 3.2 : List of primers and their sequences used for qRT-PCR. 
Analysis was carried out using The Applied Biosystems 7900HT Fast Real-Time PCR System 
by Life Technologies in a similar sequence to that of standard PCR. Following completion of 
the PCR program, the data was analysed using SDS v2.4 software (Applied Biosystems), ΔΔCt 
and 2-ΔΔCt calculations.     
  
3.3.7   Immunocytochemistry (ICC) 
Excess cells from day 9 and day 20 cells’ dissociation and replating process were kept in 2% 
FBS/PBS on ice in different vials. Undifferentiated cells were similarly prepared and stained as 
negative controls. Cell count was performed for each group. Cells were cytospun onto slides 
and stained as detailed in Chapter 2. The list of antibodies used and their dilution factor are 
listed in the table below. 
 
Antibodies React with  Developed 
in  
Dilution  Cat. No. / Company 
CK3 primary Rabbit, cow, 
human 
Mouse 1:100 [AE5] Ab77869 / 
Abcam 
P40 (ΔNp63) 
primary 
Human, mouse, 
rat, bovine 
Rabbit 1:100 NBP2-29467 / 
Novusbio 
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CK12 
primary 
human Rabbit 1:100 NBP2-34843/ 
Novusbio 
CK13 
primary (AF 
647 
conjugated) 
Human, mouse Rabbit 1:200 [EPR3671] 
Ab198585 / Abcam 
PAX6 
primary  
Mouse, rat, sheep, 
cow, dog, human, 
rhesus monkey 
Rabbit 1:50 Ab5790 / Abcam 
Anti-Mouse 
IgG (FITC)  
Mouse Goat  1:800 F2012 / Sigma 
Anti-Rabbit 
IgG (FITC) 
Rabbit  Goat 1:800 F9887 / Sigma 
Table 3.3 : List of antibodies used and their dilution factor. 
The stained slides were mounted using Vectashield (Vector Laboratories, Burlingame, CA) 
with Hoechst 33342 Solution (2000:1) (Thermo Fisher Scientific, UK) and they were covered 
with cover slips in the case of plates. Plates were stored in the fridge in the dark for up to 4 
weeks and imaging repeated. Cells were viewed using a Bioscience Axiovert microscope in 
combination with the associated CarlZeiss software-AxioVision (Zeiss, Germany). 
 
3.3.8 Microscopy 
Dry stained slides were observed under a fluorescence microscope. Pictures were taken at 
different magnifications on the same day up to 2 days after fluorescence staining to keep the 
quality of the images all the same. The images, captured at 20x magnification using the 
fluorescence microscope, were exported as JPEG files. ImageJ software was then used to count 
three random fields of the stained and unstained cells, in which a total of at least 100 cells were 
counted. Three random pictures were taken per slide per group. 
 
3.3.9 Colony forming efficiency (CFE) assay 
During the second stage of the cell culture on day 9, cells were dissociated using TrypLe express 
(Gibco, UK), counted and replated on collagen IV coated plates, some cells were kept for 
colony forming efficiency assay. Limbal stem cells (LSCs) expanded from donated human 
limbal rings consist of a mixture of undifferentiated (60 – 80%) and differentiated LSCs were 
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used as a positive control. Three wells of 6-well plate were set for each experimental group in 
each biological replicate. The CFE assay was carried out as detailed in Chapter 2 (sections 
2.2.15 and 2.2.16) and the resulting colonies were stained with rhodamine-B. 
 
3.3.10 Statistical analysis 
Statistical analysis and graphs generation were carried out using Microsoft Excel and GraphPad 
Prism 7 software. Z scores were calculated using the following formula: Z score = D/SEM 
where D is the difference between the two means and SEM is the standard error of mean 
(computed from the data). In each figures the shown values represent the mean ± SEM (n=3). 
Significance differences between the data were calculated using one-way ANOVA, in which p 
values less than 0.05 were considered as statistically significant. 
 
3.4 Results 
This monolayer experiment was designed to robustly differentiate pluripotent stem cells into 
corneal and limbal epithelium. HESCs and hiPSCs were initially plated as single cells on 
Matrigel coated plates and supplemented with mTeSR™1 medium with added ROCK inhibitor. 
The cells were plated at the density of 1.7 – 2.0 x 104 cells/cm2, based on the previous protocols 
by Leung et al. 2013, which suggested this seeding density as optimal for ectodermal 
differentiation of hESCs and avoiding neural crest cells differentiation. ROCK inhibitor was 
added only on the day of plating cells to improve cells’ survival as single cells (Watanabe et al. 
2007).  
 
3.4.1 The differentiation induction media  
On day 3, the mTeSR™1 medium was changed to several differentiation initiation media. The 
basic supplements such as N2, B27, non-essential amino acids (NEAA), glutamine and 
penicillin streptomycin were all added into the basal medium of low glucose DMEM/F12 (1:1) 
to provide the essential nutrients needed for the optimal cell growth as the substitute of serum. 
The resulting medium was called the control medium (CM) and it was supplemented to cells in 
Group 1. 
 
Specific supplements were added to the CM according to the experimental groups to observe 
the inter-relations between various differentiation pathways on the morphological and gene 
expression of the differentiating stem cells. Based on various published literatures, six specific 
supplements were selected out of which three were inhibitors of different pathways. Bone 
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morphogenetic protein-4 (BMP4) which was reported to promote ectodermal differentiation 
and inhibit neuronal differentiation by Aberdam et al. 2007 as well as lens formation (Furuta 
and Hogan 1998, Wordinger and Clark 2007) was supplemented to Group 2. Group 3 CM was 
supplemented with all-trans retinoic acid (RA) which has been described to prime embryonic 
stem cells to differentiate into ectodermal cells (Schuldiner et al. 2000).  
 
Group 4 CM was supplemented with epidermal growth factor (EGF) which stimulates stem 
cells growth, proliferation and survival of corneal and limbal stem cells (Imanishi et al. 2000, 
Trosan et al. 2012). The CM for Group 5 was supplemented with BMP4, RA and EGF to give 
the combined effects of the three different supplements. Supplementation of RA together with 
BMP4 was previously reported by Itoh et al. 2011 to be able to direct hiPSCs towards 
ectodermal differentiation. Control medium for Group 6 was supplemented with SB505124, a 
selective TGF-β type 1 receptor inhibitor to encourage differentiation towards neuro-epithelium. 
Similarly, IWP-2, a Wnt/β-catenin pathway inhibitor that induces stem cells to differentiate into 
epithelium (Chen et al. 2009) was tested. Combination of those inbibitors should allow stem 
cells differentiation towards neuro-ectodermal pathways (Schuldiner et al. 2000).  
 
Group 7 received CM with SB505124, IWP-2 and BMP4 added to observe the inter-relation 
between the TGF-β and the Wnt pathways inhibitors in the presence of BMP4. The three 
supplements in Group 7 should cause neuro-ectodermal differentiation to the stem cells as the 
presence of BMP4 will promote ectodermal differentiation (Aberdam et al. 2007). Group 8 was 
given the CM supplemented with LDN 193189, a BMP pathway inhibitor that promotes neural 
progenitor and neural crest cells differentiation (Boergermann et al. 2010). This group was 
included as a control for the BMP4 differentiation group. The eight differentiation media, its 
contents and references are summarised in the following table. 
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3.4.2 Early differentiation stage day 3 - 9 
Similar morphological appearance was observed for both the hESCs (H9) and hiPSCs (SB-Ad2 
Cl2 and SB-Ad3 Cl1) for the same experimental group on day 3. On Day 3, the plated cells in 
all groups formed small colonies as shown in Figure 3.2. Morphologically, both the hESCs and 
hiPSCs lines have the same undifferentiated appearance in term of the cells’ shape and the 
colonies. The undifferentiated cells are small with large nucleus and scanty cytoplasm, and they 
grew in compact colonies on matrigel coated plates supplemented with mTeSR™1.   
 
Groups Medium contents  Reference(s) 
Group 1 
(G1) 
1% N2, 2% B27, 1% non-essential amino 
acids, 1% glutamine, 1% Pen/Strep, low 
glucose DMEM/F12 (1:1) = control medium 
Leung et al. 2013, Yao et al. 
2006 
Group 2 
(G2) 
control medium + bone morphogenetic 
protein-4 (rhBMP4) (25 ng/ml) 
Shalom-Feuerstein et al. 
2013  
Group 3 
(G3) 
control medium + All trans retinoic acid (RA) 
(1 µM) 
Metallo et al. 2008 
Group 4 
(G4) 
control medium + epidermal growth factor 
(EGF) (10 ng/ml) 
Ahmad et al. 2007,  Herbst 
2004 
Group 5 
(G5) 
control medium + rhBMP4 (25 ng/ml ) + All 
trans RA (1 µM) + EGF (10 ng/ml) 
Shalom-Feuerstein et al. 
2013, Katikireddy et al. 2014 
Group 6 
(G6) 
control medium + SB-505124 (10 µM) + IWP-
2 (10 µM) 
Shalom-Feuerstein et al. 
2013, Mikhailova et al. 2014 
Group 7 
(G7) 
control medium + SB-505124 (10 µM) + IWP-
2(10 µM) + rhBMP4 (25 ng/ml) 
Shalom-Feuerstein et al. 
2013,  Mikhailova et al. 2014 
Group 8 
(G8) 
control medium + LDN193189 (100 nM) Leung et al. 2013, 
Boergermann et al. 2010 
Table 3.4 : The differentiation induction media, the contents and references for each. 
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Figure 3.2 : The morphology of undifferentiated hESC (H9) (A), and hiPSC (SB-Ad2 (B) 
and SB-Ad3 (C)) at day 3. Scale bar = 200 µm. 
 
Upon adding the differentiation induction medium on day 3, the cells in each group grew 
differently at least for the first three days (not shown). The colonies proliferated, became 
confluent and started to differentiate towards day 6 of the differentiation induction period. There 
were two groups, Group 4 and Group 8 that formed floating cell aggregates due to 
overconfluency (not shown in figure) on day 7. Groups that were supplemented with BMP4, 
RA and EGF showed the most differentiated morphology typical of epithelial cells on day 9 for 
both hESCs and hiPSCs. The differentiated cell morphology were observed by the formation 
of growing pockets of flatter and larger cells with higher cytoplasm to nucleus ratio (indicated 
by the arrows) in between the smaller undifferentiated stem cells areas, which are in similar to 
those reported by Xu et al. 2002. These pockets of differentiated cells could be observed as 
shown in Figures 3.3, 3.4 and 3.5 (day 9). Cells in Groups 1, 4, 6 and 8 on the other hand, 
proliferated robustly and mostly retained the stem cell appearance.  
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Figure 3.3 : The morphology of hESCs (H9) at day 9. Arrows indicate the flat epithelial-
like cells areas. Scale bar = 50 µm. 
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Figure 3.4 : The morphology of hiPSCs (SB-Ad2) at day 9. Arrows indicate the flat 
epithelial-like cells areas. Scale bar = 50 µm. 
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Figure 3.5 : Morphology of hiPSCs (SB-Ad3) at day 9. Arrows indicate the flat 
epithelial-like cells areas. Scale bar = 50 µm. 
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Gene expression profile for differentiation induction period on days 0, and 9 for hESCs and 
hiPSCs was assessed using several essential markers chosen for qRT-PCR analysis to match 
the aim for corneal and limbal epithelial differentiation in this first stage of experiment. These 
markers are as listed in Table 3.5 below. 
 
Cell lineages qRT-PCR 
markers 
Ectodermal, limbal and corneal stem cells, surface pluristratified 
epithelium  
ΔNp63  
Ectodermal and epithelial cells cytokeratin CK8 
Calcium dependent cell-cell adhesion glycoprotein in basal and 
suprabasal corneal epithelium 
ECadherin 
Oral ectoderm and developing eye PITX2  
Non-neural ectoderm, developing cornea and lens BMP4  
Neuroectoderm, anterior placodal ectoderm, developing eye and 
lens 
PAX6 
Lens ectoderm and developing forebrain  SIX3 
Retinal and early eye primordia cells RAX 
Non-neural ectoderm, developing endothelial/luminal epithelium GATA3 
Mesodermal and preplacodal ectoderm cells SIX1 
Mesodermal cells BRACHYURY 
Pluripotent and undifferentiated stem cells OCT4  
Table 3.5 : List of gene markers for qRT-PCR on day 0 - 9. 
 
All the hESCs and hiPSCs groups displayed a significant decrease in the expression of the 
pluripotency (OCT4) markers by day 9 as shown in Figures 3.6, 3.7 and 3.8. This showed that 
all the groups lost their pluripotency and entered the differentiation process.  Despite significant 
downregulation of pluripotency markers, G1, G4 and G8 of one of the hiPSCs (SB-Ad3) 
retained higher levels of OCT4 compared to all hESCs and the other hiPSCs line.  This 
correlated well with the morphological observations of pluripotent stem cell phenotype 
retention highlighted in the earlier section. 
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Figure 3.6 : OCT4 expressions for hESCs (H9). * - significantly different compared to 
day 0. Data presented as mean ± SEM. n = 3. 
 
Figure 3.7 : OCT4 expressions for hiPSCs (SB-Ad2). * - significantly different compared 
to day 0. Data presented as mean ± SEM. n = 3. 
 
Figure 3.8 : OCT4 expressions for hiPSCs (SB-Ad3). * - significantly different compared 
to day 0. Data presented as mean ± SEM. n = 3. 
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Mesodermal marker represented by BRACHYURY (Figure 3.9) was investigated to ensure that 
differentiation was not skewed towards mesoderm as a result of BMP4 supplementation. This 
analysis indicated a significant downregulation of this marker in most groups for both hESCs 
and hiPSCs with exception of G2 where BMP4 was the sole growth factor added which could 
have influenced differentiation process towards this lineage. 
 
 
Figure 3.9 : Relative expression of BRACHYURY gene on day 0 and day 9. Data presented 
as mean ± SEM. n = 3. 
 
The expression of RAX  (early eye primordia and retinal protein), PAX6 (anterior placodal 
neuroectoderm) and SIX3 (lens ectoderm and forebrain development) were increased on day 9 
compared to day 0, especially in Groups 1, 4, 6 and 8 in both hESCs and hiPSCs lines as shown 
in Figure 3.10. The increased expression of neuroectodermal and eye development markers by 
the cells in those groups suggests their differentiation towards neuroectoderm  and lens. 
 
The expression of RAX and PAX6, a marker of retinal protein and neuroectodermal, developing 
eye and lens respectively was significantly higher in G8 for all the cell lines (Figure 3.10). It is 
likely that the group has undergone lineage commitment to neural ectoderm as it was 
supplemented with BMP4 antagonist, which should inhibit non-neural ectodermal 
differentiation. 
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Figure 3.10 : Relative expression of RAX, PAX6 and SIX3 genes on day 0 and day 9. Data 
presented as mean  ± SEM. n = 3. 
In contrast, PITX2, BMP4 and mostly GATA3 expression (markers for developing eye, lens and 
non-neural ectoderm) on day 9 was increased in groups that were supplemented with BMP4 
and/or RA or EGF (Figure 3.11). This is a promising change that suggests differentiation 
towards non-neural ectoderm lineages, eye development and epithelium in those groups (G2, 
G3, G5, G7). 
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BMP4 gene which is expressed in early ectodermal tissue and helps in patterning the 
development of the head (Metallo et al. 2008 and Bothe et al. 2011), is often used as a marker 
of non-neural ectoderm, developing cornea and lens. Our qPCR analysis indicated a consistent 
and significant upregulation of BMP4 in G2, G3 and G5 across hESCs and hiPSCs (Figure 
3.15), suggesting that the differentiation factors added to these three groups encouraged 
differentiation to non-neural ectoderm which is the desired path before going further towards 
corneal epithelial cells. 
 
Figure 3.11 : Relative expression of PITX2, BMP4 and GATA3 on day 0 and day 9. Data 
presented as mean ± SEM. n = 3. 
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Finally, hESCs and hiPSCs groups that were supplemented with BMP4, RA and EGF displayed 
an increased expression of ECadherin, ΔNp63 and CK8, which are the markers for epithelial 
cells, limbal and corneal epithelium as shown in Figure 3.12.  The expression of ectodermal 
cytokeratin 8 (CK8), basal and suprabasal corneal epithelium (ECadherin) and putative limbal 
stem cells marker (ΔNp63) genes were all significantly increased in G2, G3 and G5 of both 
hESCs and hiPSCs (Figure 3.12), further suggesting cells’ commitment to corneal and limbal 
epithelial lineages. 
 
Figure 3.12 : Relative expression of ΔNp63, ECadherin and CK8 on day 0 and day 9. Data 
presented as mean ± SEM. n = 3. 
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To summarise and take into account all the significant differentiation changes resulted from the 
different protocols, z scores were calculated. The calculated z scores were then used to assess 
the early corneal epithelium differentiation in the seven different groups compared to the 
control, G1 on day 9. Although addition of BMP4 has been associated with differentiation of 
hESC and hiPSC to mesodermal lineages (Ren et al. 2011, Zhang et al. 2008); a significant 
increase in the expression of mesodermal BRACHYURY was only observed in the hESC (H9) 
and one hiPSC line (SB-Ad2; Figure 3.13A) upon BMP4 treatment (Group 2). The expression 
of RAX, a gene expressed in the eye primordia and required for retinal cell fate determination 
(Furukawa et al. 1997), was significantly downregulated in Groups 2-7 for both hESC and 
hiPSC, thus indicating that in all these groups, the differentiation to neuroectodermal lineages 
was avoided (Figure 3.13B).  
 
BMP4 is expressed in early ectodermal tissue (Metallo et al. 2008) and is often used as marker 
of non-neural ectoderm, developing cornea and lens. Our qRT-PCR analysis indicated a 
significant upregulation of BMP4 in experimental groups 2, 3 and 5 of hESC and two hiPSC 
(Figure 3.13C), suggesting that the differentiation factors added to these three groups 
encouraged differentiation to non-neural ectoderm (Leung et al. 2013). The expression of 
ectodermal cytokeratin 8 (CK8), basal and suprabasal corneal epithelium (ECadherin) and 
putative limbal stem cells (ΔNp63) markers were all significantly increased in experimental 
Groups 3 and 5 of both hESCs and hiPSC (Figures 3.13D, E and F), indicating a likely 
commitment of these groups to corneal epithelial progenitors. 
 
At this induction stage, Groups 2, 3 and 5 were selected as these groups showed a promising 
morphological changes as well as gene expressions that met the favourable differentiation 
criteria. Those selected groups expressed increased putative corneal and limbal stem cell, and 
epithelial cytokeratin markers (ΔNp63, ECadherin and CK8), increased non-neural ectodermal 
marker (BMP4) across the lines. Therefore, those that have significantly low z scores for 
mesodermal (BRACHYURY) and retinal differentiation (RAX), and high ectodermal (BMP4), 
non-neural ectoderm (CK8), epithelial (ECadherin) and putative limbal epithelial (ΔNp63) 
markers from all three cell lines were selected for further differentiation experiments. 
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Figure 3.13 : Z scores of corneal epithelial lineages differentiation markers on day 9.  
The z scores from the qRT-PCR analysis consistently showed that the experimental groups that 
were supplemented with BMP4, RA and a combination of BMP4, RA and EGF showed a 
significant upregulation of non-neural ectoderm, epithelial, cell junction and putative LSC 
markers. We therefore went on to analyse these groups by immunostaining for the expression 
of putative LSC protein, ΔNp63.  
 
No significant differences between the control non supplemented groups and the ones that 
received BMP4, RA and a combination of BMP4, RA and EGF were found (Figure 3.14A and 
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B). These immunostaining results do not corroborate the qRT-PCR analysis and a possible 
reason for this may be the post-translational modifications already reported for the p63 protein 
(Li and Xiao 2014).  The negative controls of stained undifferentiated cells on the other hand, 
did not express both PAX6 and p63 proteins (data not included). 
 
Figure 3.14 : Representative photos of ΔNp63 and PAX6 positive immunostaining at day 
9 for hESC (A). Percentages of ΔNp63 and PAX6 positive cells at day 9 in the three cell 
lines (B). * - significantly different compared to G1. Data presented as mean ± SEM. n = 
3. 
Colony forming efficiency (CFE) was highest in experimental Groups 2 and 5 of hESCs (H9) 
and one of the hiPSCs lines (SB-Ad2), suggesting that supplementation of basic media with 
BMP4 or a combination of BMP4, RA and EGF provides an optimal combination for directing 
differentiation of hESC and hiPSC to corneal epithelial-like progenitor cells. Notwithstanding, 
no significant difference in CFE ability were observed between the four experimental groups 
tested in the second hiPSCs line (SB-Ad3) as shown in Figure 3.15, indicating significant 
differences between the hiPSCs lines in their response to our differentiation protocols and the 
need for further culture modifications for non-responsive hiPSCs lines. 
81 
 
 
 
Figure 3.15 : Colony forming efficiency for all the three cell lines on day 9. * - 
significantly different compared to G1. Data presented as mean ± SEM. n = 3. 
 
3.4.3 Late differentiation stage day 10 – 20 
Figure 3.16 showed the appearance of H9 cell after 5 days being re-plated on collagen-IV coated 
plates at day 9. The medium was changed to a serum-free CnT-PR 2D-Diff corneal 
differentiation medium to provide conditions that mimic the cornea. This medium was 
supplemented to the cells in three ways: on its own, added with 10% fetal bovine serum (FBS) 
or added with 0.07 mM CaCl2.  
 
The FBS or CaCl2 supplementation was decided following initial experiment findings, where 
the re-plated H9 cells did not survive well when supplemented with CnT-PR 2D-Diff only 
medium (Figure 3.16). Addition of 10% FBS was based on a report by Medawar et al. 2008 
who showed improved differentiation of ectodermal cells into K5 and K14 expressing epithelial 
cells. The 0.07 mM calcium supplementation was based on the calcium content in the CnT-
epithelial proliferation medium (http://cellntec.com/products/cnt-pr/#datasheet). A previous 
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study also reported that addition of calcium triggers the differentiation of mouse corneal 
epithelial cells (Ma and Liu 2011). The re-plated cells were left for 2 days without medium 
change to allow longer time for the cells to attach to the collagen-IV coated  surface. 
 
 
Figure 3.16 : The hESCs on days 14 and 20 in CnT-PR 2D Diff. medium with or without 
supplementation of FBS and Ca2+. Scale bar = 25 µm.  
 
Observations on day 14 (5 days after re-plating) showed that cells were generally did not 
attached well to the plate in CnT or CnT+Ca2+ media.  There were only three (Groups 2, 3 and 
5) groups that survived until day 20 for H9 as shown in Figure 3.16 and these were cultured in 
CnT-PR + 10% FBS medium.  
 
The replating protocols on day 9 were then further improved with the addition of 10 µM ROCK 
inhibitor to the CnT-PR 2D-Diff. + 10% FBS medium for the first two days to help the cell 
survival. More cells survived until day 20 in Groups 2, 3 and 5 for all the lines as assessed by 
daily culture observation. Similar morphological changes were observed in both hESCs and 
hiPSCs during this time window (Figures 3.17, 3.18, 3.19). Cells appeared larger and flatter 
and characterised by an epithelial-like morphology by the end of the experiment on day 20. 
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Figure 3.17 : Morphology of hESCs (H9) at day 20. Scale bar = 50 µm. 
 
Figure 3.18 : Morphology of hiPSCs (SB-Ad2) at day 20. Scale bar = 50 µm. 
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Figure 3.19 : Morphology of hiPSCs (SB-Ad3) at day 20. Scale bar = 50 µm. 
In this second stage of the experiment, qRT-PCR analysis was carried out at day 20 for the 
expression of genes that are more specific to corneal and limbal epithelium. The gene markers 
used are as listed in Table 3.6 below. 
 
Cell lineages qRT-PCR 
markers 
Ectodermal,  corneal and  limbal stem cells, surface 
pluristratified epithelium 
ABCG2, ΔNp63  
Differentiated human corneal epithelium CK3, CK12 
Ectoderm and epithelial cells cytokeratins CK8 
Calcium dependent cell-cell adhesion glycoprotein in basal and 
suprabasal corneal epithelium 
ECadherin 
Neuroectodermal, anterior placodal ectoderm and developing 
lens 
PAX6  
Table 3.6 : List of gene markers for qRT-PCR on day 10 - 20. 
 
Quantitative RT-PCR analysis showed that the combination of RA, BMP4 and EGF (Group 5) 
was associated with the greatest upregulation of putative limbal stem cell marker (ΔNp63) 
across the cell lines (Figures 3.20, 3.21, 3.22). Expression of ABCG2, a putative LSC marker 
(Morita et al. 2015), was also consistently highest in groups supplemented with RA across the 
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cells lines. Differentiated corneal epithelial cytokeratin, CK3 expression was more variable 
across the cell lines, with the highest expression observed in BMP4 supplemented group for 
hESCs, RA supplemented group for hiPSC-SB-Ad3 and RA and RA, BMP4 and EGF 
supplemented group for hiPSC-SB-Ad2. CK12 expression was consistently the highest in the 
groups supplemented with RA, BMP4 and EGF. Together these data suggest some intra-line 
differences in the capacity to mature towards corneal epithelial like cells. 
 
 
Figure 3.20 : Relative gene expressions of hESCs (H9) on day 20. * - significantly 
different compared to G1. Data presented as mean ± SEM. n = 3. 
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Figure 3.21 : Relative gene expressions for hiPSCs (SB-Ad2) on day 20. * - significantly 
different compared to G1. Data presented as mean ± SEM. n = 3. 
 
Figure 3.22 : Relative gene expressions for hiPSCs (SB-Ad3) on day 20. * - significantly 
different compared to G1. Data presented as mean ± SEM. n = 3. 
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Immunostaining analysis at day 20 revealed a significant upregulation of ΔNp63 expression in 
groups supplemented with BMP4, RA and EGF across the hESCs and hiPSCs lines compared 
to G1 (Figure 3.23). It needs to be noted though that the expression of this marker decreased 
from day 9 of differentiation, indicating further differentiation of these cells to CK3 and CK12 
expressing corneal epithelial cells as shown in Figure 3.24A and B.  
 
 
Figure 3.23 : Expression or ΔNp63 protein at day 20 for all three cell lines. * - significantly 
different compared to G1 of the same cell line. # - significantly different compared to the 
other group. Data presented as mean ± SEM. n = 3. 
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Figure 3.24 : Expression of CK3 and CK12 proteins at day 20 in G5 for all the three cell 
lines. Data presented as mean ± SEM. n = 3. 
 
CFE assays also showed that the BMP4, RA and EGF supplemented group in hESCs resulted 
in the highest colony forming ability which was similar to human limbal epithelial progenitor 
cells (Figure 3.25). All the selected groups of one of the hiPSCs lines (SB-Ad2) showed an 
increased CFE ability compared to control group; however this was considerably lower than 
human limbal epithelial progenitor cells (Figure 3.25). In contrast, all the treated groups from 
the second hiPSCs line (SB-Ad3) showed a very low CFE ability and no difference to the 
untreated control group, indicating a lack of response from this cell line to differentiation factors 
added during the 20 days time window. 
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Figure 3.25 : Colony forming efficiency of all the cell lines on day 20. * - significantly 
different compared to G1. Data presented as mean ± SEM. n = 3. 
3.5 Discussion 
Efficient differentiation of a large numbers of hESCs and hiPSCs for autologous cell 
replacement therapies using robust and fast protocols has become an important aim for most 
researchers in the field. Since the main aim of our study was to design robust differentiation 
protocols for differentiation of hiPSCs to corneal epithelial like cells for autologous cell 
replacement therapies, we tested the two-step differentiation protocol in two hiPSCs lines 
generated and well characterized by our laboratory (Van De Bunt et al. 2016).  
 
In this experiment, we report a feeder-free, two-step method that results in differentiation of 
hESCs to corneal epithelial progenitors and mature corneal epithelial cells within 20 days as 
evident in the related genes and proteins expressions as well as the CFE assays. One of the 
hiPSCs lines was able to generate corneal epithelial progenitors with comparable colony 
forming ability in response to BMP4, RA or combined addition of BMP4, RA and EGF, albeit 
at lower levels than hESCs. In contrast, the second tested hiPSCs line was not able to respond 
to the two-step differentiation protocol resulting in low levels of corneal epithelial progenitor 
generation. Although it was noted that the expression of master regulatory gene of eye 
development, PAX6 was nearly absent (in groups supplemented with BMP4, RA and EGF) 
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during the early differentiation stage, this time point might represent the phase where PAX6 is 
downregulated following its upregulation phase at earlier time point (eg: day 6). However, the 
PAX6 protein expression was was shown to be significantly high in those groups. These 
findings could be rectified by testing the specificity of PAX6 antibody used for immunostaining 
using knockout cells and positive control cells, as well as comparing the ICC results with 
Western Blot analyses. Additionally, the successfully differentiated cells could be further 
distinguished from other ectodermal lineages such as conjunctiva or epidermal cells by 
assessing the expression of markers that are specific to those lineages (i.e: CK13, K1, K2, K9, 
K10) (Moll et al. 2008, Merjava et al. 2011).  
 
Differences in transcriptional and epigenetic profiles between hiPSCs lines which are linked to 
their differentiation capacity are commonly encountered, especially during directed 
differentiations, where specific molecules were used to alter the pathways of interest (Narsinh 
et al 2011a). A study published by our group indicated that hiPSCs lines that possess higher 
level of mitochondrial protein CHCHD2, have a less active TGFβ signalling activity, making 
them more prone to neural differentiation (Zhu et al. 2016). A recent report by Nishizawa et al. 
also indicated that haematopoietic commitment of hiPSCs lines depends on the expression of 
insulin-like growth factor 2 (IGF2) (Nishizawa et al. 2016). Earlier, Fujiwara and colleagues 
also found variations in the basal cardiomyocyte differentiation efficiency of hiPSCs lines 
which was overcomed by using Cyclosporin-A (Fujiwara et al. 2011).  Together, those studies 
and our findings suggest that differentiation protocols may need to be adjusted to take into 
account the endogenous expression of key transcription and growth factors as well as signalling 
pathways that govern early differentiation steps in hiPSCs. 
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CHAPTER 4. BMP PATHWAY ANALYSIS AND OPTIMISATION OF 
HIPSCS DIFFERENTIATION 
 
4.1    Introduction 
In the earlier chapter, the two types of human pluripotent stem cells (hPSCs) used for corneal 
epithelial lineages differentiation responded differently towards the differentiation cues 
exposed to them. Supplementation of BMP4, RA and EGF had directed the hESCs with 
differentiation towards corneal epithelial lineages. However, the same supplementation did not 
result in the same change in one of the human induced-pluripotent cells (hiPSCs) used.  
 
Endogenous BMP signalling activity is different in various hiPSCs lines and crosstalk between 
BMP and TGFβ signalling has also been reported (Quarto et al. 2012) affecting the propensity 
of each cell line during differentiation process. Given the importance of BMP4 signalling in 
inhibiting neural differentiation and promoting epidermal commitment of embryonic stem cells 
(Aberdam et al. 2008, Metallo et al. 2008, Guenou et al. 2009), we investigated the level of 
endogenous BMP pathway activity using a reporter based assays to confirm our quantitative 
RT-PCR assessment findings.  Since one of the hiPSCs lines was not responsive to the 
differentiation method, we assessed the BMP pathway activity of the hiPSCs lines in view of 
improving the differentiation of less responsive hiPSCs.  
 
An optimisation experiment was planned based on the findings of the endogenous BMP 
signalling assessment on the hiPSCs lines. Since there is a crosstalk between BMP and TGFβ 
signalling pathways, a selective TGFβ inhibitor, SB431542 which has been reported to improve 
the BMP pathway (Du et al. 2014) and to drive differentiation away from neuro-ectoderm (Li 
et al. 2015) was used to improve the corneal epithelial differentiation in the less responsive 
hiPSCs. This chapter will later discuss on the findings of the endogenous BMP signalling 
differences in the hiPSCs lines used and the outcome of differentiation optimisation in the less 
responsive hiPSCs line using SB431542. 
 
4.2    Specific Objectives 
The specific objectives of this chapter are: 
- to assess the endogenous BMP pathway in H9, SB-Ad2 and SB-Ad3 cells based on their gene 
expressions using quantitative RT-PCR. 
- to confirm the qRT-PCR findings on the endogenous BMP pathway using luciferase BMP 
reporter assays.  
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- to assess the effects of BMP4 and SB431542 supplementation on the endogenous BMP 
pathway in the three cell lines. 
 
4.3 Materials and Methods 
4.3.1    Lennox L Broth Base (LB) medium and LB agar preparation 
10 g Lennox L Broth Base powder (Invitrogen, UK) was dissolved in 500 mL of distilled water 
in a 1.0 L glass bottle. The bottle was labelled, loosely capped and autoclaved at 121°C for 15 
minutes. The autoclaved broth was allowed to cool to room temperature before use. 
 
16 g Lennox L Agar powder (Invitrogen, UK) was dissolved in 500 mL of distilled water in a 
1.0 L glass bottle. The bottle was labelled, loosely capped and autoclaved at 121°C for 15 
minutes. The hot agar was then allowed to slightly cool in a 60°C water bath.  
 
Ampicillin stock solution was prepared by dissolving 100 mg of ampicillin sodium salt powder 
(Sigma-Aldrich, Germany) in 1.0 mL distilled water. The resulting stock solution was kept in -
20°C. 500 µL ampicillin (from 100 mg/mL stock) was added to the warm agar and mixed by 
swirling. Sterile 10 cm plates were laid out on the bench and the agar was carefully poured into 
the plates to avoid the formation of air bubbles. The agar plates were allowed to solidify at room 
temperature before being properly wrapped and kept in a 4°C fridge until use. 
 
4.3.2 Plasmid transformation 
pGL3-Basic (Promega, WI : E1751) and pRL-Null (Promega, WI : E2271) plasmids were 
transformed into chemically competent bacteria using a heat-shock transformation method. 
Competent cells were taken out from -80°C and thawed on ice for approximately 20 – 30 
minutes. Agar plates containing 100 µg/mL ampicillin were removed from 4°C fridge and let 
warmed up to room temperature. 50 ng of each plasmid was mixed into 20 µL of competent 
cells in a micro centrifuge tube. The mixture was gently mixed by flicking the bottom of the 
tube with fingers a few times. Then the mixture was incubated on ice for 30 minutes. Each 
transformation tube was being heat-shocked by placing the bottom half of the tube into a 42°C 
water bath for 45 seconds. The tubes were put back on ice for 2 minutes. 250 µL LB medium 
(without antibiotic) was added to the bacteria and grown in 37°C shaking (225 rpm) incubator 
for 45 minutes.  
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4.3.3  Mini bacterial culture  
Plasmid names, antibiotic resistance, date and initials were written down at the bottom of the 
warmed up plates. The lab bench area was kept sterile by working near a flame or Bunsen 
burner. 50 µL of the transformation was transferred onto a 10 cm agar plate containing 
ampicillin using a sterile pipette tip. A sterile ‘L-shaped’ glass rod spreader was used to spread 
out the transformation liquid onto the agar surface.  
 
An ID1 reporter plasmid, pGL3 BRE Luciferase was a gift from Martine Roussel & Peter ten 
Dijke (Addgene plasmid #45126) and was obtained as a bacterial stab culture. The bacteria 
growing within the punctured area of the stab culture was touched using a sterile pipette tip. 
The tip was then run lightly over a section of an agar plate to spread the bacteria over 
approximately one-third of the surface area of the plate to create streak #1. A fresh sterile pipette 
tip was used to pass through streak #1 and to spread the bacteria over the next one-third section 
of the plate to create streak #2. Third fresh pipette tip was used to pass through streak #2 and 
to spread the bacteria over the next one-third section of the plate to create streak #3. 
 
 
Figure 4.1 : Bacterial streaks from a stab culture on agar plates. 
 
The plates were incubated at 37°C overnight with the bottom part on top. Colonies appeared as 
white dots growing on the solid medium. The bacterial culture plates with colonies were sealed 
using parafilm and stored in 4°C for a few weeks. 
 
4.3.4 Overnight liquid bacterial culture  
A single colony was picked from the streaked LB agar plate using a sterile pipette tip. The tip 
was then dropped into 5.0 mL of LB medium (with added ampicillin) in a 50 mL falcon tube 
and swirled around. The tube was then labelled with plasmid name and date. The liquid culture 
was loosely covered with its cap and incubated in a shaking (225 rpm) incubator at 37°C for 12 
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– 18 hours. Bacterial growth was checked after incubation, which is characterised by a cloudy 
haze in the medium. Glycerol stock could be created for long term storage of the bacteria. 
 
4.3.5 Plasmid DNA isolation by Qiagen® plasmid maxi kit  
1.0 mL of the overnight liquid bacterial culture was diluted into 100 mL selective LB medium 
(with ampicillin added). The culture was grown at 37°C for 12 – 16 hours with vigorous shaking 
(225 rpm). The bacterial cells were harvested by centrifugation at 6000 g for 15 minutes at 4°C. 
The used medium was discarded and the bacterial pellet could be kept in -20°C if the plasmid 
isolation process is not carried out immediately.  
 
The bacterial pellet was resuspended in 10 mL of Buffer P1. The bacteria was resuspended 
completely by vortexing or pipetting up and down until no clumps remain. 10 mL Buffer P2 
was added and mixed thoroughly by vigorously inverting the sealed tube 4 – 6 times. Do not 
vortex, as this will result in shearing of genomic DNA. The lysate should appear viscous. Do 
not allow the lysis reaction to proceed for more than 5 minutes. If LyseBlue has been added to 
Buffer P1, the cell suspension will turn blue after addition of Buffer P2. Mixing should result 
in a homogeneously coloured suspension. If the suspension contains localized colourless 
regions or if brownish cell clumps are still visible, continue mixing the solution until a 
homogeneously coloured suspension is achieved. The mixture was then incubated at room 
temperature for 5 minutes. 
 
10 mL of chilled Buffer P3 was added immediately and thoroughly mixed by vigorously 
inverting 4–6 times, and incubate on ice for 20 minutes. If LyseBlue reagent has been used, the 
suspension should be mixed until all trace of blue has gone and the suspension is colourless. A 
homogeneous colourless suspension indicates that the sodium dodecyl sulfate (SDS) has been 
effectively precipitated. The sample was mixed again just before being centrifuged at 20,000 g 
for 30 minutes at 4°C. Centrifugation should be performed in non-glass tubes (e.g., 
polypropylene). After centrifugation the supernatant should be clear. Supernatant containing 
plasmid DNA was removed promptly and the supernatant was centrifuged again at 20,000 g for 
15 minutes at 4°C. The resulting supernatant was removed promptly.  
 
A Qiagen-tip 500 was equilibrated by applying 10 mL Buffer QBT and the column was allowed 
to empty completely by gravity flow. Supernatant from previous centrifuging step was applied 
promptly to the equilibrated tip and allowed to enter the resin by gravity flow. The Qiagen-tip 
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was washed with 30 mL of Buffer QC twice. The buffer was allowed to move through the 
Qiagen-tip by gravity flow. DNA was eluted with 15 mL Buffer QF. The eluate was collected 
in a 50 mL tube. DNA was precipitated by adding 10.5 mL room temperature isopropanol to 
the eluted DNA. The solution was mixed and centrifuged immediately at 15,000 g for 30 
minutes at 4°C. Supernatant was carefully decanted as isopropanol pellets are more loosely 
attached to the side of the tube. DNA pellet was washed with 5.0 mL room temperature 70% 
ethanol and centrifuged at 15,000 g for 10 minutes. The supernatant was carefully decanted 
without disturbing the pellet. 
 
The pellet was air-dried for 5 – 10 minutes and excess ethanol was carefully removed using 
pipette tip. The DNA was redissolved in 100 µL of TE buffer, pH 8.0. The pellet should not be 
overdried, as overdrying will make the DNA difficult to redissolve. DNA concentration and 
quality was measured using a Nanodrop spectrophotometer 2000 machine (Thermo Fisher 
Scientific). 
 
4.3.6 Restriction digestion of plasmid DNA 
Restriction enzyme to digest the plasmids was selected by analysing the plasmid DNA sequence. 
The plasmid DNA used were pGL3 Basic, pRL Null and pGL3 BRE Luciferase was cut using 
Nhe1 enzyme (Thermo Fisher Scientific, UK). Appropriate reaction buffer (10x Tango buffer) 
was determined by reading the instructions for the selected enzyme. 
 
A restriction digestion reaction mixture was combined in a microcentrifuge tube. The mixture 
comprised: 1.0 µg DNA, 1.0 µL Nhe1 enzyme, 2.0 µL 10x buffer and a volume of dH2O to 
bring the total volume to 20 µL. The mixture was gently mixed by pipetting. The reaction tube 
was then incubated at 37°C for 1 hour. The products of the digest was visualised by gel 
electrophoresis. 
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Figure 4.2 : The sequence maps for the plasmids used; pGL3-Basic (A), pRL-Null (B) 
and pGL3-BRE-Luc (C). Adapted from Promega and Addgene. 
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4.3.7 Gel electrophoresis  
Agarose gel was prepared by dissolving agarose gel powder (Bioline.com, BIO-41025) in 1x 
Tris-acetate-EDTA (TAE) buffer (Formedium, UK). Agarose gel concentration to be prepared 
depends on the size of bands (restriction digest products) needed to be separated. The smaller 
the band size, the higher the agarose concentration. The restriction digest products size of the 
plasmid DNA used (pGL3 Basic, pRL Null and pGL3 BRE Luciferase) range from 100 - 5000 
bp. Therefore, 1% agarose was prepared by mixing 1 g of agarose powder in 100 mL of 1x TAE 
buffer in a microwavable flask. The mixture was microwaved for about 3 minutes until the 
agarose is completely dissolved but not over boiled. 
 
In the meantime, the gel tray was prepared by applying masking tapes on both ends of the tray 
and placing a well comb in place. The agarose solution was left to cool slightly before 10 µL 
GelRed (Cambridge Bioscience) was added and carefully swirled around to mix. The GelRed 
was added to allow the visualisation of DNA under ultraviolet (UV) light. The agarose solution 
was then carefully poured into the prepared gel tray to avoid bubbles formation. Any bubble 
formed was pushed away from the well comb or towards the edges of the gel with a pipette tip. 
The newly poured gel was left to set at room temperature for 20 – 30 minutes until it has 
completely solidified. 
 
2.0 µL of 6x DNA loading dye (Thermo Scientific, UK) was added to 10 µL of each restriction 
digest samples. The loading dye provides a visible dye that helps with gel loading and it 
contains a high percentage of glycerol that increases the density of the DNA causing it to settle 
to the bottom of the gel well. Once the gel has solidified, the masking tapes and gel comb were 
carefully removed and the gel was placed into the gel box (electrophoresis unit). The gel box 
was then filled with 1x TAE buffer until the gel is covered. 
 
10 µL of each molecular weight ladders, GeneRuler 100bp Plus and GeneRuler 1kb DNA 
ladder (Thermo Scientific, UK) was carefully loaded into the first and last lanes of the gel, 
respectively. Then 10 µL of each of the digest samples and loading dye mixture was loaded 
into the additional wells of the gel. The gel was run at 100V for 1.5 hours. Power was turned 
off and the electrodes were disconnected form the power source at the end of the run. The gel 
was then carefully removed from the gel box and brought to a UV DNA visualisation machine, 
GelDoc-It 310 imaging system (UVP, LLC Upland, CA) to visualise the DNA fragments. 
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4.3.8     Cell culture 
Undifferentiated hESCs (H9) and hiPSCs (SB-Ad2 and SB-Ad3) were maintained in Matrigel 
(growth factor reduced) plates with mTeSRTM1 medium (STEMCELL Technologies, 
Cambridge, MA) at 37°C and 5% CO2. hESCs and hiPSCs were passaged every 3 – 4 days 
using EDTA 0.02% (Versene, Lonza, Belgium) at 1:3 - 1:6 ratios. All cells used were between 
passages 18 and 50. 
 
The hESCs and hiPSCs were initially disassociated by incubating with Accutase for 5 minutes. 
The disassociated cells were collected and centrifuged at 500 g for 5 minutes. The cell pellet 
was resuspended into 2 ml of media and cell count was performed prior to replating cells at the 
density of 1.3 x 105 cells into each well of a Matrigel coated 24 well plate. 10 µM ROCK 
inhibitor was added to the medium during the seeding process one day before transfection.  
 
The remaining disassociated cells from the seeding process were lysed using BL + TG buffer 
and kept in -20°C for RNA extraction and qPCR. Transfected cells were cultured in mTeSRTM1 
medium alone or mTeSRTM1 supplemented with BMP4 (25 ng/mL) or BMP4 and SB431542 
(10 µM) with daily medium change for three days. Cell extracts were prepared 48 hours after 
transfection using a passive lysis buffer (PLB).  
 
a. Plating the pluripotent stem cells (hESCs) for optimisation experiment at day 0 
mTeSR™1 medium was aspirated from the wells of a 6-well plate and the wells were gently 
washed with 2.0 mL DPBS. DPBS was aspirated and 1.0 mL of warm StemPro Accutase (Gibco, 
UK) was added to each well. The cells in accutase were incubated for 2 – 3 minutes at 37°C 
before 3.0 mL cold mTeSR™1 medium per well was added to inactivate the accutase. Cells 
were collected from all wells and transferred into a 50 mL falcon tube. The cells were then 
centrifuged at 1000 rpm for 3 minutes. Supernatant was removed and cell pellet was 
resuspended in 5.0 mL of warm mTeSR™1 medium. The cells were count counted using a 
haemocytometer. 
 
Cells were plated at the density of 1.7 - 2 x 104 cells/cm2 (Leung et al. 2013) in each well of 6 
well Matrigel coated plate with mTeSR™1 media supplemented with ROCK inhibitor at 
concentration of 10 µM. Fresh mTeSR™1 medium without ROCK inhibitor was used to replace 
the used medium on days 1 and 2. The remaining cells were collected as day 0 cell pellet for 
qPCR. Three wells were assigned for every experimental group and two additional wells of 
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cells were plated for qPCR cell sample at day 3. The mTeSR™1 medium was changed every 
day until day 3. At day 3, the mTeSR™1 medium was replaced with serum free differentiation 
medium for Group 5 (as described in Chapter 3), which is supplemented with BMP4, RA and 
EGF. The SB435142 (10 µM) was gradually added to the differentiation media starting on day 
3 for 1, 2 or 3 days. Schematic representation of the differentiation protocols and the list of 
media used during the differentiation induction period are as shown in Figure 4.3. 
 
 
Figure 4.3 : Schematic outline of the optimisation experiment. 
 
b. Replating cells onto collagen-IV coated plates at day 9 
Differentiating cells were disassociated using TrypleExpress and replated at 1.7 x 104 cells/cm2. 
Cells were then supplemented with corneal differentiation medium (CnT-PR 2D Diff.) and 10% 
serum for the next 11 days. The culture medium was supplemented with 10 µM ROCK inhibitor 
for 2 days after replating. Cell morphology, gene and protein expression as well as colony 
forming efficiency were assessed at day 0, 9 and 20. The experiment was set for three technical 
and biological replicates for each group. 
 
4.3.9 qRT-PCR of endogenous BMP pathway related genes 
RNA extraction was performed on the lysed hESCs and hiPSCs samples. The extracted RNA 
was then measured and reverse transcription process was carried out to convert 1 µg of extracted 
RNA into cDNA following the method described in the instruction manual (Promega). The 
resulting cDNA was kept in -20°C. Endogenous BMP pathway genes expression in the hESCs 
and hiPSCs was assessed by qRT-PCR. The primers used are listed in the following table. 
 
Gene Name Primer sequence (5’ – 3’) 
BMP4 F: TCCACAGCACTGGTCTTGAG 
R: GGGATGTTCTCCAGATGTTCTT 
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GAPDH  F: TGCACCACCAACTGCTTAGC 
R: GGCATGGACTGTGGTCATGAG 
TGFβ1 F: GGCCAGATCCTGTCCAAGC 
R: GTGGGTTTCCACCATTAGCAC 
BMPR1A F: TGAAATCAGACTCCGACCAGA 
R: TGGCAAAGCAATGTCCATTAGTT 
BMPR1B 
 
F: TCACAAGACGTTTCCTGCGT 
R: TGGTGGTGGCATTTACAACG 
BMPR2 
 
F: GGCAGCAGTATACAGATAGGTGA 
R: ACTGCCCTGTTACTGCCATT 
JUNB F: ACGACTCATACACAGCTACGG 
R: GCTCGGTTTCAGGAGTTTGTAGT 
ID1 F: CTGCTCTACGACATGAACGG 
R: GAAGGTCCCTGATGTAGTCGAT 
ID2 
 
F: CCGTGAGGTCCGTTAGGAAA 
R: TGAGCTTGGAGTAGCAGTCG 
SMAD1 F: CCGAGCGGCTCAACCC 
R: AGTTTGAAGTCCAGAAGAGTAGAA 
SMAD5 F: CGGCCGAGCTGCTAATAAAG 
R: TTCATTGGGTCAAGTCTCGC 
SMAD6 F: CTGAGCCGAGAGAAAGAGCC 
R: AAAATGCAGTCCACCGATGC 
SMAD 9 
 
F: CACACAACGCCACCTATCCT 
R: ACTGGTCGAAAGTCTGAGTGT 
STAT1 
 
F: TTACAAACCTCAAGCCAGCC 
R: TGATAGGCAGTAACACGGGG 
SOX4 F: GAGTTCCCGGACTACTGCAC 
R: GCGCCCTTCAGTAGGTGAAA 
OCT4 
 
F: TCTCGCCCCCTCCAGGT 
R: GCCCCACTCCAACCTGG 
ECADHERIN 
 
F: CCCGGGACAACGTTTATTAC 
R: GCTGGCTCAAGTCAAAGTCC  
CK8 F: GATCGCCACCTACAGGAAGCT 
101 
 
 R: ACTCATGTTCTGCATCCCAGACT 
CK3 
 
F: CGTACAGCTGCTGAGAATGA 
R: CTGAGCGATATCCTCATACT 
ΔNp63 
 
F: CTGGAAAACAATGCCCAGAC 
R: GGGTGATGGAGAGAGAGCAT 
Table 4.1 : List of primers used for qRT-PCR. 
4.3.10 Plasmid transfection by lipofection 
Lipofectamine 3000 reagent (Thermo Fisher, Waltham, MA, USA) was used for plasmids 
transfections. For plasmid lipofection, 500 ng plasmids (pGL3-Basic (Promega, Madison, WI, 
USA) or pGL3 BRE Luciferase (Addgene, Massachusetts USA)) were used to transfect the 
cells in each well of 24 well plate following manufacturer’s recommendations. The optimum 
volume of Lipofectamine 3000 for plasmid transfection was initially determined for all cell 
lines and the optimised volume was used for all transfection procedures thereafter. Cells that 
were transfected with empty vector (pGL3-Basic) or BMP reporter (pGL3-BRE-Luciferase) 
were co-transfected with empty renilla vector (pRL-Null) (Promega, Madison, WI, USA).   
 
4.3.11    Dual luciferase assay    
Luciferase activities were evaluated with a Dual-Luciferase Assay System (Promega, Madison, 
WI, USA) according to the manufacturer’s recommendations using Varioskan LUX plate 
reader (Thermo Fisher Scientific, Waltham, MA USA). Cells were washed with DPBS before 
being lysed with appropriate volume of passive lysis buffer (PLB). Lysed cells were kept at -
20°C before the luciferase activity being analysed. Background luminescence was determined 
using untransfected cells and the background readings were then subtracted from the resulting 
luminescence readings before being normalised using the renilla luminescence and presented 
as relative luminescence unit (RLU). 
 
4.3.12     Colony forming efficiency (CFE) assay 
CFE assays were carried out on differentiating cells at days 9 and 20 of the differentiation period 
using the protocols described earlier in Chapter 2, subsections 2.2.16 and 2.2.17. 
 
4.3.13     Immunocytochemistry (ICC) 
ICC assessments were carried out on cells at days 9 and 20 following the protocols detailed 
earlier in Chapters 2, section 2.6. 
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4.4    Results 
4.4.1    Endogenous BMP pathway related gene expressions 
Quantitative RT-PCR analysis indicated that the non-responsive hiPSCs line (SB-Ad3) 
expressed higher levels of endogenous BMP4 gene when compared to the responsive hiPSCs 
line, SB-Ad2 (Figure 4.4). However, the expression of key receptors (BMPR1A, BMPR1B and 
BMPR2) and receptor activated SMAD1 and SMAD5 genes that mediate BMP signalling were 
significantly lower in SB-Ad3, suggesting that this hiPSCs line may be characterised by a much 
lower level of endogenous BMP activity. This was further corroborated by low expression of 
two BMP target genes, ID1 and JUNB which were also expressed at a significantly lower level 
in the non-responsive hiPSCs line when compared to the responsive line (Figure 4.4). Since 
both the receptor and effector genes expressions are lower, addition of exogenous BMP4 alone 
(as in our differentiation methods), is unlikely to activate the pathway in the SB-Ad3 hiPSCs 
line. To confirm this further, a BMP reporter plasmid was transfected in both hiPSCs lines 
causing a transient overexpression of BMP specific gene, ID1 (Korchynskyi and Dijke 2002). 
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Figure 4.4 : Relative gene expressions for endogenous BMP pathway in the hiPSCs 
normalised against hESCs, H9. Data presented as mean ± SEM, n = 3. * - significantly 
different compared to the other cell line.  
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4.4.2 Plasmid DNA concentration 
Purchased plasmids were transformed and and cultured overnight. The purified plasmid DNA 
(from mini bacterial culture) concentration and purity was assessed using Nanodrop 2000 
spectrophotometer. The concentrations of each purified plasmid DNA are listed in the table 
below. 
 
 Plasmid name Concentration (ng/µL) 
1 pGL3-Basic 436.8 
2 pRL-Null 550.2 
3 pGL3-BRE-Luciferase 348.5 
Table 4.2 : Concentrations of the purified plasmid DNA resulting from the mini 
bacterial culture. 
 
4.4.3  Gel electrophoresis  
In order to verify that the purified plasmid DNA obtained from the bacterial culture are having 
the right size, each of the DNA was linearised by digestion using Nhe1 enzyme and the digest 
product was then run through gel electrophoresis together with respective control plasmid 
(purchased stock). The gel analysis showed that each of the plasmid DNA was having the right 
size which is the same as the control. In case of pGL3-BRE-Luciferase DNA, this DNA was 
cut at two locations by the Nhe1 enzyme. Therefore, the digestion products consist of two 
different sized DNA fragments. The bigger fragment contained the backbone (4852 bp) of the 
plasmid and the smaller fragment (90 bp) contained the BMP reporter segment (Addgene). 
Those different sized DNA fragments can be visualised in the gel electrophoresis images shown 
in Figure 4.5.  The analysed plasmids DNA were then transfected into the pluripotent as well 
as differentiating hESCs and hiPSCs before the luciferase activity of the transfected cells were 
assessed using dual luciferase assay system (Promega).  
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Figure 4.5 : Gel electrophoresis analysis of the plasmid DNA. Lower exposure photo (A) 
and over exposed photo (B) showing the smallest DNA fragment (red circles) that contains 
the ID1 reporter. L1 - GeneRuler 1kb DNA ladder, C1 – control for pRL-Null, C2 – 
control for pGL3-Basic, L2 - GeneRuler 100bp Plus ladder. 
 
4.4.4 Effects of BMP4 and SB431542 on BMP reporter levels in H9, SB-Ad2 and SB-Ad3 
The BMP reporter analyses showed that the SB-Ad3 hiPSCs line has a significantly lower 
endogenous BMP signalling activity compared to SB-Ad2 hiPSCs (Figure 4.6A). 
Supplementation of BMP4 improved the BMP activity of both hiPSCs lines; however SB-Ad3 
hiPSCs still lagged behind SB-Ad2 (Figure 4.6B). Interestingly, combined supplementation of 
BMP4 and SB431542 did not have a significant impact on SB-Ad2; but it significantly 
increased the BMP activity of SB-Ad3 hiPSCs to the same level as SB-Ad2 (Figure 4.6B). 
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Figure 4.6 : Endogenous BMP pathway activity levels normalised to hESCs (H9)(A), and 
the changes in BMP pathway activity following BMP4 and SB431542 supplementations 
(B) on the hiPSCs. Data presented as mean ± SEM of the relative luminescence unit (RLU). 
n = 3. 
4.4.5    Early stage, day 0 – 9 of optimised differentiation 
The differentiation optimisation experiment had SB-Ad3 hiPSCs from groups 1 and 5 either 
unexposed or exposed to the TGFβ inhibitor, SB431542 for 1, 2 or 3 days (Figure 4.3). Gene 
expression assessment on day 9 of the optimised differentiation experiment revealed that all the 
hiPSCs (SB-Ad3) groups have decreased pluripotency, which can be seen in the low OCT4 
expression. Ectodermal, epithelial and putative limbal stem cell markers (BMP4, CK8, 
ECADHERIN and ΔNp63) expressions were significantly higher in G5 subgroup that was 
unexposed or exposed to SB431542 for only 1 day, compared with the control G1 with no 
SB431542 exposure. This finding is in agreement with our earlier results described in Chapter 
3, where G5 of SB-Ad3 showed significantly high z scores at day 9 (Figure 3.17). Additionally, 
the terminally differentiated corneal epithelium cytokeratin, CK3 gene expression was also 
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significantly higher in all the G5 subgroups at this early stage compared to the control (Figure 
4.7).  
 
Figure 4.7 : Relative expression of pluripotency and corneal epithelial differentiation 
related genes on day 9. Data presented as mean ± SEM, n = 3.* - significantly different 
compared to G1 0d. 
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Figure 4.8 showed that during the early differentiation stage, the percentage of ΔNp63 positive 
cells was higher in G5 subgroups with or without SB431542 exposure than their respective G1 
subgroup.  
 
 
Figure 4.8 : Immunocytochemistry analysis indicating the percentage of ΔNp63 positive 
cells at day 9 (A). Data presented as mean ± SEM. n = 3. Representative 
immunofluorescence micrographs from G5 1d (B, C and D).  
 
Although the gene expression and percentage of positive cells for ΔNp63 were improved with 
SB431542 exposure especially in the G5 subgroups that were supplemented with BMP4, RA 
and EGF, the colony forming ability of all groups at this early stage were still very low 
compared to the adult human limbal epithelial cells as shown in Figure 4.9. This suggests that 
cells at this early differentiation stage might need more cues and/or longer differentiation 
periods. 
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Figure 4.9 : Colony forming efficiency at day 9. Data presented as mean ± SEM. n = 3. * 
- significantly different compared to G1 0d. 
 
4.4.6    Late stage, day 10 – 20 of optimised differentiation 
At day 20, quantitative RT-PCR analysis indicated the putative limbal stem cells markers, 
(ABCG2 and ΔNp63) and differentiated corneal epithelial marker (CK3) were expressed at a 
significantly high level compared to the control, G1 0d. It was also found that the highest 
expression of ΔNp63 was in G5 subgroups treated for 2 or 3 days with SB431542 (Figure 4.10). 
Similarly, ICC assessment revealed that those two subgroups had higher percentage of ΔNp63 
positive cells (Figure 4.11 A).  
 
Interestingly, only the subgroups treated for 3 days with SB431542 showed significantly 
enhanced CFE ability compared to control G1(untreated with SB431542 and assigned as G1 
0d) (Figure 4.12), suggesting that continuous inhibition of TGFβ pathway for 3 days with this 
specific TGFβ inhibitor can result in differentiation of non-responsive hiPSCs lines to corneal 
epithelial progenitor cells. Most importantly, three days SB431542 exposure to G5 cells had 
significantly improved the CFE to a similar levels observed in adult human limbal epithelial 
cell.  This CFE result is in agreement with the gene and protein expressions shown by the 
putative limbal stem cell marker (ΔNp63) as shown in Figures 4.10 and 4.11. 
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Figure 4.10 : Relative gene expressions at day 20. Data presented as mean ± SEM. n = 3. 
* - significantly different compared to G1 0d. 
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Figure 4.11 : Immunocytochemistry analysis indicating the percentage of ΔNp63 positive 
cells at day 20 (A). Data presented as mean ± SEM. n = 3. Representative 
immunofluorescence micrographs from G5 2d (B, C and D). 
 
Figure 4.12 : Colony forming efficiency at day 20. Data presented as mean ± SEM. n = 3. 
* - significantly different from G1 0d. # - significantly different from the other group. ns 
= no significant difference. 
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4.5    Discussion 
These experiments indicated that the non-responsive hiPSCs line (SB-Ad3) had a low level of 
BMP signalling activity which was caused by low expression of receptors and effectors. BMP 
reporter analysis confirmed that the two hiPSCs lines have significantly different levels of 
endogenous BMP signalling activity.  
 
In view of improving the corneal differentiation potential of the less responsive line (SB-Ad3), 
we tried to alter the co-SMAD/r-SMAD interaction in the cytoplasm. Since co-SMAD (SMAD4) 
is shared between TGFβ and BMP pathways (Wrana and Attisano 2000, Wu and Hill 2009), 
we focused on the inhibition of the TGFβ pathway which should lead to an increase in the 
availability of SMAD4 for the BMP pathway. SB431542, a TGFβ inhibitor which was reported 
to be able to change the balance of co-SMAD (SMAD4) into the favour of BMP signalling (Du 
et al. 2014, Li et al. 2015) to activate the BMP pathway was used in the optimisation experiment. 
Our findings showed that the less responsive hiPSCs (SB-Ad3) line, but not the other needed 
BMP4 supplementation together with SB431542 (10 µM) for BMP signalling improvement. 
This closely corroborates those published by Shalom-Feuerstein et al. (Shalom-Feuerstein et al. 
2013) who reported improved differentiation of hiPSCs to epidermal lineages upon addition of 
SB431542 to BMP4 and ascorbic acid supplemented media. 
 
A different small molecule TGFβ inhibitor (SB505124) was used by Mikhailova et al. to guide 
differentiation of hiPSCs to corneal epithelial progenitor cells in combination with a Wnt 
inhibitor (IWP-2) and FGF (Mikhailova et al. 2014). Earlier in our setting, we also used 
SB505124 with IWP-2 alone or in combination with BMP4. Although SB505124 was reported 
to be more selective than SB431542 in TGFβ inhibition (DaCosta Byfield et al. 2004), 
SB505124 supplementation in our setting failed to enhance the expression of key epithelial and 
LSC markers, suggesting cross-talk between signalling pathways is essential for guiding 
differentiation of pluripotent stem cells to corneal epithelial lineages. Based on the BMP 
signalling improvement brought about by SB431542 supplementation on SB-Ad3 cells, we next 
planned for an optimisation experiment to improve the less responsive hiPSCs differentiation 
towards corneal epithelial like cells. 
 
Since our earlier setting showed that supplementation of BMP4, RA and EGF (G5 protocols) 
to hESCs (H9) had directed the cells’ differentiation towards corneal epithelial lineages, the G1 
and G5 protocols were used in the optimisation experiment using SB431542 on SB-Ad3 hiPSCs. 
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As expected, SB431542 exposure on SB-Ad3 hiPSCs that were supplemented with BMP4, RA 
and EGF (G5) resulted in a significant improvement of corneal epithelial lineages 
differentiation as evident in the related genes and proteins expression analyses as early as the 
first differentiation window at day 9. However, PAX6 gene was not assesses at this early stage 
in our setting. This would be a highly beneficial assessment to be carried out in future 
experiments, enabling the correlation between eye development and corneal epithelial 
differentiation genes to be understood.  
 
This outcome also showed that the hiPSCs, especially SB-Ad3 line has an impaired directed 
differentiation that is ‘repairable’ when compared to the hESCs (Narsinh et al. 2011a). Similar 
to other published studies in the field, the optimised differentiation protocols generated a high 
percentage of CK3, CK12 and ΔNp63 positive cells in the first window of differentiation. In 
addition, the findings also indicated that the hiPSCs derived epithelial progenitors from the 
optimised protocols (G5 3d) have a high colony forming efficiency which was comparable to 
the limbal epithelial progenitor cells (Figure 4.12) obtained from adult human limbal ring.  
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CHAPTER 5. TRANSLATIONAL STUDY USING GFP EXPRESSING 
DIFFERENTIATED HESCS AND HIPSCS IN ANIMAL MODEL OF 
LSCD 
 
5.1 Introduction 
In vitro studies are useful to define cell fates; however these cannot provide insight into cells’ 
capacity to engraft and function in vivo. This capacity is vital to measure the potential of the 
aforementioned cells in future clinical settings. Thus translational studies using suitable animal 
models of the target disease have to be performed prior to clinical trials (Trounson & DeWitt 
2016). 
 
Green fluorescent protein (GFP) has been used to tag cells for various experimental applications 
without changing the cells’ original function and characteristics (Tsien 1998). GFP reporters 
have been introduced into stem cells for stable GFP expression (Zaragosi et al. 2007) before 
the cells are differentiated towards the desired lineages. The GFP reporters thus provide an 
optimal in vivo detection especially for post transplantation observations.  
 
This chapter aims to summarise the results obtained from transplantations of the GFP labelled 
hESCs and hiPSCs derived corneal epithelial-like cells in a mouse model of limbal stem cell 
deficiency (LSCD). LSCD induction in the mouse was established by Dr. Alex Shortt, Harley 
Buck and Pervinder Sagoo in the University College London and is going to be described in a 
publication currently being prepared (Sagoo et al. under preparation). 
 
5.2 Specific Objectives 
The specific objectives of this chapter are: 
- to generate GFP expressing hESCs (H9) and hiPSCs (SB-Ad3) stable cell lines by 
nucleofection. 
- to differentiate the GFP expressing cells to corneal epithelial cells using the best protocol from 
earlier experiments. 
- to assess the engraftment of the transplanted cells on the cornea of LSCD mice. 
 
5.3 Materials and Methods 
5.3.1 Cell culture 
Undifferentiated hESCs (H9) and hiPSCs (SB-Ad3) were maintained in BD MatrigelTM (growth 
factor reduced) plates with mTeSRTM1 medium (STEMCELL Technologies, Cambridge, MA) 
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at 37°C and 5% CO2. hESC and hiPSC were passaged every 3 – 4 days by using 0.02% EDTA 
(Versene, Belgium) at 1:3 - 1:6 ratios. All cells used were between passages 30 and 50. 
 
a. Heat-shock transformation of competent bacteria and plasmid purification 
Standard heat-shock transformation of chemically competent bacteria was carried out using a 
cell transformation kit by Dr. Chunbo Yang in Lako’s group. Briefly competent cells were 
mixed with GFP expressing plasmid DNA, pmaxGFP (3.49 kb) in a falcon tube and incubated 
on ice for 20-30 minutes. Then, the tube was placed into a 42°C water bath for 30-60 seconds 
before being transferred back on ice for 2 minutes. 500 µL Lennox L Broth Base (LB) medium 
was added to the mixture and allowed to grow in a 37°C shaking incubator for 45 minutes. The 
transformed cells were then plated onto a 10 cm LB agar plate containing kanamycin and 
incubated overnight at 37°C. A single colony of the bacterial culture were then picked and 
inoculated into 10 mL LB medium and grown for about 8 hours with vigorous shaking (~300 
rpm).  
 
Qiagen plasmids purification maxi kit was used for purification of advanced transfection-grade 
plasmid DNA. The obtained plasmids were concentrated by centrifuging the plasmids vial at 
high speed for 15 minutes at 4°C. Then the supernatant was carefully removed and the plasmids 
pellet was air-dried in a tissue culture hood for about 10 minutes. The pellet was resuspended 
in filtered water and the plasmids/DNA concentration was measured using a Nanodrop 2000 
machine. The plasmid DNA was linearised via restriction endonuclease (PvuI) reaction and 
DNA pellet was kept in -20°C before nucleofection. 
 
b. H9 and SB-Ad3 cells’ nucleofection with pmaxGFP plasmid using a Nucleofector® Kit 
(Amaxa GmbH) 
H9 and SB-Ad3 cells at 1 or 2 days after passage were used for nucleofection. The pmaxGFP 
plasmid’s GFP expression is driven by cytomegalovirus (CMV) promoter that allows stable 
transgene expression (http://www.amaxa.com, Barrow et al. 2006). The entire supplement 
containing 2.0 μg pmaxGFP was added to the Nucleofector® Solution together with 10 µM 
ROCK inhibitor (Y27632). Fresh cell culture plates were prepared by filling in 2.0 mL of 
mTeSRTM1 supplemented with ROCK inhibitor (10 µM) for each well of a 6-well plate coated 
with Matrigel and plates were pre-incubated/equilibrated in a humidified incubator at 37°C and 
5% CO2. 
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Prior to nucleofection, the cells were detached from Matrigel plates by incubation with StemPro 
Accutase for 5 minutes at 37°C. The cells were dissociated into a single cell suspension by 
pipetting the suspension carefully up and down for 4 – 6 times. Medium was added to inactivate 
the Accutase. 2 x 106 of the detached cells were counted and aliquoted before being centrifuged 
at 115 g for 3 minutes at room temperature. The cell pellets were carefully resuspended in 100 
µL room temperature Nucleofector® Solution supplemented with 10 µM ROCK inhibitor per 
sample. Then 100 µL of cell suspension was combined with 5.0 µg DNA and transferred into a 
special cuvette. Nucleofector® Program B16 was selected and started after the cuvette with 
cell/DNA suspension was inserted into the Nucleofector® cuvette holder. 
 
500 µL of pre-incubated culture medium was added to the cuvette and the sample was 
immediately gently transferred into the prepared 6-well plate using the supplied pipette. 
Transfected cell plates were kept in an incubator at 37°C in 5% CO2. The GFP expression for 
each cells were checked after 24 hours using a fluorescence microscope. Puromycin (0.5 µg/mL) 
was added to the culture medium to select the GFP expressing cells. Individual colonies of GFP 
expressing cells were then carefully picked and expanded separately. Colonies with the 
brightest GFP intensity were chosen and expanded for the experiment. Expanded GFP cells 
were kept as frozen stocks for future experiments in a -80°C freezer and nitrogen storage tank. 
 
c. Differentiation of H9 GFP and SB-Ad3 GFP 
The H9 GFP and SB-Ad3 GFP cells were cultured using the best protocols described in the 
previous Chapter 4. Medium change was performed daily. On day 9, the cells were replated on 
collagen-IV coated plates or human amniotic membrane (HAM). The medium was changed to 
CnT-PR 2D Diff. with 10% FBS and 10 µM ROCK inhibitor for the first 2 days, and then 
without ROCK inhibitor thereafter up to day 20. Bright field and fluorescence images were 
taken at days 3, 9 and 20 and CFE assays were set on days 9 and 20. Assessment of cell 
pluripotency (OCT4), putative limbal stem cell markers (ΔNp63, ABCG2), ECADHERIN, CK8, 
CK3 and BMP4 expression was carried out by qRT-PCR on days 0, 9 and 20. The experiment 
was set for three technical and biological replicates for each group. 
 
d. Human amniotic membrane (HAM) preparation 
Human amniotic membrane (HAM) was removed from -80°C freezer and allowed to thaw on 
ice. A 6-well plate needed for washing the HAM later was prepared with 2 wells filled with 2 
mL DPBS supplemented with 1% Pen-strep and 1 well filled with 2.0 mL CnT-Prime medium. 
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The lid of a 6-well plate was taken and placed "top-side up" on bench. HAM was unwrapped 
from its nitrocellulose backing using a straight tying (non-toothed) forceps, and placed flat on 
the top surface of 6-well plate lid, epithelial side up. One edge of the HAM was held with a 
non-toothed forceps with left hand (for right-handed operator). Whilst still holding the HAM 
with the forceps in the left hand to maintain its orientation, the HAM was sequentially washed 
in the pre-prepared 6-well plate - ie. twice in DPBS and once in CnT-PR 2D Diff. medium. 
HAM constructs were prepared by stretching out and trimming the HAM, followed by wrapping 
and trapping its edges between two sterile glass coverslips. The prepared HAM was then 
transferred into a 6-well plate and immersed with CnT-PR 2D Diff. medium until needed. 
 
 
Figure 5.1 : HAM preparation process. HAM was carefully held using a forceps and 
placed on top of a glass coverslip (A). The HAM was wrapped around a coverslip and the 
edges were secured using another coverslip and the whole construct was placed in a well 
of 6-well plate (B). 
 
e. Differentiating cells on HAM 
Dissociated cells on day 9 were kept as single cells suspension after being counted. The cells 
were then carefully seeded at twice the density of the initial monolayer experiment onto the 
prepared HAM. 60 – 90 minutes were allowed for the cells to settle down well on the membrane 
with minimal amount of medium before more medium was added to the well. Medium change 
was done four days after seeding to allow enough time for the cells to attach to the membrane. 
Medium change was carried out every 2 days up to day 20. 
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f. Differentiating cells on temperature responsive plates 
Normal and temperature responsive plates were coated with collagen-IV at least a day before 
being used and were washed briefly with DPBS before being seeded with cells.  Temperature 
responsive plate filled with medium was warmed up (37°C) to assist cell attachment after 
seeding. Cells were seeded onto the plates at a predetermined cell density (1.5 or twice the 
density of the initial monolayer experiment). Cells were kept in CnT-PR 2D Diff. medium 
supplemented with 10% PBS for another 11 days before transplant. 
 
5.3.2 Mouse LSCD model for transplant     
The animal work was carried out by Dr. Alex Shortt’s research team (at University College 
London). The induction of LSCD was performed on the eye of male adult (5 – 8 weeks old) 
immunocompromised NOD/SCID/gamma (NSG) recipient mice by exposing the corneal and 
limbal epithelium of the left eye for 3 minutes to either 20% ethanol or mitomycin-C (10 
mg/mL). The right eye was kept as a normal control. Inflammatory reaction of the mice cornea 
was treated with 1% prednisolone eye drops for 24 hours prior to transplantation. LSCD 
induction via ethanol was carried out 30 minutes or 24 hours prior to transplant whilst the 
mitomycin-C inductions were done 3 weeks earlier. LSCD mice were deeply sedated and were 
treated under optimal surgical procedure during the transplant. Mice were kept on a warm 
‘surgical surface’ during surgery and an antibiotic (chloramphenicol) cream was applied on the 
mouse eyelids after being sutured shut. 
 
5.3.3 Transplantation of differentiated cells onto LSCD mouse model’s cornea 
The differentiated cells were detached using various methods (as detailed in Table 5.1) from 
culture plates/surfaces before being applied to the denuded recipient mouse cornea. One well 
of 6-well plate of cells were used per mouse cornea. The transplanted cells were protected by 
gently closing the eyelids over the graft with minimal abrasion of the surface. The eyelids were 
then sutured shut. Post operatively the sutures were removed at day 4 and the eye opened and 
examined using a fluorescent stereomicroscope. Serial imaging was performed to observe the 
number and distribution of GFP expressing engrafted cells on the cornea. Animals were 
sacrificed after 3 weeks and eyes with engrafted GFP cells were fixed in paraformaldehyde. 
 
a. First transplant  
Five mice were used for the transplant. GFP cells were differentiated on normal or temperature 
sensitive plates until day 20. Prior to transplant, the cells were disassociated either by using a 
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low temperature treatment together with a special membrane for temperature sensitive plate, or 
using dispase which was inactivated by CnT-Prime + 10% FBS medium before being 
centrifuged and resuspended in a minimal volume (20 µL) of the CnT-Prime + 10% FBS 
medium. The cells were transplanted as cells suspension on the mice cornea and later covered 
with fibrin gel. The mice eyelids were carefully closed and sutured shut. 
  
b. Second transplant  
Three mice were used for the second transplant. The GFP cells were either differentiated on 
HAM or normal plates until day 20. On the transplant day, cells were incubated for 2.5 hours 
in CnT-Prime medium + 10% FBS + Rock inhibitor (10 µM) at 37°C before disassociation. 
The cells were either scrapped off from plates or from the HAM using a cell scrapper and kept 
in CnT-Prime medium + 10% FBS + Rock inhibitor (10 µM) prior to transplant. The cells were 
transplanted as cells sheet onto the mice cornea and either Matrigel or amniotic membrane was 
applied on top to secure the transplanted cells on the cornea. The mice eyelids were then 
carefully closed and sutured shut.  
 
c. Third transplant  
Four mice were used in the last transplant attempt. LSCD was induced using 20% ethanol 24 
hours before transplant and the corneal inflammation was treated with 1% prednisolone eye 
drops after the LSCD induction. Differentiated GFP cells at day 9, day 20 and day 27 were 
cultured on normal plates. The cells were scrapped off from plates and kept in CnT-Prime 
medium + 10% FBS + Rock inhibitor (10 µM) until transplantation. The cells were transplanted 
as cells sheet and air drying step was applied to promote cells’ attachment on the cornea. The 
mice eyelids were then carefully closed and sutured shut. 
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5.4 Results 
5.4.1 Differentiation of GFP expressing cells 
The GFP cells showed similar morphology as their respective non-GFP cell lines based on the 
microscopy observations as shown in Figures 5.2 and 5.3. 
 
Figure 5.2 : Representative photomicrographs showing the morphology of differentiating 
GFP hESCs (H9) at day 3 (A), day 9 (B), day 14 on collagen-IV coated plate (C), day 14 
on HAM (D), and on collagen-IV coated temperature sensitive plate (E). 
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Figure 5.3 : Representative photomicrographs showing the morphology of differentiating 
GFP hiPSCs (SB-Ad3) at day 3 (A), day 9 (B), day 14 on collagen-IV coated plate (C), day 
14 on HAM (D), and day 14 on collagen-IV coated temperature sensitive plate (E). 
 
Quantitative RT-PCR analyses showed that both GFP expressing hESCs and hiPSCs had 
similar early gene expression changes as those in earlier experiments on the respective non-
GFP cells (Figure 5.4). Pluripotency gene (OCT4) was down regulated and the epithelial (CK8, 
ECADHERIN), non-neural ectoderm (BMP4), putative limbal stem cells (ΔNp63) and 
differentiated corneal epithelial cell (CK3) markers were all upregulated during early 
differentiation window in both cell lines.  
 
Colonies of the GFP cells amongst the feeder cells in CFE assays were easily detected and 
observed using a fluorescence microscope.  However, similar to the earlier experiment on non-
GFP cells, the colony forming potential for the GFP cells (except H9 GFP) were still 
significantly low compared to the limbal cell (Figure 5.5) at this early differentiation stage (day 
9). 
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Figure 5.4 : Gene expression assessments for both hESCs (H9) and hiPSCs (SB-Ad3) at 
day 9 compared to day 0. Data presented as fold change mean ± SEM of day 9 expression 
compared to day 0 (fold change). n = 3. 
 
Figure 5.5 : CFE of hESCs (H9) and hiPSCs (SB-Ad3) at day 9 of differentiation compared 
to adult limbal epithelial cells. Data presented as mean ± SEM. n = 3. # - significantly 
different compared to the limbal cells, ns – no significant different compared to the limbal 
epithelial cells. 
 
During the late differentiation period, both cell lines showed continued differentiation towards 
corneal epithelial lineages as observed in the fold changes of the related genes (Figure 5.6). 
Pluripotency marker OCT4 was downregulated whilst the putative limbal stem cells (ΔNp63, 
ABCG2) and differentiated corneal epithelial cells (CK3) markers were upregulated. The colony 
forming ability of both GFP cell lines at this late differentiation stage was improved and was 
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significantly higher (i.e: H9 GFP cells) compared to that of adult human limbal epithelial cells 
(Figure 5.7). 
 
 
Figure 5.6 : Gene expression assessments at day 20 compared to day 0 of both hESCs (H9) 
and hiPSCs (SB-Ad3). Data presented as log of fold change mean ± SEM of day 20 
expression compared to day 0 (fold change). n = 3. 
 
 
Figure 5.7 : CFE of hESCs (H9) and hiPSCs (SB-Ad3) at day 20 compared to adult limbal 
epithelial cells. Data presented as mean ± SEM. n = 3. # - significantly different compared 
to limbal epithelial cells. 
 
5.4.2 Transplant outcomes 
GFP expressing hESCs and hiPSCs were cultured and differentiated in Lako’s lab at Newcastle 
University and were brought in a portable incubator to Dr. Shortt’s lab at the Department of 
Immunology, University College London for transplantation into mouse models of LSCD. 
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LSCD mice were contributed and prepared by Dr. Shortt’s research team, who also performed 
all transplantation procedures. The detailed information on the transplantation experiments are 
summarised in Table 5.1 below. 
 
LSCD 
induction 
Transplanted cells’ 
age and preparation 
Culture surface 
and pretransplant 
medium used 
Method 
to secure 
cells on 
cornea 
Outcome  
20 % ethanol. 
LSCD 
induction was 
done 30 
minutes 
before 
transplant. 
1. H9 D20 cells 
scrapped off and 
resuspended as single 
cells/clumps in  25 µL 
medium 
Cold CnT-PR 2D + 
10% FBS, coll-IV 
coated temperature 
sensitive plate 
None No cell 
engrafted 4 days 
post-transplant 
2. SB-Ad3 D20 cells 
treated with dispase, 
inactivated with 
medium, centrifuged 
and resuspended in 30 
µL medium  
Cold CnT-PR 2D + 
10% FBS, coll-IV 
coated temperature 
sensitive plate 
Fibrin 
gel 
No cell 
engrafted 4 days 
post-transplant, 
cornea was 
perforated and 
bleeding 
3. SB-Ad3 D20 cells 
sheet was scrapped off 
and resuspended in 
medium  
Cold CnT-PR 2D + 
10% FBS + 
ROCKi, coll-IV 
coated normal plate  
Matrigel No cell 
engrafted 3 days 
post-transplant 
4. H9 D20 cells sheet 
was scrapped off and 
resuspended in 
medium  
Cold CnT-PR 2D + 
10% FBS + 
ROCKi, coll-IV 
coated normal plate 
Matrigel Some cells were 
engrafted 3 days 
post-transplant 
5. SB-Ad3 D20 cells 
grown on HAM, 
scrapped off as a sheet  
Cold CnT-PR 2D + 
10% FBS + 
ROCKi, HAM 
HAM No cell 
engrafted 3 days 
post-transplant 
Mitomycin C 
(10 mg/mL). 
1. H9 D20 cells 
transferred using 
Cold CnT-PR 2D + 
10% FBS, coll-IV 
None 
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LSCD 
induction was 
done 3 weeks 
before 
transplant. 
temperature sensitive 
plate’s membrane 
coated temperature 
sensitive plate  
No cell 
engrafted 4 days 
post-transplant 
 
2. SB-Ad3 D20 cells 
scrapped off and 
resuspended as single 
cells/clumps in  25 µL 
cold medium 
Cold CnT-PR 2D + 
10% FBS, coll-IV 
coated temperature 
sensitive plate  
Fibrin 
gel 
3. H9 D20 cells treated 
with dispase, 
inactivated with 
medium, centrifuged 
and resuspended in 30 
µL medium 
Cold CnT-PR 2D + 
10% FBS, coll-IV 
coated temperature 
sensitive plate  
Fibrin 
gel 
No cell 
engrafted 4 days 
post-transplant, 
cornea was 
perforated and 
bleeding 
20 % ethanol. 
LSCD 
induction was 
done 24 hours 
before 
transplant, 
1% 
prednisolone 
was used to 
treat 
inflammation
. 
1. H9 D20 cells were 
scrapped off as a sheet 
and resuspended in 
medium  
 
Cold CnT-PR 2D + 
10% FBS + 
ROCKi, coll-IV 
coated normal plate 
Air-
drying 
for 2 
minutes 
A few cells 
engrafted 4 days 
post-transplant, 
cells 
disappeared at 
second follow-
up. 
2. SB-Ad3 D27 cells 
were scrapped off as a 
sheet and resuspended 
in medium   
Cold CnT-PR 2D + 
10% FBS + 
ROCKi, coll-IV 
coated normal plate 
Air-
drying 
for 2 
minutes 
A few cells 
engrafted 4 days 
post-transplant, 
10 days later the 
cells were 
observed near 
the limbus and 
disappeared at 
third follow-up. 
3. H9 D9 cells were 
scrapped off as a sheet 
and resuspended in 
medium  
Cold CnT-PR 2D + 
10% FBS + 
ROCKi, coll-IV 
coated normal plate 
Air-
drying 
for 2 
minutes 
4. SB-Ad3 D9 cells 
were scrapped off as a 
sheet and resuspended 
in medium  
Cold CnT-PR 2D + 
10% FBS + 
ROCKi, coll-IV 
coated normal plate 
Air-
drying 
for 2 
minutes 
No cell 
engrafted 4 days 
post-transplant 
Table 5.1 : Summary table of the transplantation experiments and the outcomes. 
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The cells that were transplanted to the first batch of LSCD mice did not engraft onto the cornea 
as observed 4 days of transplantation.  Enzymatic disassociation (using dispase) resulted in eye 
perforation (Figure 5.8 D). These results brought about the idea of avoiding enzymatic cell 
disassociation, using HAM to differentiate the cells and Matrigel instead of fibrin gel 
application that may improve cell transfer and secure the transplanted cell on the cornea 
respectively, without affecting cells’ viability.  
 
 
Figure 5.8 : First transplant. Differentiated hESCs were disassociated and resuspended 
in a minimal volume of medium (A). An LSCD mouse cornea before transplantation (B). 
A mouse cornea with GFP H9 cells suspension added (C). A 'perforated'/damaged mouse 
cornea during the first follow-up (D). A normal mouse cornea during first follow-up with 
no engrafted GFP cells using bright field (E) and fluorescent (F) exposure at day 4 post-
transplant. 
 
The second transplantation showed that some of the transplanted cells survived for 3 days on 
the mice cornea (Figure 5.9). This slightly improved cells survival might be due to the 
transplantation of cells as a sheet instead of single cells suspension and the use of Matrigel to 
secure the transplanted cells in place.  
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Figure 5.9 : Second transplant. Differentiated hESCs were scraped-off from plates and 
resuspended in a minimal volume of medium (A). A mouse cornea before transplantation 
(B). A mouse cornea with GFP H9 cells sheet added (C). A mouse cornea during first 
follow-up with small number of engrafted GFP H9 cells during first follow-up at day 3 
post-transplant (D). Engrafted GFP H9 cells at a higher magnification (E). 
 
The third transplant attempt resulted in a better cells’ survival of up to 14 days. Unfortunately, 
those cells did not engraft and they disappeared from the mouse cornea after 14 days (Figure 
5.10). This improvement might have resulted from the various differentiation time points when 
the cells were transplanted as well as the treated corneal inflammation prior to transplantation. 
Since there is no successful cell engraftment and proliferation observed on the mice cornea, 
histological analysis post-transplant was not carried out.  
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Figure 5.10 : Third transplant. Differentiated hiPSCs were scraped-off from plates and 
resuspended in a minimal volume of medium (A). A mouse cornea without GFP cells 
before transplantation (B). A mouse cornea with GFP SB-Ad3 cells sheet added (C), at a 
higher magnification (D). A mouse cornea during first follow-up with a small number of 
engrafted GFP H9 cells at day 4 post-transplant (E).  
 
5.5 Discussion 
Translational studies are important as a downstream pre-clinical step to provide important clues 
for future clinical therapeutic applications. Several animal models of LSCD have been used to 
dissect the potentials of in vitro differentiated stem cells for LSCD treatment as reviewed by 
Sehic and colleagues (Sehic et al. 2015). However, there is still no successful engraftment of 
hiPSCs derived corneal epithelial lineage cells on any LSCD animal model reported to date 
especially for the advancement of cell-based therapy in ocular surface regenerative medicine.    
 
GFP expressing cells were successfully generated using both hESCs (H9) and hiPSCs (SB-Ad3) 
lines via nucleofection of GFP plasmid, enabling the resulting cells to express GFP at all time. 
SB-Ad3 cells were chosen for transplant experiment to compare the engrafment of 
differentiated cells from the optimised (with SB431542 exposure) differentiation protocols with 
the H9 cells differentiated using the initial protocol (G5). The GFP cells maintained their 
pluripotency and similar baseline gene expression profile as the non-GFP cells (data not 
included). This is important as any changes in the cells’ function or characteristics of the cells 
used in transplantation might pose a risk in future clinical setting (O’Callaghan and Daniels 
2011). The GFP cells were successfully differentiated towards corneal epithelium lineages 
using the best and optimised protocols found and reported in the earlier Chapter 3, subsection 
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3.4.3 and Chapter 4, subsection 4.4.6. Those GFP cells could be easily observed during 
differentiation easily handled during transplantation and identified in vivo post-transplant.   
 
Although the GFP cells used for transplant were successfully differentiated towards corneal 
epithelial lineages in vitro, those cells seemed not be able to engraft and proliferate on the 
cornea of LSCD mice after three transplant attempts. The reason behind this failure could be 
multiple and reflect the immaturity of hESCs and hiPSCs derived corneal epithelial cells, the 
location where the cells were transplanted or the unsuitability of the LSCD model.  There are 
several improvements that can be done as part of future work and one of these includes addition 
of a positive control group (primary adult human limbal epithelial stem cells labelled with 
fluorescent dies) which would validate the suitability of LSCD mouse model for transplantation 
of human LSCs  (Meyer-Blazejewska et al. 2011, Cotsarelis et al. 1989).  
 
Another improvement could relate to identification of the most optimal stage for transplantation. 
Our results indicated that hESCs that were differentiated for less than 20 days survived for a 
longer time in the mouse model. This suggests that shorter differentiation period might result 
in a better cell engraftment as reported by some previously published studies (Zhang et al. 2017, 
Brzeszczynska et al. 2014, Cieslar-Pobuda et al. 2016). This improvement might be due to the 
different functional characteristic of the cells at different time point. At the earlier time point 
which corresponds to our early differentiation stage of day 9, the percentage of cells expressing 
putative limbal stem cells marker, ΔNp63 was higher when compared to day 20. In contrast, 
hiPSCs at later differentiation time point (eg: day 27) were found to also have a good survival 
following transplant. This suggests that the hiPSCs needed a longer differentiation time to 
transform into corneal epithelial-like cells, as previously reported by others (Hayashi et al. 2012, 
Mikhailova et al. 2014, Hayashi et al. 2016)  
 
Another cells selection step that was not carried out in our setting is cell sorting. Since our 
differentiation protocols did not yield pure population of corneal epithelial-like cells or limbal 
epithelial stem cells, sorting the differentiated cells to select the cell of interest (e.g. ΔNp63 or 
CK3/12 positive) could result in a better cell engraftment, as reported by previous studies 
(Zhang et al. 2017, Hayashi et al. 2016). The differentiated cells could also be further 
functionally defined by inducing its stratification via air-lifting method (Zieske et al. 2004) 
during the second stage of differentiation prior to transplant.  
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Rho kinase inhibitor (ROCKi) (Y27632) was used during cell seeding and replating process as 
well as in the final incubation step before the second and third transplant in our setting. The 
supplementation of ROCKi in the media during cell seeding and replating has improved the 
cells’ survival as the seeded and replated cells were disassociated into single cell suspension, a 
condition less favoured by pluripotent stem cells (Watanabe et al. 2007). Initial incubation of 
cells with ROCKi prior to transplant were also aimed to improve cell differentiation stability, 
survival and engraftment post-transplant, as the ROCKi was reported to be beneficial in limbal 
stem cell maintenance and corneal wound healing (Miyashita et al. 2013, Sun et al. 2015). Thus, 
another transplant outcome improvement strategy could include ROCKi to be applied to the 
cornea following the transplantation of differentiated cells (Okumura et al. 2013). 
 
Transplanting cells as a sheet instead of cells suspension onto the mice cornea resulted in an 
improved cells’ survival in our experiment. A few earlier studies also reported the advantages 
of the cell-sheet transplantation in human (Umemoto et al. 2013, Burillon et al. 2012) and rabbit 
LSCD model (Burillon et al. 2012, Gomes et al. 2010, Nishida et al. 2004) but no study was 
reported in mouse models. Another avenue that is closely related and might have a huge impact 
in the translational study is the use of biomaterials to assist cells differentiation, cells transfer 
as well as engraftment. The use of silk, hydrogels or extra cellular matrix substrates as cells’ 
coating or surface for cells culture amongst others have been reported to have improved the 
outcome of cells differentiation, transfer and transplant (Wu et al. 2014, Krishnan et al. 2014, 
Meyer-Blazejewska et al. 2011, Gu et al. 2009). Thus this might be one of various ways to 
enhance the transplant outcome especially but not restricted for our setting. 
 
In conclusion our data indicates that further improvement strategies are still needed with regard 
to length of differentiation, cell harvest prior to transplantation, mode of delivery and 
improvement of the animal model management in order to establish whether hESCs and hiPSCs 
derived epithelial cells can engraft into LSCD corneas as well as establishing proof-of-principle 
for the cells’ therapeutic application in the future (ISSCR Guideline 2016). 
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CHAPTER 6. OVERALL DISCUSSIONS AND CONCLUSION 
 
6.1 Overall Discussion 
The main aim of this project was to define efficient protocols that results in robust hESCs and 
hiPSCs differentiation to corneal epithelial progenitors. Then we tested the engraftment of 
hESCs and hiPSCs derived corneal epithelial-like cells in a mouse model of total LSCD. As 
described in Chapter 3, our project has successfully defined a feeder-free, two-step protocol 
that results in differentiation of hESCs to corneal epithelial cells with colony forming ability 
similar to limbal epithelial progenitors within 20 days. The differentiation protocol included 
growth factors and morphogens (BMP4, RA, EGF) that have been shown to promote non-neural 
ectodermal commitment (Gambaro et al. 2006, Aberdam et al. 2007, Metallo et al. 2008, Li and 
Lu 2005) and proliferation of corneal epithelial progenitors (Hayashi et al. 2016, Zhang et al. 
2017). In the second window of differentiation, we attempted to replicate the LSCs niche by 
coating the cell culture surfaces with collagen-IV which was reported to be the key component 
of peripheral cornea basement membrane and limbal stroma (Schlotzer-Schrehardt et al. 2007, 
Blazejewska et al. 2009) and supplementing the cells with a defined media (CnT-PR 2D Diff) 
which is used to maintain the ex vivo expansion of human corneal epithelial progenitors 
(Gonzalez et al. 2017). 
 
Our differentiated hESCs express high ECADHERIN, CK8, ΔNp63, ABCG2, and CK3 markers 
which represent epithelial, corneal and limbal epithelial stem cells as well as terminally 
differentiated corneal epithelium respectively (Mikhailova et al. 2014, Zhang et al. 2017). In 
line with the advancement of stem cell therapy using autologous cells, our hESCs derived 
protocol was tested on two hiPSCs lines that have different transcriptional and epigenetic 
profiles. The differences in the hiPSCs lines resulted in different responses towards the two-
step hESCs derived protocol. One of the hiPSC lines (SB-Ad2) responded well to the 
differentiation protocol, but the second one (SB-Ad3) still needed further adjustment for its 
corneal epithelial lineages differentiation. This discrepancy was especially observed in the 
colony forming ability of the differentiated SB-Ad3 hiPSCs, rather than gene expression 
analysis. 
 
In Chapter 4 we assessed the differences in the two hiPSCs lines using quantitative PCR. Our 
quantitative PCR results were confirmed by a BMP reporter analysis which showed that the 
two hiPSCs lines have significantly different levels of endogenous BMP signalling activity. 
The non-responsive hiPSCs line (SB-Ad3) had a low level of BMP signalling activity which 
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was caused by low expression of receptors and effectors, which might have reduced its potential 
in corneal epithelial differentiation (Shalom- Feuerstein et al. 2012). Our findings on gene 
expression and signalling differences between the two hiPSCs lines used might have influenced 
the cells’ differentiation potential and caused the different responses towards the hESCs derived 
protocol (Ortmann and Vallier 2017). To improve the corneal differentiation potential of the 
less responsive hiPSCs line (SB-Ad3), we tried to optimise the differentiation method by 
altering the co-SMAD/r-SMAD interaction in the cytoplasm. Since co-SMAD (SMAD4) is 
shared between the TGFβ and BMP pathways (Wrana & Attisano 2000, Wu & Hill 2009), we 
focused on the inhibition of the TGFβ pathway which should lead to an increase in the 
availability of SMAD4 for the BMP pathway (Figure 6.1). To achieve this, a selective TGFβ 
inhibitor, SB431542 which has been reported to drive differentiation away from neuro-
ectoderm (Li et al. 2015) and to activate the BMP pathway (Zhu et al. 2016) was used. 
 
 
Figure 6.1 : Schematic of TGFβ and BMP pathways interrelation (blue), showing the ID1 
gene used as a BMP pathway reporter and the action point for SB431542 inhibiting the 
TGFβ pathway. Adapted from www.cellsignal.com. 
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The TGFβ pathway inhibition by SB431542 in our optimised protocol has increased the BMP 
pathway activity in the SB-Ad3 hiPSCs line and improved the corneal epithelial lineages 
differentiation as evident in the related genes and proteins expression analyses as early as the 
first differentiation window at day 9 (Figure 6.2). The optimised protocols also led to the 
generation of hiPSCs derived epithelial progenitor cells with higher colony forming efficiency, 
which was comparable to limbal epithelial progenitor cells obtained from adult human cornea 
(Figure 6.3).   
 
Figure 6.2 : The effects of BMP4 and SB431542 in stem cell differentiation pathways 
toward neural and non-neural lineages.  
 
 
Figure 6.3 : Graphical summary of the optimised differentiation protocol. 
 
We then used GFP expressing cells generated from both hESCs (H9) and hiPSCs (SB-Ad3) 
lines to test the engraftment of hiPSC derived corneal epithelial cells into a model of total LSCD. 
Our three transplant attempts using LSCD mice model indicated that SB-Ad3 hiPSCs at later 
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and H9 cells at earlier than day 20 of differentiation survived longer on the cornea. This suggests 
that shorter or longer differentiation period might result in a better cell engraftment as reported 
by most previous studies (Zhang et al. 2017, Brzeszczynska et al. 2014, Cieslar-Pobuda et al. 
2016, Hayashi et al. 2016). This improvement might also be due to the different functional 
characteristic of the cells at the time of transplantation and the use of ROCKi in the cell 
preparation for transplants that survived the longest.  
 
At the earlier time point which corresponds to our early differentiation stage of day 9, the 
percentage of cells expressing putative limbal stem cells marker, ΔNp63 was higher compared 
to day 20. This might indicate that at this early stage the differentiating cells were still having 
high proliferative potential, thus could survive longer on the cornea and limbus. In contrast, the 
cells transplanted at a later stage (day 27) might be more stable and have differentiated into 
CK3 or CK12 expressing cells that could also survive better on the corneal surface. Application 
of ROCKi (Y27632) to incubate the cells both before being harvested and before being 
transplanted have also improved the cells survival post-transplant as it was reported to be used 
in the maintenance of limbal epithelial progenitors (Miyashita et al. 2013). A recent report also 
found that the use of ROCKi with keratinocyte growth factor (KGF) could improve the gene 
expression in limbal epithelial cells (LECs) to be more similar to corneal epithelial cells (CECs) 
in vivo (Yoshihara et al. 2017). It would also be useful to try using ROCKi as an eye-drop for 
the mice after the transplant to improve the engraftment of the transplanted cells (Okumura et 
al. 2013). 
 
Transplanting cells as a sheet instead of cells suspension onto the mice cornea also resulted in 
an improved cells’ survival in our experiment, where the transplanted cells from the sheet were 
detected for 3 to 14 days longer after transplant. A few earlier studies also reported the 
advantages of the cell-sheet transplantation in human (Umemoto et al. 2013, Burillon et al. 
2012) and rabbit LSCD model (Burillon et al. 2012, Gomes et al. 2010, Nishida et al. 2004) but 
this has not been done using mice. Despite less favourable transplantation outcomes obtained, 
our translational experiments suggest that transplantation of sorted cells sheet and cells from 
earlier or later differentiation time points might be able to improve the outcome.  
 
Together our data suggest that establishment of a simple monolayer differentiation protocol for 
generation of corneal epithelial lineages that could be applied to both hESCs and hiPSCs. 
Despite the presence of corneal epithelial progenitor and cell markers and a comparable CFE 
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to human limbal epithelial cells, we were unable to maintain engraftment of these cells into the 
corneal of mice with total LSCD for longer than 14 days, which can be due to immaturity of 
corneal epithelial cells derived from hESC and hiPSC, the suitability of animal model or 
damage that may be caused to the cells during cell harvesting from tissue culture plates and 
transplantation into an inflamed cornea. 
 
6.2 Implications of the Project and Recommendations for Future Work 
Our project established a two-step protocol for corneal epithelial lineage differentiation in 
hESCs that could be applied to any responsive hiPSCs line. The differentiation protocol 
includes the supplementation of well-known ectodermal morphogens namely, RA, BMP4 and 
RA during differentiation induction period and adaptation towards corneal and limbal epithelial 
with collagen-IV coated surface with corneal epithelial specific medium, CnT-PR 2D. A non-
responsive hiPSCs line with low BMP pathway activity could still make use of the protocol 
with an additional exposure of SB431542 in the first differentiation stage. Therefore, 
endogenous BMP pathway activity assessment of any candidate hiPSCs is important to help in 
the selection of appropriate differentiation protocol to be used.  
 
Looking back at our transplant outcomes, there are many aspects that could be improved. The 
corneal inflammation that resulted following LSCD induction could be improved by the 
application of a steroid (e.g. prednisolone) or a special anti-inflammatory protein such as TNF-
α–stimulated protein 6 (TSG-6) (Oh et al. 2010). This is particularly important as any on-going 
inflammatory reactions on the mice cornea might affect the engraftment efficiency (Polack 
1965, Elliot 1971). Since we were lacking of positive control cells that should have been used 
for the transplant as the differentiated cells, fluorescence-labelled or magnetic nanoparticles 
loaded human LSCs could be used in future transplant. This will allow better assessment (via 
fluorescence miscoscopy and magneto-motive Optical Coherence Tomography (OCT) 
respectively) of the in vivo engraftment of LSCs and suitability of the animal model (Boadi et 
al. 2015). Differentiated cells at different stages of differentiation, for example cells at day 9, 
14, 20, 27 and 40 could be used for the transplant in future. This will allow the assessment of 
the best differentiation stage at which the cells’ have the characteristics that help their 
engraftment on the cornea. Another aspect is the cells’ harvesting step, which could be 
optimised so that cell sheet could be made available for transplant rather than cells in suspension.  
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Another way of getting cell as a sheet is by modifying the cell culture method, where air-lifting 
techniques might be beneficial (Shimazaki et al. 2007) to promote stratification and produce 
more functional cells for transplant. Application of supplements that could improve cell 
survival such as ROCKi (Watanabe et al. 2007) could also be continued both during cell 
preparation prior to transplant, and as a post-transplant treatment. The post-transplanted LSCD 
mice eyeballs could also be collected and assessed by immunohistochemistry for any attached 
human cells on the cornea. 
 
Although our protocol involves a short differentiation duration using monolayer culture method, 
it could only produce a mixture of differentiated cells. Therefore, the differentiated cells needed 
to be sorted prior to transplant to ensure better transplantation outcome in the future. Although 
markers that are specific for LSCs have yet to be defined (Chee et al 2006, Budak et al 2005), 
some markers (ABCG2 and ABCB5) that were reported to be useful in selecting stem cells 
from human limbal epithelial cells (Shaharuddin et al. 2017) could be used in the cell sorting. 
Those LCSs markers could be used together with a negative cell surface marker for corneal 
epithelial stem cells, connexin 43 (Cx43) (Chen et al. 2006) so that only the cells of interest are 
selected. In addition to the use of cell surface markers for sorting, generation of ΔNp63-GFP 
labelled hESCs and hiPSCs (Collin et al. 2016) prior the differentiation process could also be 
useful to help in the selection of ΔNp63 expressing differentiated cells.  The cell sorting could 
be done at an earlier (day 9) or a later time point than day 20 to capture most of the differentiated 
cells for transplant. Additionally, the sorted cells could also be expanded either on collagen-IV 
coated plates or on a compatible biological scaffold. This step could improve cell transfer and 
transplant outcome.  
 
As GFP expressing hESCs and hiPSCs were used in out translational study, verification on 
those GFP expressing cells’ genomic stability would be a way to assess their safety for future 
clinical applications. In term of the hESCs and hiPSCs derived corneal epithelial-like cells, 
there are further studies that needed to be carried out to lay out their similarities and differences 
compared to the adult human corneal epithelial or limbal stem cells (eg: RNA-seq studies). This 
would enable both typing (in terms of understanding cell composition within each 
differentiation culture or in adult cornea) as well as gene expression for each progenitor 
subpopulation derived from the differentiation protocol. 
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